{"id": 42866225, "time": "2025-01-08 00:13:40", "headline": "Dogecoin To Drop Further? Top Analyst Foresees Possible Dump For Memecoin If Bitcoin Doesn't Bounce", "summary": "A popular analyst\u00a0anticipated a further decline in Dogecoin\u2019s (CRYPTO: DOGE) value on Tuesday amid the broader slump that rocked the cryptocurrency market.", "symbols": ["BTCUSD", "DOGEUSD", "ETHUSD", "TRXUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/25/01/42866225/notable-crypto-analyst-foresees-potential-dip-in-dogecoin-price", "tags": []}
{"id": 42866455, "time": "2025-01-08 01:17:27", "headline": "Reported Earlier, Amazon Web Services Unveils $5B Infrastructure Region In Thailand, Supporting GDP Growth and Innovation", "summary": "", "symbols": ["AMZN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42866455/reported-earlier-amazon-web-services-unveils-5b-infrastructure-region-in-thailand-supporting-gdp-gro", "tags": []}
{"id": 42866458, "time": "2025-01-08 01:18:49", "headline": "Jim Cramer Sees Buying Opportunity In Nvidia But Attributes 6% Fall To 'Too Much Hot Money' After Jensen Huang's CES Keynote", "summary": "Jim Cramer urged investors to consider NVIDIA Corp.&#39;s  recent stock decline as a buying opportunity, despite the company&#39;s shares falling 6.22% on Tuesday following CEO Jensen Huang&#39;s CES 2025 keynote presentation.", "symbols": ["NVDA"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/markets/equities/25/01/42866458/jim-cramer-cites-nvidias-6-decline-to-too-much-hot-money-after-jensen-huangs-ces-keynote-watch-this-data-to-buy-stock-much-lower", "tags": ["management"]}
{"id": 42866503, "time": "2025-01-08 01:19:57", "headline": "Reported Earlier, Accenture Acquires Percipient's Digital Twin Platform To Drive Core Banking Modernization", "summary": "", "symbols": ["ACN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/01/42866503/reported-earlier-accenture-acquires-percipients-digital-twin-platform-to-drive-core-banking-moderniz", "tags": ["merger"]}
{"id": 42866514, "time": "2025-01-08 01:24:20", "headline": "HIVE Digital December 2024 Production Results: Bitcoin Holdings Reach $261.9M With HODL 2,805 BTC (+64.6% YoY), Mining Capacity Hits 5.5 EH/s", "summary": "", "symbols": ["HIVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42866514/hive-digital-december-2024-production-results-bitcoin-holdings-reach-261-9m-with-hodl-2-805-btc-64-6", "tags": []}
{"id": 42866518, "time": "2025-01-08 01:26:19", "headline": "SpaceX's Starship 7th Test Flight Delayed, Says Elon Musk: Now Expected Next Week", "summary": "SpaceX CEO Elon Musk said on Tuesday that the company&#39;s ambitious\u00a0Starship launch vehicle&#39;s next flight test is now expected to be\u00a0next week, later than his previous timeline of Jan. 10.", "symbols": [], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/general/space/25/01/42866518/spacexs-starship-7th-test-flight-delayed-says-elon-musk-now-expected-next-week", "tags": ["management"]}
{"id": 42866539, "time": "2025-01-08 01:28:40", "headline": "Sam Altman's Sister Files Lawsuit Against OpenAI CEO Alleging Sexual Abuse \u2014 Family Respond: 'Deeply Hurtful And Entirely Untrue'", "summary": "OpenAI CEO Sam Altman faces allegation from his sister Ann Altman, who filed a lawsuit Monday claiming sexual abuse, amid multiple legal challenges confronting the artificial intelligence company.", "symbols": ["MSFT", "NVDA", "SFTBY", "TSLA"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/25/01/42866539/sam-altmans-sister-files-lawsuit-against-openai-ceo-alleging-sexual-abuse", "tags": ["legal", "management"]}
{"id": 42866552, "time": "2025-01-08 01:32:30", "headline": "Reported Earlier, Quantum Computing Secures $100M In Private Placement To Fuel Quantum And Photonics Advancements", "summary": "", "symbols": ["QUBT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42866552/reported-earlier-quantum-computing-secures-100m-in-private-placement-to-fuel-quantum-and-photonics-a", "tags": ["offering"]}
{"id": 42866708, "time": "2025-01-08 01:52:14", "headline": "Reported Earlier, Canaan's Avalon Mini 3 And Nano 3S: Eco-Friendly Bitcoin Mining Devices Unveiled At CES 2025", "summary": "", "symbols": ["CAN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42866708/reported-earlier-canaans-avalon-mini-3-and-nano-3s-eco-friendly-bitcoin-mining-devices-unveiled-at-c", "tags": []}
{"id": 42866711, "time": "2025-01-08 01:54:53", "headline": "Reported Earlier, Kimbell Royalty Partners Prices $149M Upsized Public Offering Of 10M Common Units At $14.90/Unit", "summary": "", "symbols": ["KRP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42866711/reported-earlier-kimbell-royalty-partners-prices-149m-upsized-public-offering-of-10m-common-units-at", "tags": ["offering"]}
{"id": 42866717, "time": "2025-01-08 01:58:23", "headline": "Reported Earlier, Goodyear Divests Dunlop Brand For $701M To Sumitomo, Retains Motorcycle Tire Rights In Europe", "summary": "", "symbols": ["GT", "SMTUF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/01/42866717/reported-earlier-goodyear-divests-dunlop-brand-for-701m-to-sumitomo-retains-motorcycle-tire-rights-i", "tags": []}
{"id": 42866742, "time": "2025-01-08 02:01:45", "headline": "Germany Factory Orders (MoM) For November -5.4% Vs. -0.3% Est.; -1.5% Prior", "summary": "", "symbols": ["EWG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/01/42866742/germany-factory-orders-mom-for-november-5-4-vs-0-3-est-1-5-prior", "tags": []}
{"id": 42866744, "time": "2025-01-08 02:02:05", "headline": "Germany Retail Sales (MoM) For November -0.6% Vs. 0.5% Est.; -1.5% Prior", "summary": "", "symbols": ["EWG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/01/42866744/germany-retail-sales-mom-for-november-0-6-vs-0-5-est-1-5-prior", "tags": []}
{"id": 42866751, "time": "2025-01-08 02:04:15", "headline": "Reported Earlier, Micron Strengthens Semiconductor Ecosystem With $7B Singapore HBM Facility", "summary": "", "symbols": ["MU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42866751/reported-earlier-micron-strengthens-semiconductor-ecosystem-with-7b-singapore-hbm-facility", "tags": []}
{"id": 42867044, "time": "2025-01-08 02:22:00", "headline": "Galapagos Plans Spin-Off Of \u20ac2.45B New Entity SpinCo, To Build A Pipeline Of Transformational Medicines", "summary": "", "symbols": ["GLPG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42867044/galapagos-plans-spin-off-of-2-45b-new-entity-spinco-to-build-a-pipeline-of-transformational-medicine", "tags": []}
{"id": 42867084, "time": "2025-01-08 02:32:10", "headline": "Shell Projects Mixed Q4 2024 Results With LNG Volumes Between 6.8 And 7.2 MT, Citing Seasonality And Maintenance Impacts", "summary": "", "symbols": ["SHEL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42867084/shell-projects-mixed-q4-2024-results-with-lng-volumes-between-6-8-and-7-2-mt-citing-seasonality-and", "tags": ["earnings"]}
{"id": 42867098, "time": "2025-01-08 02:41:21", "headline": "Reported Earlier, Himax And AUO Unveil Next-Generation AmLED Automotive Display Platform At CES 2025", "summary": "", "symbols": ["HIMX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42867098/reported-earlier-himax-and-auo-unveil-next-generation-amled-automotive-display-platform-at-ces-2025", "tags": []}
{"id": 42867099, "time": "2025-01-08 02:41:45", "headline": "UniFirst, Acuity Brands And 3 Stocks To Watch Heading Into Wednesday", "summary": "U.S. stock futures up, UniFirst, Cal-Maine, Acuity Brands, AAR Corp, PriceSmart expected to report earnings.", "symbols": ["AIR", "AYI", "CALM", "PSMT", "UNF"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/markets/25/01/42867099/unifirst-acuity-brands-and-3-stocks-to-watch-heading-into-wednesday", "tags": ["earnings"]}
{"id": 42867168, "time": "2025-01-08 02:50:43", "headline": "Nvidia's Jensen Huang Said Something That Has All Quantum Computing Stocks Tumbling: QUBT And RGTI Down 13%, IONQ Down 11%", "summary": "Nvidia collaborates with nearly every quantum computing company worldwide, extending their CUDA platform to quantum applications", "symbols": ["IONQ", "NVDA", "QBTS", "QUBT", "RGTI"], "source": "benzinga", "author": "Pooja Rajkumari", "url": "https://www.benzinga.com/markets/equities/25/01/42867168/nvidias-jensen-huang-said-something-that-has-all-quantum-computing-stocks-tumbling-qubt-and-rgti-down-13-ionq-down-11", "tags": []}
{"id": 42867184, "time": "2025-01-08 02:53:40", "headline": "Yield Curve Normalization, Cheap Valuation, EPS Growth To Boost Banks In 2025: Truist Initiates Coverage On These 14 Regional Names", "summary": "Truist Securities initiated coverage on 24 stocks anticipating earnings and loan growth, steeper yield curve, and ample capital for expansion.", "symbols": ["ALLY", "AXP", "BAC", "BK", "C", "CFG", "CMA", "COF", "DFS", "FCNCA", "FITB", "HBAN", "JPM", "KEY", "MTB", "NTRS", "PNC", "RF", "SCHW", "STT", "SYF", "USB", "WFC", "WTFC"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/general/market-summary/25/01/42867184/yield-curve-normalization-cheap-valuation-eps-growth-to-boost-banks-in-2025-truist-initiates-coverage-on-these-14-regional-names", "tags": ["analyst_init", "earnings"]}
{"id": 42867216, "time": "2025-01-08 03:00:13", "headline": "Citigroup Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts", "summary": " ", "symbols": ["C"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/01/42867216/citigroup-gears-up-for-q4-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts", "tags": ["guidance"]}
{"id": 42867218, "time": "2025-01-08 03:00:16", "headline": "Reported Earlier, Plains All American Expands Crude Oil Footprint With $670M Acquisitions, Boosts Distribution Quarterly By 20%", "summary": "", "symbols": ["PAA", "PAGP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42867218/reported-earlier-plains-all-american-expands-crude-oil-footprint-with-670m-acquisitions-boosts-distr", "tags": []}
{"id": 42867233, "time": "2025-01-08 03:01:35", "headline": "Reported Earlier, Marcus & Millichap Secures $174M In Financing For 348-Unit New Jersey Multifamily Asset", "summary": "", "symbols": ["MMI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42867233/reported-earlier-marcus-millichap-secures-174m-in-financing-for-348-unit-new-jersey-multifamily-asse", "tags": []}
{"id": 42867248, "time": "2025-01-08 03:04:41", "headline": "Reported Earlier, Intel Introduces ACU U310 And Whole-Vehicle Platform To Accelerate EV And SDV Development", "summary": "", "symbols": ["INTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42867248/reported-earlier-intel-introduces-acu-u310-and-whole-vehicle-platform-to-accelerate-ev-and-sdv-devel", "tags": []}
{"id": 42867252, "time": "2025-01-08 03:05:59", "headline": "xAI's Grok Chatbot To Be Integrated Into Tesla Vehicles 'Soon,' Says Elon Musk", "summary": "Tesla CEO Elon Musk said that Grok chatbot, created by his AI startup xAI, is going to be integrated into Tesla vehicles &#34;soon.&#34;", "symbols": ["TSLA"], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/tech/25/01/42867252/xais-grok-chatbot-to-be-integrated-into-tesla-vehicles-soon-says-elon-musk", "tags": ["management"]}
{"id": 42867366, "time": "2025-01-08 03:27:43", "headline": "Clarivate Announced The Release Of The Twelfth Annual Drugs To Watch Report, A Trusted Guide To The Therapies Poised To Redefine The Future Of Healthcare", "summary": "", "symbols": ["CLVT"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/25/01/42867366/clarivate-announced-the-release-of-the-twelfth-annual-drugs-to-watch-report-a-trusted-guide-to-the-t", "tags": []}
{"id": 42867398, "time": "2025-01-08 03:32:08", "headline": "Earnings Scheduled For January 8, 2025", "summary": " ", "symbols": ["ACI", "ANGO", "AYI", "FC", "GBX", "HELE", "JEF", "MSM", "PCYO", "PENG", "PSMT", "SAR", "SMPL", "UNF"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/01/42867398/earnings-scheduled-for-january-8-2025", "tags": ["earnings"]}
{"id": 42867409, "time": "2025-01-08 03:34:30", "headline": "S&P 500 Down Over 1% As Nvidia, Tesla Tumble: Greed Index Remains In 'Fear' Zone", "summary": " ", "symbols": ["AYI", "META", "NVDA", "PSMT", "TSLA", "UNF"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/01/42867409/sp-500-down-over-1-amid-decline-in-nvidia-fear-greed-index-remains-in-fear-zone", "tags": []}
{"id": 42867453, "time": "2025-01-08 03:39:35", "headline": "Exxon Mobil Sues California AG Over Defamation Of Recycling Efforts, Citing Ties To Competitors", "summary": "Exxon Mobil filed a federal lawsuit Monday against California Attorney General Rob Bonta and environmental groups.", "symbols": ["FMG", "XOM"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/markets/equities/25/01/42867453/exxon-mobil-sues-california-ag-over-defamation-of-recycling-efforts-citing-ties-to-competitors", "tags": ["legal"]}
{"id": 42867568, "time": "2025-01-08 03:55:44", "headline": "OpenAI CEO Sam Altman Predicts AGI Will Arrive During The Trump Presidency, Says CHIPS Act Not Effective Enough", "summary": " ", "symbols": ["DXYZ", "INTC", "MSFT"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/media/25/01/42867568/openai-ceo-sam-altman-predicts-agi-will-arrive-during-the-trump-presidency-says-chips-act-not-effective-enough", "tags": ["management"]}
{"id": 42867611, "time": "2025-01-08 04:04:24", "headline": "Vertical Aerospace Has Taken Another Significant Step In Its Testing Programme By Successfully Completing Its First Piloted Thrustborne Flight Manoeuvres", "summary": "", "symbols": ["EVTL"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/25/01/42867611/vertical-aerospace-has-taken-another-significant-step-in-its-testing-programme-by-successfully-compl", "tags": []}
{"id": 42867663, "time": "2025-01-08 04:18:30", "headline": "Piper Sandler Upgrades Autodesk to Overweight, Raises Price Target to $357", "summary": "", "symbols": ["ADSK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42867663/piper-sandler-upgrades-autodesk-to-overweight-raises-price-target-to-357", "tags": ["analyst_up", "price_target_up"]}
{"id": 42867736, "time": "2025-01-08 04:25:54", "headline": "US Bitcoin Miners Hoard Apex Crypto To Shield Against Rising Expenses \u2014 MARA, Riot Replicate MicroStrategy's Playbook", "summary": "Leading Bitcoin (CRYPTO: BTC) miners in the U.S. are accumulating BTC as a buffer against growing competition and narrowing profit margins.", "symbols": ["BTCUSD", "CLSK", "MARA", "RIOT"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/markets/cryptocurrency/25/01/42867736/us-bitcoin-miners-hoard-apex-crypto-to-shield-against-rising-expenses-mara-riot-replicate-microstrategys-playbook", "tags": []}
{"id": 42867772, "time": "2025-01-08 04:30:12", "headline": "Piper Sandler Maintains Overweight on Bentley Systems, Lowers Price Target to $57", "summary": "", "symbols": ["BSY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42867772/piper-sandler-maintains-overweight-on-bentley-systems-lowers-price-target-to-57", "tags": ["analyst_other", "price_target_down"]}
{"id": 42867778, "time": "2025-01-08 04:31:18", "headline": "Piper Sandler Maintains Overweight on Riskified, Lowers Price Target to $6", "summary": "", "symbols": ["RSKD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42867778/piper-sandler-maintains-overweight-on-riskified-lowers-price-target-to-6", "tags": ["analyst_other", "price_target_down"]}
{"id": 42867792, "time": "2025-01-08 04:35:53", "headline": "Jeff Bezos-Backed Anthropic Set To Become One Of The Top 5 US Startups As It Reportedly Eyes $60 Billion Valuation With $2 Billion Funding Round", "summary": "The AI sector has seen a surge in investment activities, with companies like OpenAI and Elon Musk&#39;s xAI raising substantial funds.", "symbols": ["AMZN", "MSFT", "PLTR"], "source": "benzinga", "author": "Pooja Rajkumari", "url": "https://www.benzinga.com/markets/equities/25/01/42867792/jeff-bezos-backed-anthropic-set-to-become-one-of-the-top-5-us-startups-as-it-reportedly-eyes-60-billion-valuation-with-2-billion-funding-round", "tags": []}
{"id": 42867931, "time": "2025-01-08 04:51:13", "headline": "Pony.ai Announced That It Plans To Provide Driverless Transportation Services At The Hong Kong International Airport (HKIA), One Of The World's Busiest Airports", "summary": "", "symbols": ["PONY"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/25/01/42867931/pony-ai-announced-that-it-plans-to-provide-driverless-transportation-services-at-the-hong-kong-inter", "tags": []}
{"id": 42867939, "time": "2025-01-08 04:53:14", "headline": "Mortgage Rate (GBP) For December 7.50% Vs. 7.59% Prior", "summary": "", "symbols": ["EWU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/01/42867939/mortgage-rate-gbp-for-december-7-50-vs-7-59-prior", "tags": []}
{"id": 42867967, "time": "2025-01-08 05:00:22", "headline": "Elon Musk-Owned X's Rival Bluesky Valued At $700 Million After Explosive Growth Post Trump Victory: Report", "summary": "Bluesky, a social media platform rivaling Elon Musk&#39;s X, is nearing a $700 million valuation following explosive user growth to 25.9 million.", "symbols": ["META"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/25/01/42867967/elon-musks-x-rival-bluesky-is-being-valued-at-700-million-after-explosive-growth-post-trumps-victory-report", "tags": []}
{"id": 42867968, "time": "2025-01-08 05:00:26", "headline": "Stifel Initiates Coverage On Altimmune with Buy Rating, Announces Price Target of $18", "summary": "", "symbols": ["ALT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42867968/stifel-initiates-coverage-on-altimmune-with-buy-rating-announces-price-target-of-18", "tags": ["analyst_init"]}
{"id": 42867849, "time": "2025-01-08 04:48:19", "headline": "Microsoft CEO Satya Nadella Draws Attention To AI-Powered Agriculture For 'Healthier, More Sustainable Harvests' Amid $80 Billion Investment Push", "summary": "Satya Nadella showcased the company&#39;s AI initiatives in agriculture, highlighting a broader push into AI backed by an $80 billion investment.", "symbols": ["MSFT"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/markets/equities/25/01/42867849/microsoft-ceo-satya-nadella-draws-attention-to-ai-powered-agriculture-for-healthier-more-sustainable-harvests-amid-80-billion-investment-push", "tags": ["management"]}
{"id": 42868080, "time": "2025-01-08 05:09:12", "headline": "Stifel Initiates Coverage On Structure Therapeutics with Buy Rating, Announces Price Target of $50", "summary": "", "symbols": ["GPCR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42868080/stifel-initiates-coverage-on-structure-therapeutics-with-buy-rating-announces-price-target-of-50", "tags": ["analyst_init"]}
{"id": 42868104, "time": "2025-01-08 05:16:10", "headline": "Why Cal-Maine Foods Shares Are Trading Higher By 4%; Here Are 20 Stocks Moving Premarket", "summary": " ", "symbols": ["AMPG", "AREB", "BHAT", "BWMN", "CALM", "CDT", "DATS", "DRIO", "EONR", "GRFX", "HOTH", "JBDI", "LAES", "RGTI", "RIME", "SANA", "SLDB", "SRM", "SVMH", "XTIA"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/01/42868104/why-cal-maine-foods-shares-are-trading-higher-by-4-here-are-20-stocks-moving-premarket", "tags": ["why_moving"]}
{"id": 42868296, "time": "2025-01-08 05:25:18", "headline": "111, Inc. Changes ADS Ratio To One ADS Representing Twenty Ordinary Shares, Effective January 24, 2025", "summary": "", "symbols": ["YI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42868296/111-inc-changes-ads-ratio-to-one-ads-representing-twenty-ordinary-shares-effective-january-24-2025", "tags": []}
{"id": 42868340, "time": "2025-01-08 05:36:24", "headline": "Piper Sandler Downgrades Olo to Neutral, Maintains Price Target to $8", "summary": "", "symbols": ["OLO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42868340/piper-sandler-downgrades-olo-to-neutral-maintains-price-target-to-8", "tags": ["analyst_down", "analyst_other"]}
{"id": 42868367, "time": "2025-01-08 05:43:47", "headline": "BMO Capital Downgrades Paycor HCM to Market Perform, Lowers Price Target to $22.5", "summary": "", "symbols": ["PYCR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42868367/bmo-capital-downgrades-paycor-hcm-to-market-perform-lowers-price-target-to-22-5", "tags": ["analyst_down", "price_target_down"]}
{"id": 42868387, "time": "2025-01-08 05:45:27", "headline": "US Stocks To Open Higher As Futures Advance: Christopher Wood Expects Trump's Inflationary Policies To Hurt Market", "summary": "U.S. stock futures advanced on Wednesday after a lower close on Tuesday. Futures of all four major indices rose in premarket trade.", "symbols": ["AIR", "AYI", "BHAT", "CALM", "FUBO", "META", "NVDA", "QQQ", "SPY", "TSLA", "XTIA"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/25/01/42868387/us-stocks-to-open-higher-as-futures-advance-christopher-wood-expects-trumps-inflationary-policies-to-hurt-market", "tags": []}
{"id": 42868619, "time": "2025-01-08 05:50:40", "headline": "B of A Securities Upgrades Ferguson Enterprises to Buy, Raises Price Target to $225", "summary": "", "symbols": ["FERG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42868619/b-of-a-securities-upgrades-ferguson-enterprises-to-buy-raises-price-target-to-225", "tags": ["analyst_up", "price_target_up"]}
{"id": 42868620, "time": "2025-01-08 05:50:58", "headline": "MKBHD Ranks Tesla's FSD Best Among Assisted Driving Systems, Adds 'It's Not Perfect'", "summary": "MKBHD tested assisted-driving modes from multiple automakers to zero in on Tesla full self-driving technology (FSD) as the best among the lot.", "symbols": ["TSLA"], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/tech/25/01/42868620/mkbhd-ranks-teslas-fsd-best-among-assisted-driving-systems-adds-its-not-perfect", "tags": []}
{"id": 42868659, "time": "2025-01-08 05:58:40", "headline": "Telsey Advisory Group Maintains Outperform on Holley, Maintains $4.5 Price Target", "summary": "", "symbols": ["HLLY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42868659/telsey-advisory-group-maintains-outperform-on-holley-maintains-4-5-price-target", "tags": ["analyst_other"]}
{"id": 42868714, "time": "2025-01-08 06:01:25", "headline": "Acuity Brands Q1 2025 Adj. EPS $3.97 Beats $3.89 Estimate, Sales $951.600M Miss $956.175M Estimate", "summary": "", "symbols": ["AYI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/01/42868714/acuity-brands-q1-2025-adj-eps-3-97-beats-3-89-estimate-sales-951-600m-miss-956-175m-estimate", "tags": ["earnings"]}
{"id": 42868715, "time": "2025-01-08 06:01:40", "headline": "TD Cowen Upgrades Sana Biotechnology to Buy", "summary": "", "symbols": ["SANA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42868715/td-cowen-upgrades-sana-biotechnology-to-buy", "tags": ["analyst_up"]}
{"id": 42868752, "time": "2025-01-08 06:02:50", "headline": "N2OFF Received Formal Notification From NASDAQ Stock Market That It Has Been Granted An Additional 180-day Compliance Period, Or Until July 7, 2025, To Regain Compliance With Nasdaq's Minimum $1.00 Bid Price Per Share Requirement", "summary": "", "symbols": ["NITO"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/25/01/42868752/n2off-received-formal-notification-from-nasdaq-stock-market-that-it-has-been-granted-an-additional-1", "tags": []}
{"id": 42868753, "time": "2025-01-08 06:03:41", "headline": "Jefferies Upgrades GE HealthCare Techs to Buy, Raises Price Target to $103", "summary": "", "symbols": ["GEHC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42868753/jefferies-upgrades-ge-healthcare-techs-to-buy-raises-price-target-to-103", "tags": ["analyst_up", "price_target_up"]}
{"id": 42868761, "time": "2025-01-08 06:06:41", "headline": "Citigroup Downgrades Aris Water Solutions to Neutral, Raises Price Target to $26", "summary": "", "symbols": ["ARIS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42868761/citigroup-downgrades-aris-water-solutions-to-neutral-raises-price-target-to-26", "tags": ["analyst_down", "price_target_up"]}
{"id": 42868777, "time": "2025-01-08 06:07:48", "headline": "TransUnion Signed A Definitive Agreement To Acquire U.K.-based Monevo, A Credit Prequalification And Distribution Platform, For An Undisclosed Amount", "summary": "", "symbols": ["TRU"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/m-a/25/01/42868777/transunion-signed-a-definitive-agreement-to-acquire-u-k-based-monevo-a-credit-prequalification-and-d", "tags": ["merger", "contract"]}
{"id": 42868790, "time": "2025-01-08 06:08:37", "headline": "Citigroup Downgrades SolarEdge Technologies to Sell, Lowers Price Target to $9", "summary": "", "symbols": ["SEDG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42868790/citigroup-downgrades-solaredge-technologies-to-sell-lowers-price-target-to-9", "tags": ["analyst_down", "price_target_down"]}
{"id": 42868804, "time": "2025-01-08 06:10:00", "headline": "Deutsche Bank Downgrades Adobe to Hold, Lowers Price Target to $475", "summary": "", "symbols": ["ADBE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42868804/deutsche-bank-downgrades-adobe-to-hold-lowers-price-target-to-475", "tags": ["analyst_down", "price_target_down"]}
{"id": 42868805, "time": "2025-01-08 06:10:06", "headline": "Natural Gas Jumps 4%, Oil Hits $75; Europe Markets Advance - Global Markets Today While Us Slept", "summary": " ", "symbols": ["ADIV", "AGOV", "ASHR", "BBEU", "BOIL", "CQQQ", "DBC", "EEM", "EEMA", "EWU", "EZU", "FLAX", "FXA", "FXB", "FXC", "FXE", "FXI", "GLD", "GSG", "GXC", "IEMG", "IEUR", "IEV", "KDIV", "SPEM", "SPY", "UNG", "USDU", "USO", "UUP", "VGK", "VWO"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/markets/forex/25/01/42868805/natural-gas-jumps-4-oil-hits-75-europe-markets-advance-global-markets-today-while-us-slept", "tags": []}
{"id": 42868815, "time": "2025-01-08 06:11:39", "headline": "Citigroup Upgrades HA Sustainable to Buy, Announces $36 Price Target", "summary": "", "symbols": ["HASI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42868815/citigroup-upgrades-ha-sustainable-to-buy-announces-36-price-target", "tags": ["analyst_up"]}
{"id": 42868816, "time": "2025-01-08 06:11:46", "headline": "Deutsche Bank Upgrades Workday to Buy, Raises Price Target to $300", "summary": "", "symbols": ["WDAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42868816/deutsche-bank-upgrades-workday-to-buy-raises-price-target-to-300", "tags": ["analyst_up", "price_target_up"]}
{"id": 42868860, "time": "2025-01-08 06:13:00", "headline": "Starship's Raptor Engine Needs 'Few Final Touches' Before Reaching Perfection, Says SpaceX CEO Elon Musk", "summary": "SpaceX CEO Elon Musk said on Wednesday that the Raptor engine of its Starship launch vehicle is not perfect and needs a few more changes.", "symbols": [], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/general/space/25/01/42868860/starships-raptor-engine-needs-few-final-touches-before-reaching-perfection-says-spacex-ceo-elon-musk", "tags": ["management"]}
{"id": 42868861, "time": "2025-01-08 06:13:09", "headline": "Deutsche Bank Downgrades Dayforce to Hold, Lowers Price Target to $80", "summary": "", "symbols": ["DAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42868861/deutsche-bank-downgrades-dayforce-to-hold-lowers-price-target-to-80", "tags": ["analyst_down", "price_target_down"]}
{"id": 42868870, "time": "2025-01-08 06:13:34", "headline": "Amazon Web Services Expands In Asia Pacific With $5 Billion Investment In Thailand Region", "summary": "AWS launches Thailand region with $5B investment, creating jobs and contributing to GDP. Plans to add 15 more zones and invest $11B in Georgia.", "symbols": ["AMZN", "FDIS", "ONLN"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/large-cap/25/01/42868870/amazon-web-services-expands-in-asia-pacific-with-5-billion-investment-in-thailand-region", "tags": []}
{"id": 42868879, "time": "2025-01-08 06:14:17", "headline": "UBS Downgrades JELD-WEN Holding to Neutral, Lowers Price Target to $9", "summary": "", "symbols": ["JELD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42868879/ubs-downgrades-jeld-wen-holding-to-neutral-lowers-price-target-to-9", "tags": ["analyst_down", "price_target_down"]}
{"id": 42868935, "time": "2025-01-08 06:15:09", "headline": "Deutsche Bank Downgrades Palo Alto Networks to Hold, Lowers Price Target to $190", "summary": "", "symbols": ["PANW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42868935/deutsche-bank-downgrades-palo-alto-networks-to-hold-lowers-price-target-to-190", "tags": ["analyst_down", "price_target_down"]}
{"id": 42868937, "time": "2025-01-08 06:16:53", "headline": "UBS Downgrades Ferguson Enterprises to Neutral, Announces $193 Price Target", "summary": "", "symbols": ["FERG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42868937/ubs-downgrades-ferguson-enterprises-to-neutral-announces-193-price-target", "tags": ["analyst_down"]}
{"id": 42868939, "time": "2025-01-08 06:17:19", "headline": "Deutsche Bank Upgrades Nasdaq to Buy, Raises Price Target to $98", "summary": "", "symbols": ["NDAQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42868939/deutsche-bank-upgrades-nasdaq-to-buy-raises-price-target-to-98", "tags": ["analyst_up", "price_target_up"]}
{"id": 42868957, "time": "2025-01-08 06:18:38", "headline": "Deutsche Bank Downgrades Federated Hermes to Hold, Lowers Price Target to $43", "summary": "", "symbols": ["FHI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42868957/deutsche-bank-downgrades-federated-hermes-to-hold-lowers-price-target-to-43", "tags": ["analyst_down", "price_target_down"]}
{"id": 42868958, "time": "2025-01-08 06:18:53", "headline": "Yum! Brands Terminates Franchise Agreements With Franchisee Is IS Gida A.S., The Owner And Operator Of All KFC And Pizza Hut Restaurants In Turkey After Failure To Meet Its Standards - Filing", "summary": "", "symbols": ["YUM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42868958/yum-brands-terminates-franchise-agreements-with-franchisee-is-is-gida-a-s-the-owner-and-operator-of", "tags": []}
{"id": 42868959, "time": "2025-01-08 06:18:55", "headline": "UBS Upgrades Advanced Drainage Systems to Buy, Announces $155 Price Target", "summary": "", "symbols": ["WMS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42868959/ubs-upgrades-advanced-drainage-systems-to-buy-announces-155-price-target", "tags": ["analyst_up"]}
{"id": 42869187, "time": "2025-01-08 06:20:29", "headline": "Evercore ISI Group Maintains Outperform on Viper Energy, Raises Price Target to $58", "summary": "", "symbols": ["VNOM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869187/evercore-isi-group-maintains-outperform-on-viper-energy-raises-price-target-to-58", "tags": ["analyst_other", "price_target_up"]}
{"id": 42869189, "time": "2025-01-08 06:20:42", "headline": "UBS Upgrades PulteGroup to Buy, Lowers Price Target to $148", "summary": "", "symbols": ["PHM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869189/ubs-upgrades-pultegroup-to-buy-lowers-price-target-to-148", "tags": ["analyst_up", "price_target_down"]}
{"id": 42869222, "time": "2025-01-08 06:23:19", "headline": "Evercore ISI Group Upgrades Aon to Outperform, Raises Price Target to $420", "summary": "", "symbols": ["AON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869222/evercore-isi-group-upgrades-aon-to-outperform-raises-price-target-to-420", "tags": ["analyst_up", "price_target_up"]}
{"id": 42869250, "time": "2025-01-08 06:25:20", "headline": "Evercore ISI Group Upgrades Globe Life to Outperform, Raises Price Target to $143", "summary": "", "symbols": ["GL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869250/evercore-isi-group-upgrades-globe-life-to-outperform-raises-price-target-to-143", "tags": ["analyst_up", "price_target_up"]}
{"id": 42869251, "time": "2025-01-08 06:26:22", "headline": "Wells Fargo Upgrades RPM Intl to Overweight, Raises Price Target to $140", "summary": "", "symbols": ["RPM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869251/wells-fargo-upgrades-rpm-intl-to-overweight-raises-price-target-to-140", "tags": ["analyst_up", "price_target_up"]}
{"id": 42869190, "time": "2025-01-08 06:21:07", "headline": "Yum! Brands Anticipates Pre-tax Special Charge Of $60M In Q4 Of 2024 Consisting Primarily Of Transaction Costs On German Franchise Acquisition And Termination-Related Costs On Turkey Business", "summary": "", "symbols": ["YUM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/01/42869190/yum-brands-anticipates-pre-tax-special-charge-of-60m-in-q4-of-2024-consisting-primarily-of-transacti", "tags": []}
{"id": 42869257, "time": "2025-01-08 06:27:50", "headline": "Top 3 Tech Stocks That May Rocket Higher This Quarter", "summary": " ", "symbols": ["MCHP", "MNDY", "WDC"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/01/42869257/top-3-tech-stocks-that-may-rocket-higher-this-quarter", "tags": []}
{"id": 42869294, "time": "2025-01-08 06:30:07", "headline": "Goldman Sachs Downgrades American Intl Gr to Neutral, Lowers Price Target to $79", "summary": "", "symbols": ["AIG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869294/goldman-sachs-downgrades-american-intl-gr-to-neutral-lowers-price-target-to-79", "tags": ["analyst_down", "price_target_down"]}
{"id": 42869313, "time": "2025-01-08 06:30:20", "headline": "Chardan Capital Maintains Buy on Immuneering, Maintains $13 Price Target", "summary": "", "symbols": ["IMRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869313/chardan-capital-maintains-buy-on-immuneering-maintains-13-price-target", "tags": ["analyst_other"]}
{"id": 42869327, "time": "2025-01-08 06:32:04", "headline": "AngioDynamics Q2 2025 Adj EPS $(0.04) Beats $(0.11) Estimate, Sales $73.02M Beat $70.93M Estimate", "summary": "", "symbols": ["ANGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/01/42869327/angiodynamics-q2-2025-adj-eps-0-04-beats-0-11-estimate-sales-73-02m-beat-70-93m-estimate", "tags": ["earnings"]}
{"id": 42869329, "time": "2025-01-08 06:32:21", "headline": "Goldman Sachs Downgrades Fidelis Insurance Hldgs to Sell, Lowers Price Target to $16", "summary": "", "symbols": ["FIHL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869329/goldman-sachs-downgrades-fidelis-insurance-hldgs-to-sell-lowers-price-target-to-16", "tags": ["analyst_down", "price_target_down"]}
{"id": 42869332, "time": "2025-01-08 06:32:26", "headline": "Chart Industries Announce Its Signing Of A Global Master Goods And Services Agreement With ExxonMobil", "summary": "", "symbols": ["GTLS", "XOM"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/25/01/42869332/chart-industries-announce-its-signing-of-a-global-master-goods-and-services-agreement-with-exxonmobi", "tags": ["contract"]}
{"id": 42869343, "time": "2025-01-08 06:33:29", "headline": "Needham Maintains Buy on Generation Bio, Lowers Price Target to $8", "summary": "", "symbols": ["GBIO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869343/needham-maintains-buy-on-generation-bio-lowers-price-target-to-8", "tags": ["analyst_other", "price_target_down"]}
{"id": 42869344, "time": "2025-01-08 06:33:30", "headline": "MSC Industrial Direct Co Q1 2025 Adj. EPS $0.86 Beats $0.73 Estimate, Sales $928.500M Beat $904.604M Estimate", "summary": "", "symbols": ["MSM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/01/42869344/msc-industrial-direct-co-q1-2025-adj-eps-0-86-beats-0-73-estimate-sales-928-500m-beat-904-604m-esti", "tags": ["earnings"]}
{"id": 42869345, "time": "2025-01-08 06:33:45", "headline": "Goldman Sachs Upgrades Travelers Companies to Buy, Announces $278 Price Target", "summary": "", "symbols": ["TRV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869345/goldman-sachs-upgrades-travelers-companies-to-buy-announces-278-price-target", "tags": ["analyst_up"]}
{"id": 42869349, "time": "2025-01-08 06:35:11", "headline": "Dell Simplifies PC Lineup With Apple-Like Branding: XPS, Inspiron Brands Are Gone For Good", "summary": "Dell is rebranding its PCs by retiring names like &#34;XPS&#34; and &#34;Inspiron&#34; in favor of a simplified Apple-inspired system \u2014 Dell, Dell Pro, and Dell Pro Max.", "symbols": ["AAPL", "DELL", "MSFT"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/25/01/42869349/dell-takes-bold-step-to-revive-pc-sales-with-simplified-apple-like-brandingxps-and-inspiron-are-gone-for-good", "tags": []}
{"id": 42869360, "time": "2025-01-08 06:35:48", "headline": "MSC Industrial Projects Q2 Fiscal 2025 ADS Decline Of 3%-5% And Operating Margin Of 6.5%-7.5%", "summary": "", "symbols": ["MSM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/01/42869360/msc-industrial-projects-q2-fiscal-2025-ads-decline-of-3-5-and-operating-margin-of-6-5-7-5", "tags": []}
{"id": 42869361, "time": "2025-01-08 06:35:51", "headline": "Morgan Stanley Upgrades NetEase to Overweight, Raises Price Target to $108", "summary": "", "symbols": ["NTES"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869361/morgan-stanley-upgrades-netease-to-overweight-raises-price-target-to-108", "tags": ["analyst_up", "price_target_up"]}
{"id": 42869362, "time": "2025-01-08 06:35:55", "headline": "Needham Maintains Buy on Stoke Therapeutics, Maintains $22 Price Target", "summary": "", "symbols": ["STOK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869362/needham-maintains-buy-on-stoke-therapeutics-maintains-22-price-target", "tags": ["analyst_other"]}
{"id": 42869363, "time": "2025-01-08 06:35:59", "headline": "Top 2 Financial Stocks That May Fall Off A Cliff In January", "summary": " ", "symbols": ["CPBI", "LSAK"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/01/42869363/top-2-financial-stocks-that-may-fall-off-a-cliff-in-january", "tags": []}
{"id": 42869374, "time": "2025-01-08 06:36:31", "headline": "Air Lease Announced That It Delivered 18 New Aircraft From ALC's Orderbook And Sold 14 Aircraft To Third-party Buyers In The Q4 FY24", "summary": "", "symbols": ["AL"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/25/01/42869374/air-lease-announced-that-it-delivered-18-new-aircraft-from-alcs-orderbook-and-sold-14-aircraft-to-th", "tags": []}
{"id": 42869350, "time": "2025-01-08 06:35:14", "headline": "The Wall Street Journal Reported Advanced Micro Devices Invests $20M n Drug-Discovery Startup Absci", "summary": "", "symbols": ["ABSI", "AMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/01/42869350/the-wall-street-journal-reported-advanced-micro-devices-invests-20m-n-drug-discovery-startup-absci", "tags": []}
{"id": 42869381, "time": "2025-01-08 06:37:32", "headline": "AngioDynamics Continues To Expect 2025 Net Sales Of $282M-$288M, Representing Growth Of Between 4.2%\u20136.4% Over Fiscal 2024 Pro Forma Revenue Of $270.7M Versus Consensus Of $283.86M", "summary": "", "symbols": ["ANGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/01/42869381/angiodynamics-continues-to-expect-2025-net-sales-of-282m-288m-representing-growth-of-between-4-2-6-", "tags": ["earnings"]}
{"id": 42869382, "time": "2025-01-08 06:37:39", "headline": "B. Riley Securities Initiates Coverage On Nektar Therapeutics with Buy Rating, Announces Price Target of $4", "summary": "", "symbols": ["NKTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869382/b-riley-securities-initiates-coverage-on-nektar-therapeutics-with-buy-rating-announces-price-target", "tags": ["analyst_init"]}
{"id": 42869383, "time": "2025-01-08 06:37:48", "headline": "Needham Maintains Buy on Personalis, Maintains $7.25 Price Target", "summary": "", "symbols": ["PSNL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869383/needham-maintains-buy-on-personalis-maintains-7-25-price-target", "tags": ["analyst_other"]}
{"id": 42869384, "time": "2025-01-08 06:38:54", "headline": "Truist Securities Downgrades Merck & Co to Hold, Lowers Price Target to $110", "summary": "", "symbols": ["MRK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869384/truist-securities-downgrades-merck-co-to-hold-lowers-price-target-to-110", "tags": ["analyst_down", "price_target_down"]}
{"id": 42869386, "time": "2025-01-08 06:39:06", "headline": "AngioDynamics Expects 2025 Adjusted EPS Loss Of $0.34 to $0.38 Compared To Prior Guidance Of $0.38-$0.42 And Consensus Of $0.40", "summary": "", "symbols": ["ANGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/01/42869386/angiodynamics-expects-2025-adjusted-eps-loss-of-0-34-to-0-38-compared-to-prior-guidance-of-0-38-0-4", "tags": ["earnings", "guidance"]}
{"id": 42869409, "time": "2025-01-08 06:40:13", "headline": "Truist Securities Maintains Buy on AbbVie, Lowers Price Target to $211", "summary": "", "symbols": ["ABBV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869409/truist-securities-maintains-buy-on-abbvie-lowers-price-target-to-211", "tags": ["analyst_other", "price_target_down"]}
{"id": 42869410, "time": "2025-01-08 06:40:30", "headline": "HC Wainwright & Co. Maintains Buy on Personalis, Maintains $11 Price Target", "summary": "", "symbols": ["PSNL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869410/hc-wainwright-co-maintains-buy-on-personalis-maintains-11-price-target", "tags": ["analyst_other"]}
{"id": 42869411, "time": "2025-01-08 06:41:12", "headline": "Truist Securities Maintains Buy on Bristol-Myers Squibb, Raises Price Target to $65", "summary": "", "symbols": ["BMY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869411/truist-securities-maintains-buy-on-bristol-myers-squibb-raises-price-target-to-65", "tags": ["analyst_other", "price_target_up"]}
{"id": 42869415, "time": "2025-01-08 06:41:53", "headline": "HC Wainwright & Co. Maintains Buy on Unicycive Therapeutics, Maintains $4 Price Target", "summary": "", "symbols": ["UNCY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869415/hc-wainwright-co-maintains-buy-on-unicycive-therapeutics-maintains-4-price-target", "tags": ["analyst_other"]}
{"id": 42869427, "time": "2025-01-08 06:43:00", "headline": "Truist Securities Maintains Hold on Amgen, Lowers Price Target to $298", "summary": "", "symbols": ["AMGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869427/truist-securities-maintains-hold-on-amgen-lowers-price-target-to-298", "tags": ["analyst_other", "price_target_down"]}
{"id": 42869439, "time": "2025-01-08 06:44:24", "headline": "Truist Securities Maintains Buy on Biogen, Lowers Price Target to $220", "summary": "", "symbols": ["BIIB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869439/truist-securities-maintains-buy-on-biogen-lowers-price-target-to-220", "tags": ["analyst_other", "price_target_down"]}
{"id": 42869440, "time": "2025-01-08 06:44:30", "headline": "CNN Reported President Elect Trump Is Considering A National Economic Emergency Declaration To Allow For New Tariff Program", "summary": "", "symbols": ["EWC", "EWU", "EWW", "FXI", "SPY", "VGK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/01/42869440/cnn-reported-president-elect-trump-is-considering-a-national-economic-emergency-d", "tags": []}
{"id": 42869451, "time": "2025-01-08 06:45:03", "headline": "Needham Maintains Buy on Flutter Entertainment, Maintains $300 Price Target", "summary": "", "symbols": ["FLUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869451/needham-maintains-buy-on-flutter-entertainment-maintains-300-price-target", "tags": ["analyst_other"]}
{"id": 42869460, "time": "2025-01-08 06:45:37", "headline": "Truist Securities Maintains Buy on Regeneron Pharmaceuticals, Lowers Price Target to $1004", "summary": "", "symbols": ["REGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869460/truist-securities-maintains-buy-on-regeneron-pharmaceuticals-lowers-price-target-to-1004", "tags": ["analyst_other", "price_target_down"]}
{"id": 42869462, "time": "2025-01-08 06:47:12", "headline": "Needham Maintains Buy on Salesforce, Raises Price Target to $400", "summary": "", "symbols": ["CRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869462/needham-maintains-buy-on-salesforce-raises-price-target-to-400", "tags": ["analyst_other", "price_target_up"]}
{"id": 42869463, "time": "2025-01-08 06:47:16", "headline": "Helen Of Troy Q3 Adj $2.67 Beats $2.60 Estimate, Sales $549.61M Beat $534.31M Estimate", "summary": "", "symbols": ["HELE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/01/42869463/helen-of-troy-q3-adj-2-67-beats-2-60-estimate-sales-549-61m-beat-534-31m-estimate", "tags": []}
{"id": 42869465, "time": "2025-01-08 06:47:29", "headline": "Stifel Reinstates Buy on Beacon Roofing Supply, Announces $115 Price Target", "summary": "", "symbols": ["BECN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869465/stifel-reinstates-buy-on-beacon-roofing-supply-announces-115-price-target", "tags": []}
{"id": 42869466, "time": "2025-01-08 06:47:37", "headline": "W&T Offshore Disclosed That It Recently Signed A Purchase And Sale Agreement To Sell A Non-core Interest In Garden Banks Blocks 385 And 386 Which Included Latest Net Production Of About 195 Barrels Of Oil Equivalent Per Day (boe/d) (72% Oil) For $12.3M", "summary": "", "symbols": ["WIT"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/25/01/42869466/w-t-offshore-disclosed-that-it-recently-signed-a-purchase-and-sale-agreement-to-sell-a-non-core-inte", "tags": ["contract"]}
{"id": 42869478, "time": "2025-01-08 06:49:30", "headline": "Stifel Reinstates Buy on Builders FirstSource, Announces $175 Price Target", "summary": "", "symbols": ["BLDR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869478/stifel-reinstates-buy-on-builders-firstsource-announces-175-price-target", "tags": []}
{"id": 42869702, "time": "2025-01-08 06:50:39", "headline": "Wall Street's Most Accurate Analysts Give Their Take On 3 Materials Stocks Delivering High-Dividend Yields", "summary": " ", "symbols": ["CC", "DOW", "HUN"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/01/42869702/wall-streets-most-accurate-analysts-give-their-take-on-3-materials-stocks-delivering-high-dividend-yields-2", "tags": ["dividend"]}
{"id": 42869703, "time": "2025-01-08 06:50:49", "headline": "Helen Of Troy Sees Lowers FY25 Revenue Outlook To $1.888B - $1.913B Vs. $1.91B Est.", "summary": "", "symbols": ["HELE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869703/helen-of-troy-sees-lowers-fy25-revenue-outlook-to-1-888b-1-913b-vs-1-91b-est", "tags": ["earnings", "guidance"]}
{"id": 42869712, "time": "2025-01-08 06:51:17", "headline": "Merck Announced That The National Medical Products Administration Of China Approved Gardasil [Human Papillomavirus Quadrivalent (Types 6, 11, 16, And 18) Vaccine] For Use In Males 9-26 Years Of Age To Help Prevent Certain HPV-related Cancers And Diseases", "summary": "", "symbols": ["MRK"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/25/01/42869712/merck-announced-that-the-national-medical-products-administration-of-china-approved-gardasil-human-p", "tags": []}
{"id": 42869729, "time": "2025-01-08 06:53:18", "headline": "Helen Of Troy Narrows FY15 Adj EPS Outlook To $7.15-$7.40  from $7.00 - $7.50 Vs. $7.19 Est.", "summary": "", "symbols": ["HELE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869729/helen-of-troy-narrows-fy15-adj-eps-outlook-to-7-15-7-40-from-7-00-7-50-vs-7-19-est", "tags": ["earnings", "guidance"]}
{"id": 42869730, "time": "2025-01-08 06:53:37", "headline": "Novo Nordisk And Valo Health Entered Into An Expanded Agreement To Discover And Develop Treatments For Obesity, Type 2 Diabetes, And Cardiovascular Disease, Valo Is Entitled To Receive An Upfront Payment, Equity Investment, And A Potential Near-term Milestone Payment Of $190M And Milestone Payments Of Approximately $4.6B", "summary": "", "symbols": ["NVO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/01/42869730/novo-nordisk-and-valo-health-entered-into-an-expanded-agreement-to-discover-and-develop-treatment", "tags": ["contract"]}
{"id": 42869732, "time": "2025-01-08 06:53:58", "headline": "Canaccord Genuity Maintains Buy on Aurora Innovation, Raises Price Target to $10", "summary": "", "symbols": ["AUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869732/canaccord-genuity-maintains-buy-on-aurora-innovation-raises-price-target-to-10", "tags": ["analyst_other", "price_target_up"]}
{"id": 42869737, "time": "2025-01-08 06:54:26", "headline": "Bitcoin RSI Plunges To 'Oversold' Level Not Seen Since $60K, Signaling Potential Short-Term Recovery", "summary": "Following a sharp decline in Bitcoin\u2019s (CRYPTO: BTC) price, a key metric has hit its lowest level in several months, leading to expectations of a short-term recovery. At the time of writing, BTC was down to $94,794.64, as per Benzinga Pro.", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Pooja Rajkumari", "url": "https://www.benzinga.com/news/25/01/42869737/bitcoin-rsi-plunges-to-oversold-level-not-seen-since-60k-signaling-potential-short-term-recovery", "tags": []}
{"id": 42869754, "time": "2025-01-08 06:55:00", "headline": "Canaccord Genuity Maintains Buy on Archer Aviation, Raises Price Target to $14", "summary": "", "symbols": ["ACHR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869754/canaccord-genuity-maintains-buy-on-archer-aviation-raises-price-target-to-14", "tags": ["analyst_other", "price_target_up"]}
{"id": 42869755, "time": "2025-01-08 06:56:22", "headline": "Canaccord Genuity Maintains Buy on Joby Aviation, Raises Price Target to $11.5", "summary": "", "symbols": ["JOBY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869755/canaccord-genuity-maintains-buy-on-joby-aviation-raises-price-target-to-11-5", "tags": ["analyst_other", "price_target_up"]}
{"id": 42869761, "time": "2025-01-08 06:57:36", "headline": "Canaccord Genuity Maintains Buy on Intuitive Machines, Raises Price Target to $26", "summary": "", "symbols": ["LUNR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869761/canaccord-genuity-maintains-buy-on-intuitive-machines-raises-price-target-to-26", "tags": ["analyst_other", "price_target_up"]}
{"id": 42869762, "time": "2025-01-08 06:59:02", "headline": "Canaccord Genuity Maintains Buy on SharkNinja, Raises Price Target to $129", "summary": "", "symbols": ["SN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869762/canaccord-genuity-maintains-buy-on-sharkninja-raises-price-target-to-129", "tags": ["analyst_other", "price_target_up"]}
{"id": 42869865, "time": "2025-01-08 07:00:14", "headline": "Breaking Down Fidelis Insurance Hldgs: 4 Analysts Share Their Views", "summary": " ", "symbols": ["FIHL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42869865/breaking-down-fidelis-insurance-hldgs-4-analysts-share-their-views", "tags": []}
{"id": 42869888, "time": "2025-01-08 07:00:25", "headline": "Mizuho Upgrades Twilio to Outperform, Raises Price Target to $140", "summary": "", "symbols": ["TWLO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869888/mizuho-upgrades-twilio-to-outperform-raises-price-target-to-140", "tags": ["analyst_up", "price_target_up"]}
{"id": 42869892, "time": "2025-01-08 07:00:27", "headline": "The Analyst Verdict: Stoke Therapeutics In The Eyes Of 4 Experts", "summary": " ", "symbols": ["STOK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42869892/the-analyst-verdict-stoke-therapeutics-in-the-eyes-of-4-experts", "tags": []}
{"id": 42869893, "time": "2025-01-08 07:00:37", "headline": "Breaking Down Viper Energy: 13 Analysts Share Their Views", "summary": " ", "symbols": ["VNOM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42869893/breaking-down-viper-energy-13-analysts-share-their-views", "tags": []}
{"id": 42869895, "time": "2025-01-08 07:00:44", "headline": "Beyond The Numbers: 7 Analysts Discuss Advanced Drainage Systems Stock", "summary": " ", "symbols": ["WMS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42869895/beyond-the-numbers-7-analysts-discuss-advanced-drainage-systems-stock", "tags": []}
{"id": 42869902, "time": "2025-01-08 07:00:52", "headline": "Forecasting The Future: 8 Analyst Projections For Aris Water Solutions", "summary": " ", "symbols": ["ARIS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42869902/forecasting-the-future-8-analyst-projections-for-aris-water-solutions", "tags": []}
{"id": 42869903, "time": "2025-01-08 07:00:58", "headline": "Demystifying Autodesk: Insights From 20 Analyst Reviews", "summary": " ", "symbols": ["ADSK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42869903/demystifying-autodesk-insights-from-20-analyst-reviews", "tags": []}
{"id": 42869926, "time": "2025-01-08 07:01:54", "headline": "Piper Sandler Initiates Coverage On Norwood Financial with Neutral Rating, Announces Price Target of $28", "summary": "", "symbols": ["NWFL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869926/piper-sandler-initiates-coverage-on-norwood-financial-with-neutral-rating-announces-price-target-of", "tags": ["analyst_init"]}
{"id": 42869928, "time": "2025-01-08 07:01:58", "headline": "Simply Good Foods Q1 2025 Adj. EPS $0.49 Beats $0.47 Estimate, Sales $341.268M Miss $347.367M Estimate", "summary": "", "symbols": ["SMPL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/01/42869928/simply-good-foods-q1-2025-adj-eps-0-49-beats-0-47-estimate-sales-341-268m-miss-347-367m-estimate", "tags": ["earnings"]}
{"id": 42869931, "time": "2025-01-08 07:02:01", "headline": "DA Davidson Upgrades Symbotic to Buy, Announces $35 Price Target", "summary": "", "symbols": ["SYM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42869931/da-davidson-upgrades-symbotic-to-buy-announces-35-price-target", "tags": ["analyst_up"]}
{"id": 42869963, "time": "2025-01-08 07:02:49", "headline": "Boston Scientific Enters Definitive Deal To Acquire Bolt Medical; Transaction Consists Of  Upfront Payment Of $443M For The 74% Stake Not Yet Owned", "summary": "", "symbols": ["BSX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/01/42869963/boston-scientific-enters-definitive-deal-to-acquire-bolt-medical-transaction-consists-of-upfront-pay", "tags": ["merger", "contract"]}
{"id": 42869984, "time": "2025-01-08 07:03:23", "headline": "Castellum Announces That It Has Successfully Helped Onboard Its Two Small Business Administration Approved Mentor-prot\u00e9g\u00e9 Companies, Epic Systems, Inc. And Krilla Kaleiwahea, LLC, To Its Seaport Next Generation Contract Via Rolling Admissions II", "summary": "", "symbols": ["CTM"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/25/01/42869984/castellum-announces-that-it-has-successfully-helped-onboard-its-two-small-business-administration-ap", "tags": ["contract"]}
{"id": 42870011, "time": "2025-01-08 07:04:36", "headline": "Agios Pharmaceuticals Says FDA Accepted sNDA For PYRUKYND (Mitapivat) For Treatment Of Adult Patients With Non-Transfusion-Dependent And Transfusion-Dependent Alpha- Or Beta-thalassemia", "summary": "", "symbols": ["AGIO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42870011/agios-pharmaceuticals-says-fda-accepted-snda-for-pyrukynd-mitapivat-for-treatment-of-adult-patients", "tags": ["fda"]}
{"id": 42870023, "time": "2025-01-08 07:04:52", "headline": "Compugen Announced That The First Patient Was Dosed In A Phase 1 Clinical Trial With Com503, A Potential First-in-class Antibody Against Il-18 Binding Protein Licensed By Compugen To Gilead", "summary": "", "symbols": ["CGEN", "GILD"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/25/01/42870023/compugen-announced-that-the-first-patient-was-dosed-in-a-phase-1-clinical-trial-with-com503-a-potent", "tags": ["fda"]}
{"id": 42870024, "time": "2025-01-08 07:04:58", "headline": "Air Industries Land $5.9M Contract For F-5/T-38 Aircraft Actuators", "summary": "", "symbols": ["AIRI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42870024/air-industries-land-5-9m-contract-for-f-5t-38-aircraft-actuators", "tags": ["contract"]}
{"id": 42870033, "time": "2025-01-08 07:05:48", "headline": "BitFuFu Launches New Software Service, BitFuFuOS, Which Can Increase Mining Overall Earnings By Up To 20%", "summary": "", "symbols": ["FUFU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42870033/bitfufu-launches-new-software-service-bitfufuos-which-can-increase-mining-overall-earnings-by-up-to", "tags": ["earnings"]}
{"id": 42870035, "time": "2025-01-08 07:05:51", "headline": "The Simply Good Foods Company Sees FY25 Net Sales To Increase 8.5%-10.5%, Adjusted EBITDA Expected To Increase 4%-6%", "summary": "", "symbols": ["SMPL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42870035/the-simply-good-foods-company-sees-fy25-net-sales-to-increase-8-5-10-5-adjusted-ebitda-expected-to-i", "tags": []}
{"id": 42870066, "time": "2025-01-08 07:06:57", "headline": "Halozyme Reports Preliminary Results, Reiterated Full Year 2024 Financial Guidance", "summary": "", "symbols": ["HALO"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/25/01/42870066/halozyme-reports-preliminary-results-reiterated-full-year-2024-financial-guidance", "tags": ["guidance"]}
{"id": 42870074, "time": "2025-01-08 07:07:11", "headline": "EDAP TMS Announced That The First Patient Has Been Treated In Phase 1/2 PULS Trial Evaluating Proprietary High-Intensity Focused Ultrasound Technology For Pancreatic Tumors", "summary": "", "symbols": ["EDAP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42870074/edap-tms-announced-that-the-first-patient-has-been-treated-in-phase-12-puls-trial-evaluating-proprie", "tags": ["fda"]}
{"id": 42870082, "time": "2025-01-08 07:07:24", "headline": "Absci, AMD Announce Strategic Collaboration; AMD To Also Make $20M Investment In Absci, Structured As Private Investment In Public Equity", "summary": "", "symbols": ["ABSI", "AMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42870082/absci-amd-announce-strategic-collaboration-amd-to-also-make-20m-investment-in-absci-structured-as-pr", "tags": []}
{"id": 42870103, "time": "2025-01-08 07:08:27", "headline": "Lithium Woes Spillover Into 2025, But US And China Quietly Build Reserves", "summary": "Lithium market concerns persist in 2025 due to oversupply and slower EV adoption. Analysts predict $10,685/ton stabilization. China grows reserves.", "symbols": ["LAC", "NVLHF"], "source": "benzinga", "author": "Stjepan Kalinic", "url": "https://www.benzinga.com/25/01/42870103/lithium-woes-spillover-into-2025-but-us-and-china-quietly-build-reserves", "tags": []}
{"id": 42870105, "time": "2025-01-08 07:08:40", "headline": "This Nasdaq Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday", "summary": " ", "symbols": ["ADSK", "NDAQ", "PHM", "RPM", "TWLO"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/01/42870105/this-nasdaq-analyst-turns-bullish-here-are-top-5-upgrades-for-wednesday-2", "tags": ["analyst_up"]}
{"id": 42870128, "time": "2025-01-08 07:09:14", "headline": "MoonLake Immunotherapeutics Announced That Patients Have Been Screened In Three New Trials Across Three New Indications To Evaluate Sonelokimab To Treat Inflammatory Disease", "summary": "", "symbols": ["MLTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/01/42870128/moonlake-immunotherapeutics-announced-that-patients-have-been-screened-in-three-new-trials-across", "tags": []}
{"id": 42870130, "time": "2025-01-08 07:09:33", "headline": "I-Mab Chairman Wei Fu Informs His Intent To Purchase Up To $2M Of Company's American Depository Shares", "summary": "", "symbols": ["IMAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42870130/i-mab-chairman-wei-fu-informs-his-intent-to-purchase-up-to-2m-of-companys-american-depository-shares", "tags": []}
{"id": 42870202, "time": "2025-01-08 07:10:15", "headline": "Halozyme Raises 2025 Financial Guidance Ranges For Total Revenue To $1.150B - $1.225B From $1.095B to $1.170B (Vs. Cons. Of $1.156B), Adj. EPS To $4.95 - $5.35 From $4.45 to $4.85 (Vs. Cons. $4.83)", "summary": "", "symbols": ["HALO"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/25/01/42870202/halozyme-raises-2025-financial-guidance-ranges-for-total-revenue-to-1-150b-1-225b-from-1-095b-to-1-1", "tags": ["earnings", "guidance"]}
{"id": 42870205, "time": "2025-01-08 07:11:01", "headline": "uniQure Prices Public Offering Of 4.41M Of Its Ordinary Shares At $17.00 Per Share", "summary": "", "symbols": ["QURE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42870205/uniqure-prices-public-offering-of-4-41m-of-its-ordinary-shares-at-17-00-per-share", "tags": ["offering"]}
{"id": 42870206, "time": "2025-01-08 07:11:04", "headline": "Kamada Reaffirms 2024 Targets, Unveils 2025 Guidances, Revenue Of $178M-$182M Vs. $171.18M Est. And Adj.EBITDA Of $38M-$42M", "summary": "", "symbols": ["KMDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42870206/kamada-reaffirms-2024-targets-unveils-2025-guidances-revenue-of-178m-182m-vs-171-18m-est-and-adj-ebi", "tags": ["earnings"]}
{"id": 42870207, "time": "2025-01-08 07:11:06", "headline": "Butterfly Network Announced That It Expects To Report Revenue Growth For The Fourth Quarter Ended December 31, 2024 Of Approximately 35% Year Over Year", "summary": "", "symbols": ["BFLY"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/25/01/42870207/butterfly-network-announced-that-it-expects-to-report-revenue-growth-for-the-fourth-quarter-ended-de", "tags": ["earnings"]}
{"id": 42870210, "time": "2025-01-08 07:11:12", "headline": "JMP Securities Initiates Coverage On Context Therapeutics with Market Outperform Rating, Announces Price Target of $4", "summary": "", "symbols": ["CNTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42870210/jmp-securities-initiates-coverage-on-context-therapeutics-with-market-outperform-rating-announces-pr", "tags": ["analyst_init"]}
{"id": 42870222, "time": "2025-01-08 07:12:04", "headline": "Viking Therapeutics Initiates Phase 2 Clinical Trial Of The Oral Tablet Formulation Of VK2735", "summary": "", "symbols": ["VKTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42870222/viking-therapeutics-initiates-phase-2-clinical-trial-of-the-oral-tablet-formulation-of-vk2735", "tags": ["fda"]}
{"id": 42870230, "time": "2025-01-08 07:12:27", "headline": "Garmin Announced A New Montana Series \u2013 The Montana 710, Montana 710i And Robust Montana 760i \u2013 To Its Collection Of Handheld GPS Navigators", "summary": "", "symbols": ["GRMN"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/25/01/42870230/garmin-announced-a-new-montana-series-the-montana-710-montana-710i-and-robust-montana-760i-to-its-co", "tags": []}
{"id": 42870240, "time": "2025-01-08 07:13:15", "headline": "Currenc Group Announced The Launch Of Its Seamless Ai Call Centre Solutions, A Suite Of AI-powered Tools Designed To Reduce Costs, Increase Efficiency And Boost Customer Satisfaction", "summary": "", "symbols": ["CURR"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/25/01/42870240/currenc-group-announced-the-launch-of-its-seamless-ai-call-centre-solutions-a-suite-of-ai-powered-to", "tags": []}
{"id": 42870242, "time": "2025-01-08 07:13:22", "headline": "JP Morgan Maintains Neutral on MercadoLibre, Lowers Price Target to $1950", "summary": "", "symbols": ["MELI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42870242/jp-morgan-maintains-neutral-on-mercadolibre-lowers-price-target-to-1950", "tags": ["analyst_other", "price_target_down"]}
{"id": 42870243, "time": "2025-01-08 07:13:27", "headline": "Piper Sandler Upgrades Arthur J. Gallagher to Overweight, Raises Price Target to $315", "summary": "", "symbols": ["AJG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42870243/piper-sandler-upgrades-arthur-j-gallagher-to-overweight-raises-price-target-to-315", "tags": ["analyst_up", "price_target_up"]}
{"id": 42870245, "time": "2025-01-08 07:14:13", "headline": "Jasper Therapeutics Reported Positive Preliminary Data From Jasper's Ongoing BEACON Phase 1b/2a Study Of Subcutaneous Briquilimab In Adult Participants With CSU", "summary": "", "symbols": ["JSPR"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/25/01/42870245/jasper-therapeutics-reported-positive-preliminary-data-from-jaspers-ongoing-beacon-phase-1b2a-study", "tags": []}
{"id": 42870299, "time": "2025-01-08 07:14:56", "headline": "InMode Expects Q4 Revenue Of $97.0M-$97.5M (Est $114.22M); Preliminary Results Reflect Stronger-than-Expected Headwinds In Aesthetics Industry", "summary": "", "symbols": ["INMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42870299/inmode-expects-q4-revenue-of-97-0m-97-5m-est-114-22m-preliminary-results-reflect-stronger-than-expec", "tags": ["earnings"]}
{"id": 42870303, "time": "2025-01-08 07:15:02", "headline": "Biostem Technologies Announces The Initiation Of The Br-am-dfu (bioretain Amniotic Membrane - Diabetic Foot Ulcers) Clinical Trial To Evaluate Vendaje Versus Standard Of Care For Patients Suffering With Non-healing Diabetic Foot Ulcers", "summary": "", "symbols": ["BSEM"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/25/01/42870303/biostem-technologies-announces-the-initiation-of-the-br-am-dfu-bioretain-amniotic-membrane-diabetic", "tags": ["fda"]}
{"id": 42870305, "time": "2025-01-08 07:15:31", "headline": "Barclays Upgrades Tapestry to Overweight, Raises Price Target to $87", "summary": "", "symbols": ["TPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42870305/barclays-upgrades-tapestry-to-overweight-raises-price-target-to-87", "tags": ["analyst_up", "price_target_up"]}
{"id": 42870306, "time": "2025-01-08 07:15:37", "headline": "Tiziana Life Sciences Announced That A Review Article Was Published In Nature Reviews Neurology, Highlighting The Therapeutic Potential Of Intranasal Foralumab In Various Neurodegenerative Diseases", "summary": "", "symbols": ["TLSA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/01/42870306/tiziana-life-sciences-announced-that-a-review-article-was-published-in-nature-reviews-neurology-h", "tags": []}
{"id": 42870307, "time": "2025-01-08 07:15:39", "headline": "This Adobe Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday", "summary": " ", "symbols": ["ADBE", "AIG", "MRK", "PANW", "SEDG"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/01/42870307/this-adobe-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-wednesday", "tags": ["analyst_down"]}
{"id": 42870319, "time": "2025-01-08 07:16:10", "headline": "ECARX Holdings Announced That Its Cloudpeak Hypervisor, A Core Component Of Its Cloudpeak Software Stack, Received The Highest Level Of Functional Safety Certification, Automotive Safety Integrity Level D, Under The ISO 26262 Standard", "summary": "", "symbols": ["ECX"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/25/01/42870319/ecarx-holdings-announced-that-its-cloudpeak-hypervisor-a-core-component-of-its-cloudpeak-software-st", "tags": []}
{"id": 42870320, "time": "2025-01-08 07:16:12", "headline": "Truist Securities Initiates Coverage On Solid Biosciences with Buy Rating, Announces Price Target of $16", "summary": "", "symbols": ["SLDB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42870320/truist-securities-initiates-coverage-on-solid-biosciences-with-buy-rating-announces-price-target-of", "tags": ["analyst_init"]}
{"id": 42870322, "time": "2025-01-08 07:16:30", "headline": "InMode Cuts FY24 Revenue Outlook From $410M - $420M To $394M - $394.5M, Est $411.188M", "summary": "", "symbols": ["INMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42870322/inmode-cuts-fy24-revenue-outlook-from-410m-420m-to-394m-394-5m-est-411-188m", "tags": ["earnings", "guidance"]}
{"id": 42870343, "time": "2025-01-08 07:17:33", "headline": "What MicroStrategy's (Declining) Net Asset Value Premium Really Means For Bitcoin", "summary": "Experts are raising concerns about MicroStrategy\u2018s (NASDAQ:MSTR) increasingly leveraged Bitcoin (CRYPTO: BTC) strategy, as its Net Asset Value (NAV) premium narrows and the ", "symbols": ["BTCUSD", "MSTR"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/25/01/42870343/what-microstrategys-declining-net-asset-value-premium-really-means-for-bitcoin", "tags": []}
{"id": 42870345, "time": "2025-01-08 07:17:44", "headline": "InMode Expects Full-Year 2025 Revenue Of $395M - $405M, Est $421.368M", "summary": "", "symbols": ["INMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42870345/inmode-expects-full-year-2025-revenue-of-395m-405m-est-421-368m", "tags": ["earnings"]}
{"id": 42870375, "time": "2025-01-08 07:19:35", "headline": "United Natural Foods Plans To  Realign Its Commercial Wholesale Organization Into Two Product-centered Divisions, Conventional Grocery Products And Natural, Organic, Specialty & Fresh Products", "summary": "", "symbols": ["UNFI"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/25/01/42870375/united-natural-foods-plans-to-realign-its-commercial-wholesale-organization-into-two-product-centere", "tags": []}
{"id": 42870638, "time": "2025-01-08 07:20:37", "headline": "ECARX's Cloudpeak Hypervisor Achieves ISO 26262 ASIL-D Certification", "summary": "", "symbols": ["ECX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42870638/ecarxs-cloudpeak-hypervisor-achieves-iso-26262-asil-d-certification", "tags": []}
{"id": 42870650, "time": "2025-01-08 07:20:39", "headline": "Truist Securities Initiates Coverage On Summit Therapeutics with Buy Rating, Announces Price Target of $35", "summary": "", "symbols": ["SMMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42870650/truist-securities-initiates-coverage-on-summit-therapeutics-with-buy-rating-announces-price-target-o", "tags": ["analyst_init"]}
{"id": 42870671, "time": "2025-01-08 07:21:00", "headline": "ICON Plc Released The Findings Of A Survey Of Over 120 Biotech And Pharma Professionals Developing Treatments For Neurodegenerative Disorders", "summary": "", "symbols": ["ICLR"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/25/01/42870671/icon-plc-released-the-findings-of-a-survey-of-over-120-biotech-and-pharma-professionals-developing-t", "tags": []}
{"id": 42870682, "time": "2025-01-08 07:22:14", "headline": "Carvana Announced Plans For An Auction And Reconditioning 'megasite' Integration In Atlanta", "summary": "", "symbols": ["CVNA"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/25/01/42870682/carvana-announced-plans-for-an-auction-and-reconditioning-megasite-integration-in-atlanta", "tags": []}
{"id": 42870683, "time": "2025-01-08 07:22:46", "headline": "Ceva Partners With Oritek To Power Next-Gen ADAS Chipsets For Safer, Smarter Electric Vehicles", "summary": "", "symbols": ["CEVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42870683/ceva-partners-with-oritek-to-power-next-gen-adas-chipsets-for-safer-smarter-electric-vehicles", "tags": ["contract"]}
{"id": 42870705, "time": "2025-01-08 07:23:12", "headline": "Canadian Solar Announced That E-storage, Which Is Part Of The Company's Majority-owned Subsidiary CSI Solar Co., Ltd., Has Signed Contracts With Copenhagen Infrastructure Partners, Through Its Flagship Fund CI IV", "summary": "", "symbols": ["CSIQ"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/25/01/42870705/canadian-solar-announced-that-e-storage-which-is-part-of-the-companys-majority-owned-subsidiary-csi", "tags": []}
{"id": 42870707, "time": "2025-01-08 07:23:18", "headline": "Barclays Initiates Coverage On Levi Strauss with Overweight Rating, Announces Price Target of $24", "summary": "", "symbols": ["LEVI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42870707/barclays-initiates-coverage-on-levi-strauss-with-overweight-rating-announces-price-target-of-24", "tags": ["analyst_init"]}
{"id": 42870713, "time": "2025-01-08 07:24:50", "headline": "EVgo Announced It Has Received Its First Drawdown Of $75M From Its $1.25B Guaranteed Loan From The U.S. Department Of Energy Loan Programs Office Under Its Title 17 Clean Energy Financing Program", "summary": "", "symbols": ["EVGO"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/25/01/42870713/evgo-announced-it-has-received-its-first-drawdown-of-75m-from-its-1-25b-guaranteed-loan-from-the-u-s", "tags": []}
{"id": 42870730, "time": "2025-01-08 07:25:42", "headline": "Barclays Upgrades Floor & Decor Hldgs to Equal-Weight, Raises Price Target to $91", "summary": "", "symbols": ["FND"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42870730/barclays-upgrades-floor-decor-hldgs-to-equal-weight-raises-price-target-to-91", "tags": ["analyst_up", "price_target_up"]}
{"id": 42870731, "time": "2025-01-08 07:26:31", "headline": "Lithium Americas Announced It Achieved 2024 Production Guidance With Approximately 25,400 Tonnes Of Lithium Carbonate Produced In 2024", "summary": "", "symbols": ["LAAC"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/25/01/42870731/lithium-americas-announced-it-achieved-2024-production-guidance-with-approximately-25-400-tonnes-of", "tags": ["guidance"]}
{"id": 42870736, "time": "2025-01-08 07:27:00", "headline": "Lithium Americas Expects 2025 Production Guidance of 30,000 - 35,000 Tonnes Of Lithium Carbonate", "summary": "", "symbols": ["LAAC"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/25/01/42870736/lithium-americas-expects-2025-production-guidance-of-30-000-35-000-tonnes-of-lithium-carbonate", "tags": ["guidance"]}
{"id": 42870737, "time": "2025-01-08 07:27:27", "headline": "Barclays Upgrades RH to Overweight, Raises Price Target to $515", "summary": "", "symbols": ["RH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42870737/barclays-upgrades-rh-to-overweight-raises-price-target-to-515", "tags": ["analyst_up", "price_target_up"]}
{"id": 42870745, "time": "2025-01-08 07:29:20", "headline": "Nippon Steel CEO Slams Tariffs, Defends $15 Billion US Steel Merger Amid National Security Concerns: 'We Never Think That Industry Can Become Stronger Through Tariffs Alone'", "summary": "The legal cases filed on Monday claim Biden&#39;s decision constitutes &#34;wrongful interference.&#34;", "symbols": ["NISTF", "NPSCY", "X"], "source": "benzinga", "author": "Pooja Rajkumari", "url": "https://www.benzinga.com/markets/25/01/42870745/nippon-steel-ceo-slams-tariffs-defends-15-billion-us-steel-merger-amid-national-security-concerns-we-never-think-that-industry-can-become-stronger-through-tariffs-alone", "tags": ["merger", "management"]}
{"id": 42870812, "time": "2025-01-08 07:31:12", "headline": "Shell Lowers Integrated Gas Production Outlook; Shares Slide", "summary": "Shell plc lowered its Q4 production forecast for integrated gas, expecting 880,000-920,000 oil-equivalent barrels per day, citing maintenance and expiring hedging contracts. ", "symbols": ["EQNR", "SHEL"], "source": "benzinga", "author": "Shivani Kumaresan", "url": "https://www.benzinga.com/news/guidance/25/01/42870812/shell-lowers-integrated-gas-production-outlook-shares-slide", "tags": ["guidance"]}
{"id": 42870827, "time": "2025-01-08 07:32:23", "headline": "Flowers Foods Inked A Definitive Agreement To Acquire Simple Mills For $795 Million In Cash", "summary": "", "symbols": ["FLO"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/m-a/25/01/42870827/flowers-foods-inked-a-definitive-agreement-to-acquire-simple-mills-for-795-million-in-cash", "tags": ["merger", "contract"]}
{"id": 42870830, "time": "2025-01-08 07:33:28", "headline": "23andme Announced The Launch Of Discover23, A New Research Offering Enabling Authorized Collaborators To Securely Access The Power And Diversity Of The 23andme Research Cohort Through A Trusted Research Environment Developed By Lifebit", "summary": "", "symbols": ["ME"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/25/01/42870830/23andme-announced-the-launch-of-discover23-a-new-research-offering-enabling-authorized-collaborators", "tags": ["offering"]}
{"id": 42870833, "time": "2025-01-08 07:34:02", "headline": "Salesforce To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Wednesday", "summary": " ", "symbols": ["ADSK", "BMY", "CRM", "GEHC", "LUNR", "MELI", "MRK", "NTES", "WDAY"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/01/42870833/salesforce-to-rally-more-than-23-here-are-10-top-analyst-forecasts-for-wednesday", "tags": []}
{"id": 42870835, "time": "2025-01-08 07:34:10", "headline": "Trevi Therapeutics Announced Business Updates Ahead Of Its Participation In The 14th Annual Lifesci Partners Corporate Access Event Taking Place In San Francisco, Ca, From January 13-15, 2025", "summary": "", "symbols": ["TRVI"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/25/01/42870835/trevi-therapeutics-announced-business-updates-ahead-of-its-participation-in-the-14th-annual-lifesci", "tags": []}
{"id": 42870859, "time": "2025-01-08 07:35:06", "headline": "Emergent BioSolutions To Deliver BioThrax Vaccine Under $20M DoD Contract Option", "summary": "", "symbols": ["EBS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42870859/emergent-biosolutions-to-deliver-biothrax-vaccine-under-20m-dod-contract-option", "tags": ["contract"]}
{"id": 42870864, "time": "2025-01-08 07:36:18", "headline": "Albertsons Companies Q3 2024 Adj. EPS $0.71 Beats $0.66 Estimate, Sales $18.774B Miss $18.820B Estimate", "summary": "", "symbols": ["ACI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/01/42870864/albertsons-companies-q3-2024-adj-eps-0-71-beats-0-66-estimate-sales-18-774b-miss-18-820b-estimate", "tags": ["earnings"]}
{"id": 42870866, "time": "2025-01-08 07:36:30", "headline": "Foresight Regains Compliance With Nasdaq's Minimum Bid Price Rule,", "summary": "", "symbols": ["FRSX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42870866/foresight-regains-compliance-with-nasdaqs-minimum-bid-price-rule", "tags": []}
{"id": 42870872, "time": "2025-01-08 07:36:52", "headline": "RBC Capital Downgrades OptimizeRx to Sector Perform, Lowers Price Target to $6", "summary": "", "symbols": ["OPRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42870872/rbc-capital-downgrades-optimizerx-to-sector-perform-lowers-price-target-to-6", "tags": ["analyst_down", "price_target_down"]}
{"id": 42870874, "time": "2025-01-08 07:37:15", "headline": "Profound Medical Announced Preliminary Unaudited Revenues For The Fourth Quarter, Expecting Revenue Of $4.1M To $4.2M (Vs. Cons. Of $4.3M), up 105% And 110% Y/Y", "summary": "", "symbols": ["PROF"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/25/01/42870874/profound-medical-announced-preliminary-unaudited-revenues-for-the-fourth-quarter-expecting-revenue-o", "tags": ["earnings"]}
{"id": 42870889, "time": "2025-01-08 07:38:26", "headline": "RBC Capital Upgrades Phreesia to Outperform, Raises Price Target to $32", "summary": "", "symbols": ["PHR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42870889/rbc-capital-upgrades-phreesia-to-outperform-raises-price-target-to-32", "tags": ["analyst_up", "price_target_up"]}
{"id": 42870890, "time": "2025-01-08 07:38:39", "headline": "Profound Medical Sees Full Year 2024 Revenue Of Around $11.1M To $11.2M vs. Cons. Of $11.284M", "summary": "", "symbols": ["PROF"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/25/01/42870890/profound-medical-sees-full-year-2024-revenue-of-around-11-1m-to-11-2m-vs-cons-of-11-284m", "tags": ["earnings"]}
{"id": 42870891, "time": "2025-01-08 07:39:27", "headline": "The Real Brokerage Announced It Has Expanded Its Presence Throughout Florida's Space Coast With The Addition Of The Burgman Group", "summary": "", "symbols": ["REAX"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/25/01/42870891/the-real-brokerage-announced-it-has-expanded-its-presence-throughout-floridas-space-coast-with-the-a", "tags": []}
{"id": 42870956, "time": "2025-01-08 07:40:27", "headline": "W. P. Carey Announces $1.6B Investment Volume For 2024, Driven By Record $845M In Q4 Deals", "summary": "", "symbols": ["WPC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42870956/w-p-carey-announces-1-6b-investment-volume-for-2024-driven-by-record-845m-in-q4-deals", "tags": []}
{"id": 42870957, "time": "2025-01-08 07:40:28", "headline": "Citigroup Maintains Buy on Amer Sports, Raises Price Target to $36", "summary": "", "symbols": ["AS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42870957/citigroup-maintains-buy-on-amer-sports-raises-price-target-to-36", "tags": ["analyst_other", "price_target_up"]}
{"id": 42870961, "time": "2025-01-08 07:41:23", "headline": "Why Is Quantum Computing Stock Falling Today?", "summary": "Quantum Computing shares are falling following the announcement of a $100 million private placement offering at a price of $12.25 per share.", "symbols": ["QUBT"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/25/01/42870961/why-quantum-computing-stock-is-falling-today", "tags": ["why_moving", "offering"]}
{"id": 42870962, "time": "2025-01-08 07:41:27", "headline": "This Levi Strauss Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday", "summary": " ", "symbols": ["ALT", "CNTX", "LEVI", "NKTR", "SMMT"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/01/42870962/this-levi-strauss-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-wednesday", "tags": ["analyst_init"]}
{"id": 42870970, "time": "2025-01-08 07:41:44", "headline": "Albertsons Companies Raises FY24 Outlook: Projects Adjusted EPS Of $2.25-$2.31 Per Share Versus $2.26 Estimate (Prior View: $2.20-$2.30); Expects Identical Sales Growth In The Range Of 1.8%-2.0% (Previously 1.8%-2.2%)", "summary": "", "symbols": ["ACI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42870970/albertsons-companies-raises-fy24-outlook-projects-adjusted-eps-of-2-25-2-31-per-share-versus-2-26-es", "tags": ["earnings", "guidance"]}
{"id": 42870995, "time": "2025-01-08 07:43:33", "headline": "Albertsons Companies Declared A Cash Dividend For Q4 Of $0.15 Per Share Of Common Stock, Which Is Payable On February 7", "summary": "", "symbols": ["ACI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42870995/albertsons-companies-declared-a-cash-dividend-for-q4-of-0-15-per-share-of-common-stock-which-is-paya", "tags": ["dividend"]}
{"id": 42870996, "time": "2025-01-08 07:43:33", "headline": "Citigroup Maintains Sell on Hershey, Lowers Price Target to $159", "summary": "", "symbols": ["HSY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42870996/citigroup-maintains-sell-on-hershey-lowers-price-target-to-159", "tags": ["analyst_other", "price_target_down"]}
{"id": 42870997, "time": "2025-01-08 07:44:00", "headline": "Sensei Biotherapeutics Advances SNS-101, Positioned For Key Data Milestones In 2025", "summary": "", "symbols": ["SNSE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42870997/sensei-biotherapeutics-advances-sns-101-positioned-for-key-data-milestones-in-2025", "tags": []}
{"id": 42870999, "time": "2025-01-08 07:44:45", "headline": "Citigroup Maintains Buy on Mondelez International, Lowers Price Target to $71", "summary": "", "symbols": ["MDLZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42870999/citigroup-maintains-buy-on-mondelez-international-lowers-price-target-to-71", "tags": ["analyst_other", "price_target_down"]}
{"id": 42871007, "time": "2025-01-08 07:45:20", "headline": "NLS Pharmaceutics And Kadimastem Announce The Successful Completion Of The Initial Closing Of $500,000 Of The Previously Announced $1M Financing Between NLS And An Accredited Investor Under A Securities Purchase Agreement", "summary": "", "symbols": ["NLSP"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/25/01/42871007/nls-pharmaceutics-and-kadimastem-announce-the-successful-completion-of-the-initial-closing-of-500-00", "tags": ["contract"]}
{"id": 42871008, "time": "2025-01-08 07:45:51", "headline": "Serve Robotics Stock Tumbles In Pre-Market As CEO Sells Shares: Here's What Technical Analysis Shows", "summary": "Serve Robotics Shares Rise In Premarket After Steep Fall As CEO Sells 46,425 Shares, But Technical Analysis Indicate Strong Bullish Uptrend.", "symbols": ["QQQ", "SERV"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/trading-ideas/technicals/25/01/42871008/serve-robotics-stock-tumbles-in-pre-market-as-ceo-sells-shares-heres-what-technical-analysis-shows", "tags": ["management"]}
{"id": 42871019, "time": "2025-01-08 07:46:44", "headline": "Vir Biotechnology Is Presenting Initial Phase 1 Data From Two Of Its Dual-masked T-cell Engagers (TCEs): VIR-5818, Targeting A Variety Of HER2-expressing Solid Tumors; And VIR-5500, Targeting PSMA In Metastatic Castration-resistant Prostate Cancer", "summary": "", "symbols": ["VIR"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/25/01/42871019/vir-biotechnology-is-presenting-initial-phase-1-data-from-two-of-its-dual-masked-t-cell-engagers-tce", "tags": ["fda"]}
{"id": 42871047, "time": "2025-01-08 07:48:02", "headline": "Citigroup Maintains Neutral on Generac Hldgs, Lowers Price Target to $162", "summary": "", "symbols": ["GNRC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42871047/citigroup-maintains-neutral-on-generac-hldgs-lowers-price-target-to-162", "tags": ["analyst_other", "price_target_down"]}
{"id": 42871056, "time": "2025-01-08 07:48:31", "headline": "BYD Reportedly Brought Chinese Workers With Irregular Visas To Work At Factory, Says Brazilian Labor Inspector", "summary": "Chinese EV maker BYD Co Ltd reportedly brought hundreds of Chinese workers with irregular visas to work at its upcoming factory in Brazil.", "symbols": ["BYDDY"], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/tech/25/01/42871056/byd-reportedly-brought-chinese-workers-with-irregular-visas-to-work-at-factory-says-brazilian-labor-inspector", "tags": []}
{"id": 42871066, "time": "2025-01-08 07:49:20", "headline": "Citigroup Maintains Neutral on Enphase Energy, Raises Price Target to $72", "summary": "", "symbols": ["ENPH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42871066/citigroup-maintains-neutral-on-enphase-energy-raises-price-target-to-72", "tags": ["analyst_other", "price_target_up"]}
{"id": 42871302, "time": "2025-01-08 07:51:00", "headline": "CORRECTION: Helen Of Troy Q3 2025 Adj. EPS $2.67 Beats $2.60 Estimate, Sales $530.706M Miss $534.311M Estimate", "summary": "", "symbols": ["HELE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/01/42871302/correction-helen-of-troy-q3-2025-adj-eps-2-67-beats-2-60-estimate-sales-530-706m-miss-534-311m-esti", "tags": ["earnings"]}
{"id": 42871311, "time": "2025-01-08 07:52:10", "headline": "Northland Capital Markets Maintains Outperform on BioLife Solns, Raises Price Target to $31", "summary": "", "symbols": ["BLFS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42871311/northland-capital-markets-maintains-outperform-on-biolife-solns-raises-price-target-to-31", "tags": ["analyst_other", "price_target_up"]}
{"id": 42871322, "time": "2025-01-08 07:52:44", "headline": "Citigroup Maintains Neutral on NEXTracker, Lowers Price Target to $45", "summary": "", "symbols": ["NXT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42871322/citigroup-maintains-neutral-on-nextracker-lowers-price-target-to-45", "tags": ["analyst_other", "price_target_down"]}
{"id": 42871339, "time": "2025-01-08 07:53:57", "headline": "Meta Announces A Test In Germany, France And The US That Will Enable Buyers To Browse Listings From eBay Directly On Facebook Marketplace", "summary": "", "symbols": ["EBAY", "META"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42871339/meta-announces-a-test-in-germany-france-and-the-us-that-will-enable-buyers-to-browse-listings-from-e", "tags": []}
{"id": 42871340, "time": "2025-01-08 07:54:12", "headline": "Regional Banks Can Thrive Despite Big Bank Dominance: Truist Securities Highlights Three Key Paths For Thriving Regional Banks", "summary": "Regional banks still have room to thrive, says Truist Securities in its note, highlighting three key paths for regional banks to succeed.", "symbols": ["ALLY", "AXP", "CFG", "CMA", "COF", "DFS", "FCNCA", "FITB", "HBAN", "KEY", "MTB", "RF", "SYF", "WTFC"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/general/market-summary/25/01/42871340/regional-banks-can-thrive-despite-big-bank-dominance-truist-securities-highlights-three-key-paths-for-thriving-regional-banks", "tags": []}
{"id": 42871341, "time": "2025-01-08 07:54:12", "headline": "Citigroup Maintains Neutral on Oklo, Raises Price Target to $31", "summary": "", "symbols": ["OKLO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42871341/citigroup-maintains-neutral-on-oklo-raises-price-target-to-31", "tags": ["analyst_other", "price_target_up"]}
{"id": 42871347, "time": "2025-01-08 07:54:21", "headline": "Northland Capital Markets Maintains Outperform on Asure Software, Raises Price Target to $14", "summary": "", "symbols": ["ASUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42871347/northland-capital-markets-maintains-outperform-on-asure-software-raises-price-target-to-14", "tags": ["analyst_other", "price_target_up"]}
{"id": 42871375, "time": "2025-01-08 07:56:48", "headline": "D. Boral Capital Maintains Buy on Tetra Technologies, Maintains $5.5 Price Target", "summary": "", "symbols": ["TTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42871375/d-boral-capital-maintains-buy-on-tetra-technologies-maintains-5-5-price-target", "tags": ["analyst_other"]}
{"id": 42871409, "time": "2025-01-08 07:57:16", "headline": "Northland Capital Markets Maintains Outperform on inTest, Raises Price Target to $16", "summary": "", "symbols": ["INTT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42871409/northland-capital-markets-maintains-outperform-on-intest-raises-price-target-to-16", "tags": ["analyst_other", "price_target_up"]}
{"id": 42871466, "time": "2025-01-08 08:00:08", "headline": "D. Boral Capital Maintains Buy on AVITA Medical, Maintains $25 Price Target", "summary": "", "symbols": ["RCEL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42871466/d-boral-capital-maintains-buy-on-avita-medical-maintains-25-price-target", "tags": ["analyst_other"]}
{"id": 42871609, "time": "2025-01-08 08:00:35", "headline": "Beyond The Numbers: 7 Analysts Discuss Globe Life Stock", "summary": " ", "symbols": ["GL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42871609/beyond-the-numbers-7-analysts-discuss-globe-life-stock", "tags": []}
{"id": 42871616, "time": "2025-01-08 08:00:48", "headline": "The Analyst Verdict: SharkNinja In The Eyes Of 6 Experts", "summary": " ", "symbols": ["SN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42871616/the-analyst-verdict-sharkninja-in-the-eyes-of-6-experts", "tags": []}
{"id": 42871624, "time": "2025-01-08 08:01:04", "headline": "What Analysts Are Saying About Regeneron Pharmaceuticals Stock", "summary": " ", "symbols": ["REGN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42871624/what-analysts-are-saying-about-regeneron-pharmaceuticals-stock", "tags": []}
{"id": 42871640, "time": "2025-01-08 08:01:16", "headline": "Demystifying Federated Hermes: Insights From 8 Analyst Reviews", "summary": " ", "symbols": ["FHI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42871640/demystifying-federated-hermes-insights-from-8-analyst-reviews", "tags": []}
{"id": 42871645, "time": "2025-01-08 08:01:42", "headline": "UniFirst Q1 Sales $604.91M Miss $606.62M Estimate", "summary": "", "symbols": ["UNF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/01/42871645/unifirst-q1-sales-604-91m-miss-606-62m-estimate", "tags": []}
{"id": 42871655, "time": "2025-01-08 08:01:53", "headline": "Denali Therapeutics Receives FDA Breakthrough Therapy Designation For Tividenofusp Alfa In Treatment Of Hunter Syndrome (MPS II)", "summary": "", "symbols": ["DNLI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42871655/denali-therapeutics-receives-fda-breakthrough-therapy-designation-for-tividenofusp-alfa-in-treatment", "tags": ["fda"]}
{"id": 42871665, "time": "2025-01-08 08:02:16", "headline": "Bitdeer Announces December 2024 Production And Operations Update; 145 Bitcoins Mined; 594 Bitcoins Held; Production Of ~35 EH/s Of SEALMINER A2s Through Q3 2025 Remains On Track", "summary": "", "symbols": ["BTDR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42871665/bitdeer-announces-december-2024-production-and-operations-update-145-bitcoins-mined-594-bitcoins-hel", "tags": []}
{"id": 42871681, "time": "2025-01-08 08:02:54", "headline": "HC Wainwright & Co. Maintains Buy on Stoke Therapeutics, Maintains $35 Price Target", "summary": "", "symbols": ["STOK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42871681/hc-wainwright-co-maintains-buy-on-stoke-therapeutics-maintains-35-price-target", "tags": ["analyst_other"]}
{"id": 42871694, "time": "2025-01-08 08:04:05", "headline": "HC Wainwright & Co. Maintains Buy on OPKO Health, Maintains $3 Price Target", "summary": "", "symbols": ["OPK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42871694/hc-wainwright-co-maintains-buy-on-opko-health-maintains-3-price-target", "tags": ["analyst_other"]}
{"id": 42871697, "time": "2025-01-08 08:04:08", "headline": "Honeywell And NXP Expand Partnership To Accelerate Next-Gen Aviation Tech With AI-Driven Cockpit Displays, Enhanced Autonomy, And Operational Efficiency; Vertical Aerospace To Leverage New Solutions For eVTOL Aircraft", "summary": "", "symbols": ["HON", "NXPI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42871697/honeywell-and-nxp-expand-partnership-to-accelerate-next-gen-aviation-tech-with-ai-driven-cockpit-dis", "tags": ["contract"]}
{"id": 42871698, "time": "2025-01-08 08:04:09", "headline": "Allurion Announces Positive Topline Results From AUDACITY Trial; At 48 Weeks, Allurion Balloon Subjects Had A Greater Than 50% Responder Rate And Substantially Greater Weight Loss Than Control Subjects", "summary": "", "symbols": ["ALUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/01/42871698/allurion-announces-positive-topline-results-from-audacity-trial-at-48-weeks-allurion-balloon-subj", "tags": ["fda"]}
{"id": 42871699, "time": "2025-01-08 08:04:11", "headline": "AXIL Brands Q2 EPS $0.08 Up From $0.05 YoY, Sales $7.70M Down From $8.40M YoY", "summary": "", "symbols": ["AXIL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/01/42871699/axil-brands-q2-eps-0-08-up-from-0-05-yoy-sales-7-70m-down-from-8-40m-yoy", "tags": ["earnings"]}
{"id": 42871706, "time": "2025-01-08 08:04:57", "headline": "Windtree Therapeutics Unveils New Strategy Aimed At Acquiring FDA-Approved Revenue Assets While Advancing Cardiovascular And Oncology Pipeline; Plans To Acquire Small Biotech Companies To Capitalize On Market Opportunities And Drive Growth", "summary": "", "symbols": ["WINT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42871706/windtree-therapeutics-unveils-new-strategy-aimed-at-acquiring-fda-approved-revenue-assets-while-adva", "tags": ["earnings", "fda", "merger"]}
{"id": 42871746, "time": "2025-01-08 08:05:27", "headline": "Johnson & Johnson's Posdinemab And Tau Active Immunotherapy Granted FDA Fast Track Designations For Alzheimer's", "summary": "", "symbols": ["JNJ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42871746/johnson-johnsons-posdinemab-and-tau-active-immunotherapy-granted-fda-fast-track-designations-for-alz", "tags": ["fda"]}
{"id": 42871747, "time": "2025-01-08 08:05:29", "headline": "Xometry Appoints Sanjeev Singh Sahni As President To Lead Global Operations, Product, Technology, And Supplier Services", "summary": "", "symbols": ["XMTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42871747/xometry-appoints-sanjeev-singh-sahni-as-president-to-lead-global-operations-product-technology-and-s", "tags": ["management"]}
{"id": 42871753, "time": "2025-01-08 08:06:05", "headline": "Horizon Aircraft Announces The Exercise Of 2.5M Warrants For Gross Proceeds Of ~$2.7M; This Additional Working Capital Follows The Co's Recent Announcement Of A Strategic Investment Of $8.4M, Totaling $11.1M Of Capital Infusion In The Last 30 Days", "summary": "", "symbols": ["HOVR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42871753/horizon-aircraft-announces-the-exercise-of-2-5m-warrants-for-gross-proceeds-of-2-7m-this-additional", "tags": []}
{"id": 42871754, "time": "2025-01-08 08:06:18", "headline": "60 Degrees Pharmaceuticals Enrolls First Patient In Tafenoquine Expanded Access Study For Persistent Babesiosis", "summary": "", "symbols": ["SXTP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/01/42871754/60-degrees-pharmaceuticals-enrolls-first-patient-in-tafenoquine-expanded-access-study-for-persist", "tags": []}
{"id": 42871755, "time": "2025-01-08 08:06:20", "headline": "D. Boral Capital Maintains Buy on Trevi Therapeutics, Maintains $21 Price Target", "summary": "", "symbols": ["TRVI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42871755/d-boral-capital-maintains-buy-on-trevi-therapeutics-maintains-21-price-target", "tags": ["analyst_other"]}
{"id": 42871758, "time": "2025-01-08 08:06:23", "headline": "Palvella Therapeutics Doses Firrst Patient In Phase 2 TOIVA Clinical Trial Of QTORIN 3.9% Rapamycin Anhydrous Gel", "summary": "", "symbols": ["PVLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42871758/palvella-therapeutics-doses-firrst-patient-in-phase-2-toiva-clinical-trial-of-qtorin-3-9-rapamycin-a", "tags": ["fda"]}
{"id": 42871764, "time": "2025-01-08 08:07:03", "headline": "TriSalus Announces James Young Appointed Chief Financial Officer, Richard Marshak Appointed Chief Commercial Officer, Jodi Devlin Appointed Chief of Clinical Strategy and Operations; All Appointments Were Effective As Of January 6, 2025", "summary": "", "symbols": ["TLSI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42871764/trisalus-announces-james-young-appointed-chief-financial-officer-richard-marshak-appointed-chief-com", "tags": ["fda"]}
{"id": 42871766, "time": "2025-01-08 08:07:16", "headline": "American Battery Technology Regains Nasdaq Compliance", "summary": "", "symbols": ["ABAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42871766/american-battery-technology-regains-nasdaq-compliance", "tags": []}
{"id": 42871768, "time": "2025-01-08 08:07:19", "headline": "Electric Wheels Agrees To Distribute The Volcon VLCN HF1 UTV In The UK", "summary": "", "symbols": ["VLCN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42871768/electric-wheels-agrees-to-distribute-the-volcon-vlcn-hf1-utv-in-the-uk", "tags": []}
{"id": 42871786, "time": "2025-01-08 08:08:00", "headline": "Acuity Brands Q1 Earnings: Revenue Miss, Smart Spaces Revenue Soars 14.5%, Expands Into Cloud Tech With $1.2 Billion Deal", "summary": "Acuity Brands reports 1.8% YoY net sales growth of $951.6 million in Q1 2025, beating EPS estimates and expanding margins. Stock up 49% in a year.", "symbols": ["AYI", "QCLN", "XMHQ"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/25/01/42871786/acuity-brands-earnings-beats-profit-estimates-smart-spaces-revenue-soars-145-expands-into-cloud-tech-with-12-billion-deal", "tags": ["earnings", "contract"]}
{"id": 42871787, "time": "2025-01-08 08:08:02", "headline": "Replimune Begins RP2 Clinical Trials With First Patients Enrolled In Metastatic Uveal Melanoma And Hepatocellular Carcinoma", "summary": "", "symbols": ["REPL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/01/42871787/replimune-begins-rp2-clinical-trials-with-first-patients-enrolled-in-metastatic-uveal-melanoma-an", "tags": ["fda"]}
{"id": 42871793, "time": "2025-01-08 08:08:18", "headline": "DA Davidson Maintains Buy on Zillow Gr, Raises Price Target to $80", "summary": "", "symbols": ["ZG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42871793/da-davidson-maintains-buy-on-zillow-gr-raises-price-target-to-80", "tags": ["analyst_other", "price_target_up"]}
{"id": 42871799, "time": "2025-01-08 08:08:24", "headline": "Bit Digital, Inc. Announces Monthly Production Update For December 2024; Treasury Holdings Of BTC And ETH Were 742.1 And 27,623.9 With A Fair Market Value Of ~$69.3M And $92.1M", "summary": "", "symbols": ["BTBT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42871799/bit-digital-inc-announces-monthly-production-update-for-december-2024-treasury-holdings-of-btc-and-e", "tags": []}
{"id": 42871801, "time": "2025-01-08 08:08:33", "headline": "Citius Pharmaceuticals Announces $3M Registered Direct Offering Priced At-The-Market, Issuing 743K Shares And Warrants With $3.91 Exercise Price; Proceeds To Support Product Development And Corporate Initiatives", "summary": "", "symbols": ["CTXR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42871801/citius-pharmaceuticals-announces-3m-registered-direct-offering-priced-at-the-market-issuing-743k-sha", "tags": ["offering"]}
{"id": 42871802, "time": "2025-01-08 08:08:52", "headline": "DOGE Co-lead Elon Musk And Vivek Ramaswamy Reportedly On A Hiring Spree For Full Timers", "summary": "For technical roles, candidates must demonstrate exceptional ability and provide a contact number.", "symbols": [], "source": "benzinga", "author": "Pooja Rajkumari", "url": "https://www.benzinga.com/news/25/01/42871802/doge-co-lead-elon-musk-and-vivek-ramaswamy-reportedly-on-a-hiring-spree-for-full-timers", "tags": []}
{"id": 42871810, "time": "2025-01-08 08:09:14", "headline": "Ryde And Delivery Chinatown Strengthen Partnership To Enhance Singapore's Delivery Ecosystem, Supporting F&B Merchants, Empowering Drivers, And Expanding Access To Authentic Local Flavors", "summary": "", "symbols": ["RYDE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42871810/ryde-and-delivery-chinatown-strengthen-partnership-to-enhance-singapores-delivery-ecosystem-supporti", "tags": ["contract"]}
{"id": 42871813, "time": "2025-01-08 08:09:36", "headline": "UniFirst Continues To Expect FY25 EPS To Be $6.79 - $7.19", "summary": "", "symbols": ["UNF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42871813/unifirst-continues-to-expect-fy25-eps-to-be-6-79-7-19", "tags": ["earnings"]}
{"id": 42871814, "time": "2025-01-08 08:09:40", "headline": "Bitcoin Slides 5%, Touches $95,000 Mark: Why Is BTC Going Down?", "summary": "Bitcoin (CRYPTO: BTC) continues to slide following Tuesday\u2019s stronger-than-expected\u00a0December Purchasing Managers&#39; Index reading, ", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/25/01/42871814/bitcoin-slides-5-touches-95000-mark-why-is-btc-going-down", "tags": []}
{"id": 42871826, "time": "2025-01-08 08:10:15", "headline": "BJ's Wholesale Club Partners With Genpact In Multi-Year Deal To Boost Agility, Drive Innovation, And Support Growth Plans Across Finance, HR, Procurement, And Merchandising Functions", "summary": "", "symbols": ["BJ", "G"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42871826/bjs-wholesale-club-partners-with-genpact-in-multi-year-deal-to-boost-agility-drive-innovation-and-su", "tags": ["contract"]}
{"id": 42872011, "time": "2025-01-08 08:10:46", "headline": "Compass Therapeutics Provides Corporate Update And Announces Advancement Of A New Drug Candidate; Tovecimig Phase 2/3 Data For BTC On Track By Q1 2025, CTX-10726 IND Expected YE 2025; CTX-471, Tovecimig Phase 2 Trials Mid-2025. CTX-8371 Phase 1 Enrollment Completed, Estimated $127M Cash To Sustain Operations Into Q1 2027", "summary": "", "symbols": ["CMPX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/01/42872011/compass-therapeutics-provides-corporate-update-and-announces-advancement-of-a-new-drug-candidate-", "tags": ["fda"]}
{"id": 42872012, "time": "2025-01-08 08:10:47", "headline": "Rosenblatt Maintains Buy on NVIDIA, Maintains $220 Price Target", "summary": "", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872012/rosenblatt-maintains-buy-on-nvidia-maintains-220-price-target", "tags": ["analyst_other"]}
{"id": 42872013, "time": "2025-01-08 08:10:52", "headline": "Collegium Sees 2025 Net Product Revenues $735M-$750M, Adj. EBITDA $435M-$450M", "summary": "", "symbols": ["COLL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872013/collegium-sees-2025-net-product-revenues-735m-750m-adj-ebitda-435m-450m", "tags": []}
{"id": 42872014, "time": "2025-01-08 08:10:54", "headline": "UniFirst Q1 2025 Adj EPS $2.40 Beats $2.22 Estimate", "summary": "", "symbols": ["UNF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/01/42872014/unifirst-q1-2025-adj-eps-2-40-beats-2-22-estimate", "tags": ["earnings"]}
{"id": 42871756, "time": "2025-01-08 08:06:20", "headline": "UniFirst Revises FY25 Revenue Outlook From $2.425B - $2.445B To $2.425B - $2.440B, Est $2.434B", "summary": "", "symbols": ["UNF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42871756/unifirst-revises-fy25-revenue-outlook-from-2-425b-2-445b-to-2-425b-2-440b-est-2-434b", "tags": ["earnings", "guidance"]}
{"id": 42872027, "time": "2025-01-08 08:11:59", "headline": "Arcadium Lithium Secures CFIUS Clearance For Acquisition By Rio Tinto, With Key Regulatory Approvals Completed In Multiple Countries; Transaction Expected To Close Before Mid-2025", "summary": "", "symbols": ["ALTM", "RIO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/01/42872027/arcadium-lithium-secures-cfius-clearance-for-acquisition-by-rio-tinto-with-key-regulatory-approvals", "tags": []}
{"id": 42872028, "time": "2025-01-08 08:12:06", "headline": "Cocrystal Pharma Reports Phase 1 Results With Oral, Broad-Acting Antiviral Drug CDI-988 For Prophylaxis And Treatment Of Norovirus, Coronaviruses And Other Viral Infections; Data Show Favorable Safety And Tolerability With Dosing Up To 800 mg For 10 Days; Plans To Initiate Human Challenge Study In 2025 In Norovirus-infected Subjects", "summary": "", "symbols": ["COCP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/01/42872028/cocrystal-pharma-reports-phase-1-results-with-oral-broad-acting-antiviral-drug-cdi-988-for-prophy", "tags": ["fda"]}
{"id": 42872057, "time": "2025-01-08 08:13:35", "headline": "Barclays Maintains Underweight on Allegion, Lowers Price Target to $134", "summary": "", "symbols": ["ALLE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872057/barclays-maintains-underweight-on-allegion-lowers-price-target-to-134", "tags": ["analyst_other", "price_target_down"]}
{"id": 42872058, "time": "2025-01-08 08:13:38", "headline": "Golden Heaven Group Holdings Enters Into ~$2.1M Long Term Service Agreement For Management Solutions With Fuzhou Yibang Amusement Park Co.", "summary": "", "symbols": ["GDHG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872058/golden-heaven-group-holdings-enters-into-2-1m-long-term-service-agreement-for-management-solutions-w", "tags": ["contract"]}
{"id": 42872060, "time": "2025-01-08 08:14:03", "headline": "AVITA Medical, Quantum Computing And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session", "summary": " ", "symbols": ["FUBO", "IONQ", "LAES", "NIO", "QBTS", "QUBT", "RCEL", "RGTI"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/trading-ideas/movers/25/01/42872060/avita-medical-quantum-computing-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session", "tags": ["why_moving"]}
{"id": 42872061, "time": "2025-01-08 08:14:15", "headline": "Barclays Maintains Overweight on Carrier Global, Lowers Price Target to $90", "summary": "", "symbols": ["CARR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872061/barclays-maintains-overweight-on-carrier-global-lowers-price-target-to-90", "tags": ["analyst_other", "price_target_down"]}
{"id": 42872073, "time": "2025-01-08 08:14:31", "headline": "Soluna Announces Monthly Business Update; Achieves Milestone Of 100 GWh In Curtailed Energy Monetization", "summary": "", "symbols": ["SLNH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872073/soluna-announces-monthly-business-update-achieves-milestone-of-100-gwh-in-curtailed-energy-monetizat", "tags": []}
{"id": 42872075, "time": "2025-01-08 08:14:53", "headline": "Barclays Maintains Overweight on Constellation Brands, Lowers Price Target to $282", "summary": "", "symbols": ["STZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872075/barclays-maintains-overweight-on-constellation-brands-lowers-price-target-to-282", "tags": ["analyst_other", "price_target_down"]}
{"id": 42872082, "time": "2025-01-08 08:15:11", "headline": "Mineralys Therapeutics Secures FDA Clearance To Launch Phase 2 Trial Of Lorundrostat For Obstructive Sleep Apnea In Patients With Hypertension, Expanding Its Market Potential In Aldosterone-Driven Diseases; Trial Set To Begin In Q1 2025", "summary": "", "symbols": ["MLYS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/01/42872082/mineralys-therapeutics-secures-fda-clearance-to-launch-phase-2-trial-of-lorundrostat-for-obstruct", "tags": ["fda"]}
{"id": 42872084, "time": "2025-01-08 08:15:14", "headline": "Nexstar Media Renews Affiliation Agreements With NBC; Multi-Year Renewal Covers 33 Affiliated Nexstar-Owned And Partner Television Stations; Financial Terms Were Not Disclosed", "summary": "", "symbols": ["NXST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872084/nexstar-media-renews-affiliation-agreements-with-nbc-multi-year-renewal-covers-33-affiliated-nexstar", "tags": []}
{"id": 42872086, "time": "2025-01-08 08:15:26", "headline": "ADP Nonfarm Employment Change (Dec) +122K vs +139K Est.", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/01/42872086/adp-nonfarm-employment-change-dec-122k-vs-139k-est", "tags": []}
{"id": 42872090, "time": "2025-01-08 08:15:30", "headline": "Barclays Maintains Overweight on Fortive, Lowers Price Target to $90", "summary": "", "symbols": ["FTV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872090/barclays-maintains-overweight-on-fortive-lowers-price-target-to-90", "tags": ["analyst_other", "price_target_down"]}
{"id": 42872114, "time": "2025-01-08 08:15:47", "headline": "CrowdStrike Achieves FedRAMP Authorization For New Modules To Secure Highly Regulated Industries In The Cloud", "summary": "", "symbols": ["CRWD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872114/crowdstrike-achieves-fedramp-authorization-for-new-modules-to-secure-highly-regulated-industries-in", "tags": []}
{"id": 42872116, "time": "2025-01-08 08:16:10", "headline": "Barclays Maintains Overweight on Honeywell Intl, Lowers Price Target to $255", "summary": "", "symbols": ["HON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872116/barclays-maintains-overweight-on-honeywell-intl-lowers-price-target-to-255", "tags": ["analyst_other", "price_target_down"]}
{"id": 42872118, "time": "2025-01-08 08:16:36", "headline": "LifeVantage Reports Preliminary Q2 Revenue of $67.5M vs $51.45, Up 31% YoY and 43% Sequentially, Raises FY25 Revenue Guidance to $235M-$245M vs Prior $200M-$210M (Est. $204.3M)", "summary": "", "symbols": ["LFVN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872118/lifevantage-reports-preliminary-q2-revenue-of-67-5m-vs-51-45-up-31-yoy-and-43-sequentially-raises-fy", "tags": ["earnings", "guidance"]}
{"id": 42872128, "time": "2025-01-08 08:16:43", "headline": "Edible Garden Reports Over 45% YoY Increase In Preliminary Holiday Sales Of Herbs And Produce, Building On Record Thanksgiving Growth And Strengthening Its Position In Sustainable Agriculture", "summary": "", "symbols": ["EDBL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872128/edible-garden-reports-over-45-yoy-increase-in-preliminary-holiday-sales-of-herbs-and-produce-buildin", "tags": []}
{"id": 42872139, "time": "2025-01-08 08:17:32", "headline": "Indaptus Therapeutics Provides 2025 Outlook, Launching Decoy20 Combination Cohort With BeiGene's Tislelizumab, Expanding Clinical Sites Beyond 8, Updating Higher Dose Cohort, First Patient Dosed In Combination, Focus On Cancer Challenges", "summary": "", "symbols": ["INDP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/01/42872139/indaptus-therapeutics-provides-2025-outlook-launching-decoy20-combination-cohort-with-beigenes-ti", "tags": ["guidance", "fda"]}
{"id": 42872143, "time": "2025-01-08 08:18:07", "headline": "Kratos Awarded $48M Contract For Geolocation Global Support Services", "summary": "", "symbols": ["KTOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872143/kratos-awarded-48m-contract-for-geolocation-global-support-services", "tags": ["contract"]}
{"id": 42872149, "time": "2025-01-08 08:18:34", "headline": "Helen Of Troy Sales Decline As Beauty Products Demand Softens; Shares Plunge", "summary": "Helen of Troy reported a 3.4% year-on-year decline in Q3 FY25 sales,. The decline in sales was mainly attributed to weaker performance in the Beauty &amp; Wellness segment, which saw a 9.3% drop. ", "symbols": ["HELE"], "source": "benzinga", "author": "Shivani Kumaresan", "url": "https://www.benzinga.com/news/earnings/25/01/42872149/helen-of-troy-sales-decline-as-beauty-products-demand-softens-shares-plunge", "tags": []}
{"id": 42872167, "time": "2025-01-08 08:19:21", "headline": "Gain Therapeutics Forms Clinical Advisory Board To Support Advancement Of Lead Drug Candidate GT-02287", "summary": "", "symbols": ["GANX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/01/42872167/gain-therapeutics-forms-clinical-advisory-board-to-support-advancement-of-lead-drug-candidate-gt-", "tags": ["fda"]}
{"id": 42872168, "time": "2025-01-08 08:19:34", "headline": "Asher Bio Announces Clinical Trial Collaboration And Supply Agreement With Amgen On Etakafusp Alfa In Combination With Bispecific T-cell Engager In Patients With Small Cell Lung Cancer", "summary": "", "symbols": ["AMGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/01/42872168/asher-bio-announces-clinical-trial-collaboration-and-supply-agreement-with-amgen-on-etakafusp-alf", "tags": ["fda", "contract"]}
{"id": 42872448, "time": "2025-01-08 08:20:56", "headline": "BlueLinx And Louisiana-Pacific Announced Expansion Of Distribution Partnership, Adding LP SmartSide Products In Central Region, Increasing BlueLinx's Footprint To 17 Locations Across Four Regions In The U.S.", "summary": "", "symbols": ["BXC", "LPX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872448/bluelinx-and-louisiana-pacific-announced-expansion-of-distribution-partnership-adding-lp-smartside-p", "tags": ["contract"]}
{"id": 42872456, "time": "2025-01-08 08:20:56", "headline": "Barclays Maintains Equal-Weight on Illinois Tool Works, Lowers Price Target to $265", "summary": "", "symbols": ["ITW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872456/barclays-maintains-equal-weight-on-illinois-tool-works-lowers-price-target-to-265", "tags": ["analyst_other", "price_target_down"]}
{"id": 42872471, "time": "2025-01-08 08:21:42", "headline": "Corbus Pharmaceuticals Announces That Clinical Data For CRB-701 From Western Dose Escalation Study To Be Presented At ASCO GU 2025", "summary": "", "symbols": ["CRBP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/01/42872471/corbus-pharmaceuticals-announces-that-clinical-data-for-crb-701-from-western-dose-escalation-stud", "tags": ["fda"]}
{"id": 42872478, "time": "2025-01-08 08:22:03", "headline": "Barclays Maintains Overweight on Ingersoll Rand, Lowers Price Target to $115", "summary": "", "symbols": ["IR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872478/barclays-maintains-overweight-on-ingersoll-rand-lowers-price-target-to-115", "tags": ["analyst_other", "price_target_down"]}
{"id": 42872487, "time": "2025-01-08 08:23:07", "headline": "NV5 Enters 2025 With A Budget Exceeding $1B In Gross Revenues And Has Also Announced A New Goal To Reach $1.6B In Annual Revenues By 2028", "summary": "", "symbols": ["NVEE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872487/nv5-enters-2025-with-a-budget-exceeding-1b-in-gross-revenues-and-has-also-announced-a-new-goal-to-re", "tags": []}
{"id": 42872488, "time": "2025-01-08 08:23:09", "headline": "Barclays Maintains Equal-Weight on Kennametal, Lowers Price Target to $30", "summary": "", "symbols": ["KMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872488/barclays-maintains-equal-weight-on-kennametal-lowers-price-target-to-30", "tags": ["analyst_other", "price_target_down"]}
{"id": 42872522, "time": "2025-01-08 08:23:56", "headline": "Sky Quarry Receives Permission To Operate Fractionation Facility At Eagle Springs Refinery Site In Nevada", "summary": "", "symbols": ["SKYQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872522/sky-quarry-receives-permission-to-operate-fractionation-facility-at-eagle-springs-refinery-site-in-n", "tags": []}
{"id": 42872523, "time": "2025-01-08 08:24:02", "headline": "Barclays Maintains Underweight on Otis Worldwide, Lowers Price Target to $91", "summary": "", "symbols": ["OTIS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872523/barclays-maintains-underweight-on-otis-worldwide-lowers-price-target-to-91", "tags": ["analyst_other", "price_target_down"]}
{"id": 42872530, "time": "2025-01-08 08:24:31", "headline": "SELLAS Outlines 2025 Objectives: Phase 3 REGAL Interim Analysis In January, Phase 2 SLS009 Topline Data And FDA Review Expected 1H 2025, Tambiciclib Named As INN For SLS009, Non-Dilutive Grant Funding Application Submitted For AML Expansion, And Pediatric Program Development Underway", "summary": "", "symbols": ["SLS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/01/42872530/sellas-outlines-2025-objectives-phase-3-regal-interim-analysis-in-january-phase-2-sls009-topline-", "tags": ["offering", "fda"]}
{"id": 42872531, "time": "2025-01-08 08:24:52", "headline": "Barclays Maintains Overweight on Philip Morris Intl, Lowers Price Target to $145", "summary": "", "symbols": ["PM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872531/barclays-maintains-overweight-on-philip-morris-intl-lowers-price-target-to-145", "tags": ["analyst_other", "price_target_down"]}
{"id": 42872532, "time": "2025-01-08 08:25:01", "headline": "Bitcoin Depot Announces The Deployment Of 50 Additional Bitcoin ATMs In Partnership With A Prominent Convenience Store Operator With Locations Across The Texas Panhandle And Nearby States", "summary": "", "symbols": ["BTM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872532/bitcoin-depot-announces-the-deployment-of-50-additional-bitcoin-atms-in-partnership-with-a-prominent", "tags": ["contract"]}
{"id": 42872547, "time": "2025-01-08 08:25:42", "headline": "Barclays Maintains Overweight on Regal Rexnord, Lowers Price Target to $190", "summary": "", "symbols": ["RRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872547/barclays-maintains-overweight-on-regal-rexnord-lowers-price-target-to-190", "tags": ["analyst_other", "price_target_down"]}
{"id": 42872549, "time": "2025-01-08 08:25:45", "headline": "Trading Halt: Halted at 8:25:41 a.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["ACCD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/01/42872549/trading-halt-halted-at-8-25-41-a-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 42872569, "time": "2025-01-08 08:26:26", "headline": "Barclays Maintains Equal-Weight on Rockwell Automation, Lowers Price Target to $285", "summary": "", "symbols": ["ROK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872569/barclays-maintains-equal-weight-on-rockwell-automation-lowers-price-target-to-285", "tags": ["analyst_other", "price_target_down"]}
{"id": 42872576, "time": "2025-01-08 08:27:13", "headline": "Barclays Maintains Underweight on Roper Techs, Lowers Price Target to $562", "summary": "", "symbols": ["ROP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872576/barclays-maintains-underweight-on-roper-techs-lowers-price-target-to-562", "tags": ["analyst_other", "price_target_down"]}
{"id": 42872577, "time": "2025-01-08 08:27:17", "headline": "SLB Has Been Awarded A Series Of Major Drilling Contracts By Shell To Support Capital-Efficient Energy Development Across Its Deep- And Ultra-Deepwater Assets In The UK North Sea, Trinidad And Tobago, The Gulf Of Mexico And Others", "summary": "", "symbols": ["SLB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872577/slb-has-been-awarded-a-series-of-major-drilling-contracts-by-shell-to-support-capital-efficient-ener", "tags": ["contract"]}
{"id": 42872581, "time": "2025-01-08 08:27:31", "headline": "Micron's $7 Billion Bet on AI-Driven Memory In Singapore Facility Set to Boost Innovation", "summary": " Micron Technology, Inc. (NASDAQ: MU) broke ground on a new HBM advanced packaging facility in Singapore, expanding its capacity and creating jobs.\n \n\n", "symbols": ["JEPI", "MU", "NVDA", "QTEC"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/25/01/42872581/microns-7-billion-bet-on-ai-driven-memory-singapore-facility-set-to-boost-innovation-and-jobs", "tags": []}
{"id": 42872585, "time": "2025-01-08 08:27:44", "headline": "Galapagos NV Spinco Plans To Also List On Nasdaq", "summary": "", "symbols": ["GLPG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872585/galapagos-nv-spinco-plans-to-also-list-on-nasdaq", "tags": []}
{"id": 42872594, "time": "2025-01-08 08:27:58", "headline": "Barclays Maintains Equal-Weight on Stanley Black & Decker, Lowers Price Target to $94", "summary": "", "symbols": ["SWK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872594/barclays-maintains-equal-weight-on-stanley-black-decker-lowers-price-target-to-94", "tags": ["analyst_other", "price_target_down"]}
{"id": 42872611, "time": "2025-01-08 08:29:01", "headline": "Barclays Maintains Overweight on 3M, Lowers Price Target to $161", "summary": "", "symbols": ["MMM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872611/barclays-maintains-overweight-on-3m-lowers-price-target-to-161", "tags": ["analyst_other", "price_target_down"]}
{"id": 42872653, "time": "2025-01-08 08:30:06", "headline": "USA Initial Jobless Claims 201K Vs 214K Est.; 211K Prior", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/01/42872653/usa-initial-jobless-claims-201k-vs-214k-est-211k-prior", "tags": []}
{"id": 42872665, "time": "2025-01-08 08:30:08", "headline": "Silo Pharma Awarded US Patent For PTSD Treatment Titled 'Pharmacological Prophylactics Against Stress-Induced Affective Disorders in Females.' And Prepares For SPC-15 Clinical Trial", "summary": "", "symbols": ["SILO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/01/42872665/silo-pharma-awarded-us-patent-for-ptsd-treatment-titled-pharmacological-prophylactics-against-str", "tags": ["fda", "contract"]}
{"id": 42872666, "time": "2025-01-08 08:30:09", "headline": "EXCLUSIVE: Lo Rosa Holding Tells Benzinga Co. Acquires Real Estate Brokerage Franchisee With Approximately $2.7M In Revenue For Trailing Twelve Months And Positive Net Income As Of Nov. 30, 2024", "summary": "", "symbols": ["LRHC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872666/exclusive-lo-rosa-holding-tells-benzinga-co-acquires-real-estate-brokerage-franchisee-with-approxima", "tags": ["earnings", "merger"]}
{"id": 42872681, "time": "2025-01-08 08:30:19", "headline": "EXCLUSIVE: La Rosa Snaps La Rosa Realty Beaches Franchisee", "summary": "La Rosa Holdings Corp (NASDAQ: LRHC) completed acquisition of Realty Beaches, reporting $2.7M TTM revenue and positive net income. Expects $100M run rate by 2024 and profitability by 2025.", "symbols": ["LRHC"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/news/25/01/42872681/exclusive-la-rosa-snaps-la-rosa-realty-beaches-franchisee", "tags": ["earnings"]}
{"id": 42872687, "time": "2025-01-08 08:30:26", "headline": "USA Continuing Jobless Claims 1,867K Vs 1,870K Est.; 1,843K Prior", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/01/42872687/usa-continuing-jobless-claims-1-867k-vs-1-870k-est-1-843k-prior", "tags": []}
{"id": 42872688, "time": "2025-01-08 08:30:28", "headline": "Barclays Maintains Overweight on Vontier, Lowers Price Target to $45", "summary": "", "symbols": ["VNT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872688/barclays-maintains-overweight-on-vontier-lowers-price-target-to-45", "tags": ["analyst_other", "price_target_down"]}
{"id": 42872785, "time": "2025-01-08 08:32:14", "headline": "Multi Ways Holdings Sells 23 SANY Cranes For Over $6.6M, Strengthening Partnership With SANY And Meeting Growing Demand For Advanced Construction Equipment", "summary": "", "symbols": ["MWG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872785/multi-ways-holdings-sells-23-sany-cranes-for-over-6-6m-strengthening-partnership-with-sany-and-meeti", "tags": ["contract"]}
{"id": 42872793, "time": "2025-01-08 08:33:01", "headline": "IGC Pharma Names Alzheimer's Agitation Phase 2 Trial \"CALMA\" And Expands Recruitment With Geofencing Technology, Targeting Completion In 2H 2025 After Achieving 200%-300% Enrollment Boost At Select Sites", "summary": "", "symbols": ["IGC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/01/42872793/igc-pharma-names-alzheimers-agitation-phase-2-trial-calma-and-expands-recruitment-with-geofencing", "tags": ["fda"]}
{"id": 42872794, "time": "2025-01-08 08:33:01", "headline": "Alpha Cognition Announces Exclusive Licensing Agreement For Development And Commercialization Of ZUNVEYL In Asia, Australia And New Zealand; Agreement Is $44M Including $6M In Upfront Payments", "summary": "", "symbols": ["ACOG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872794/alpha-cognition-announces-exclusive-licensing-agreement-for-development-and-commercialization-of-zun", "tags": ["contract"]}
{"id": 42872796, "time": "2025-01-08 08:33:41", "headline": "Transcarent To Acquire Accolade For $7.03 Per Share In Cash", "summary": "", "symbols": ["ACCD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/01/42872796/transcarent-to-acquire-accolade-for-7-03-per-share-in-cash", "tags": ["merger"]}
{"id": 42872802, "time": "2025-01-08 08:34:48", "headline": "Franchise Fallout: Yum! Terminates Turkey Deal Over Standards Issues, Expects Pre-Tax Special Charge", "summary": "Yum! Brands terminates its franchise agreements with IS Gida in Turkey, closing 537 locations, while reacquiring master franchise rights in Germany.", "symbols": ["YUM"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/news/guidance/25/01/42872802/franchise-fallout-yum-terminates-turkey-deal-over-standards-issues-expects-pre-tax-special-charge", "tags": ["contract"]}
{"id": 42872817, "time": "2025-01-08 08:35:12", "headline": "Fed's Waller Says Long-Term Yields May Have More Of An Inflation Premium, But Says Fed Will Fix That; U.S. Deficits May Also Be Driving Long Yields Higher; Some Of Ongoing Service Price Inflation May Represent Lagged Wage Increases, Which Should Ease; Tremendous Uncertainty Around What Will Happen With Tariffs; Do Not Think \"Draconian\" Tariffs Will Be Implemented; In The Near Term Do Not Think There Will Be A Huge Impact On Inflation From Tariffs", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872817/feds-waller-says-long-term-yields-may-have-more-of-an-inflation-premium-but-says-fed-will-fix-that-u", "tags": []}
{"id": 42872818, "time": "2025-01-08 08:35:16", "headline": "MetLife Investment Management To Acquire Three Investment Teams And Assets Managed By Mesirow; Terms Subject To Customary Approvals And Consents", "summary": "", "symbols": ["MET"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/01/42872818/metlife-investment-management-to-acquire-three-investment-teams-and-assets-managed-by-mesirow-terms", "tags": ["merger"]}
{"id": 42872843, "time": "2025-01-08 08:35:48", "headline": "Yum! Brands Terminates Franchise Agreements With Franchisee IS Gida A.S., The Owner And Operator Of All KFC And Pizza Hut Restaurants In Turkey After Failure To Meet Its Standards - Filing", "summary": "", "symbols": ["YUM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872843/yum-brands-terminates-franchise-agreements-with-franchisee-is-gida-a-s-the-owner-and-operator-of-all", "tags": []}
{"id": 42872844, "time": "2025-01-08 08:36:00", "headline": "SunCar Awarded Exclusive $6.8M Contract For Walmart China's 2025 Sam's Club Premium Membership Car Wash Project", "summary": "", "symbols": ["SDA", "WMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872844/suncar-awarded-exclusive-6-8m-contract-for-walmart-chinas-2025-sams-club-premium-membership-car-wash", "tags": ["contract"]}
{"id": 42872865, "time": "2025-01-08 08:36:24", "headline": "Ondas Secures Order From Major Defense Company For AI-Driven Iron Drone Raider System, Expanding Capabilities To Address Ground Threats And Increase TAM; Expects Additional Orders To Support Defense And Homeland Security Applications; Financial Terms Not Disclosed", "summary": "", "symbols": ["ONDS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872865/ondas-secures-order-from-major-defense-company-for-ai-driven-iron-drone-raider-system-expanding-capa", "tags": []}
{"id": 42872968, "time": "2025-01-08 08:37:56", "headline": "Moleculin Biotech Received U.S. Institutional Review Board Approval For Phase 3 Clinical Trial And Engaged Leading Contract Research Organization.", "summary": "", "symbols": ["MBRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/01/42872968/moleculin-biotech-received-u-s-institutional-review-board-approval-for-phase-3-clinical-trial-and", "tags": ["fda", "contract"]}
{"id": 42872969, "time": "2025-01-08 08:38:02", "headline": "Brenmiller Energy Expands U.S. Commercial Pipeline To Over $210M With Rock Energy Storage, Targeting State And Federal Grants For bGen ZERO Long-Duration Energy Storage Projects", "summary": "", "symbols": ["BNRG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872969/brenmiller-energy-expands-u-s-commercial-pipeline-to-over-210m-with-rock-energy-storage-targeting-st", "tags": []}
{"id": 42872973, "time": "2025-01-08 08:38:09", "headline": "Giftify, Inc.  Says Its 2024 Revenue Was Greater Than Previous Forecast Of $85M", "summary": "", "symbols": ["GIFT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872973/giftify-inc-says-its-2024-revenue-was-greater-than-previous-forecast-of-85m", "tags": ["earnings", "guidance"]}
{"id": 42872985, "time": "2025-01-08 08:38:15", "headline": "Scotiabank Downgrades Loblaw Cos to Sector Perform, Announces C$200 Price Target", "summary": "", "symbols": ["TSX:L"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872985/scotiabank-downgrades-loblaw-cos-to-sector-perform-announces-c-200-price-target", "tags": ["analyst_down"]}
{"id": 42872986, "time": "2025-01-08 08:39:00", "headline": "MMA.inc And UFC Gym Group Expand Collaborative Programs", "summary": "", "symbols": ["MMA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42872986/mma-inc-and-ufc-gym-group-expand-collaborative-programs", "tags": []}
{"id": 42873079, "time": "2025-01-08 08:41:13", "headline": "OSI Systems Receives $23M Order To Assist In Deployment And Integration Of Long-range Radio Frequency", "summary": "", "symbols": ["OSIS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42873079/osi-systems-receives-23m-order-to-assist-in-deployment-and-integration-of-long-range-radio-frequency", "tags": []}
{"id": 42873081, "time": "2025-01-08 08:41:40", "headline": "Scotiabank Upgrades George Weston to Sector Outperform, Raises Price Target to C$240", "summary": "", "symbols": ["TSX:WN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42873081/scotiabank-upgrades-george-weston-to-sector-outperform-raises-price-target-to-c-240", "tags": ["analyst_up", "price_target_up"]}
{"id": 42873097, "time": "2025-01-08 08:42:33", "headline": "DatChat Announces $5.1M Registered Direct Offering Priced At-The-Market, Issuing 1.2M Shares At $4.25 Each; Proceeds To Support Working Capital And Corporate Expenses", "summary": "", "symbols": ["DATS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42873097/datchat-announces-5-1m-registered-direct-offering-priced-at-the-market-issuing-1-2m-shares-at-4-25-e", "tags": ["offering"]}
{"id": 42873111, "time": "2025-01-08 08:43:30", "headline": "Alpha Cognition Inks $44 Million Licensing Pact For Its Alzheimer's Drug In China", "summary": "Alpha Cognition and China Medical System sign a $44M licensing deal for Zunveyl. ALPHA-1062 preclinical data shows benefits for blast-related brain injuries.", "symbols": ["ACOG"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/25/01/42873111/alpha-cognition-inks-44-million-licensing-pact-for-its-alzheimers-drug-in-china", "tags": ["contract"]}
{"id": 42873130, "time": "2025-01-08 08:44:33", "headline": "Safety Shot To Acquire Yerba\u00e9 Brands; Company To Acquire All Yerbae Shares In Consideration For The Right To Receive 20M Shares", "summary": "", "symbols": ["SHOT", "YERBF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/01/42873130/safety-shot-to-acquire-yerba-brands-company-to-acquire-all-yerbae-shares-in-consideration-for-the-ri", "tags": ["merger"]}
{"id": 42873131, "time": "2025-01-08 08:44:58", "headline": "Scotiabank Maintains Sector Outperform on HubSpot, Raises Price Target to $825", "summary": "", "symbols": ["HUBS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42873131/scotiabank-maintains-sector-outperform-on-hubspot-raises-price-target-to-825", "tags": ["analyst_other", "price_target_up"]}
{"id": 42873171, "time": "2025-01-08 08:45:50", "headline": "Fed's Waller Says Until Trump Policies Are Clear It Will Be Hard For Markets And The Fed To Assess The Next Year; A Return To The Zero Lower Bound Does Not Seem Likely Anytime Soon; 2010s May Prove An Outlier; The Labor Market Is Not Behaving Like An Economy That Is Overheating; Current U.S. Rates Are Restrictive Though Not Tight Enough To Cause A Recession", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42873171/feds-waller-says-until-trump-policies-are-clear-it-will-be-hard-for-markets-and-the-fed-to-assess-th", "tags": []}
{"id": 42873182, "time": "2025-01-08 08:46:08", "headline": "US Private Businesses Add 122,000 Jobs In December: 'Slowdown In Both Hiring And Pay Gains'", "summary": "Private employers add 122,000 jobs in December, a slowdown from November and falling short of expectations. Hiring contracts in key industries.", "symbols": ["SPY", "UUP"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/economics/macro-economic-events/25/01/42873182/us-private-businesses-add-122000-jobs-in-december-the-labor-market-downshifted-to-a-more-modest-pace-of-growth", "tags": []}
{"id": 42873185, "time": "2025-01-08 08:46:16", "headline": "Neurocrine Biosciences Publishes Narrative Review Discussing Challenges Of Traditional Glucocorticoid Treatment in Classic Congenital Adrenal Hyperplasia", "summary": "", "symbols": ["NBIX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/01/42873185/neurocrine-biosciences-publishes-narrative-review-discussing-challenges-of-traditional-glucocorti", "tags": []}
{"id": 42873195, "time": "2025-01-08 08:46:47", "headline": "Scotiabank Maintains Sector Perform on Kura Oncology, Lowers Price Target to $10", "summary": "", "symbols": ["KURA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42873195/scotiabank-maintains-sector-perform-on-kura-oncology-lowers-price-target-to-10", "tags": ["analyst_other", "price_target_down"]}
{"id": 42873196, "time": "2025-01-08 08:46:47", "headline": "Wearable Devices And RayNeo To Launch Gesture-Controlled RayNeo X3 Pro AR Glasses At CES 2025, Featuring Mudra Neural Wristband And Snapdragon XR Platform For Enhanced Intuitive Interaction And Immersive Experience", "summary": "", "symbols": ["WLDS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42873196/wearable-devices-and-rayneo-to-launch-gesture-controlled-rayneo-x3-pro-ar-glasses-at-ces-2025-featur", "tags": []}
{"id": 42873253, "time": "2025-01-08 08:48:51", "headline": "Scotiabank Maintains Sector Perform on Syndax Pharmaceuticals, Lowers Price Target to $16", "summary": "", "symbols": ["SNDX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42873253/scotiabank-maintains-sector-perform-on-syndax-pharmaceuticals-lowers-price-target-to-16", "tags": ["analyst_other", "price_target_down"]}
{"id": 42873273, "time": "2025-01-08 08:49:57", "headline": "How To Earn $500 A Month From Goldman Sachs Stock Ahead Of Q4 Earnings", "summary": "Goldman Sachs offers an annual dividend yield of 2.07% (a quarterly dividend amount of $3.00 per share). Here&#39;s how to earn $500 monthly.", "symbols": ["GS"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/news/earnings/25/01/42873273/how-to-earn-500-a-month-from-goldman-sachs-stock-ahead-of-q4-earnings", "tags": ["earnings", "dividend"]}
{"id": 42873285, "time": "2025-01-08 08:50:19", "headline": "Dunlop Brand Changes Hands: Goodyear Strikes $701 Million Deal with Sumitomo To Power Forward Plan", "summary": "Goodyear sells Dunlop brand to Sumitomo Rubber for $701 million. Deal includes brand transfer, ongoing agreements, and debt reduction.", "symbols": ["GT", "RFV"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/25/01/42873285/goodyear-sells-dunlop-brand-to-sumitomo-rubber-expects-65-million-annual-soi-impact", "tags": ["contract"]}
{"id": 42873581, "time": "2025-01-08 08:51:17", "headline": "Tempus Partners With Genialis To Develop RNA-Based Biomarker Algorithms Using Tempus' Multimodal Dataset And Genialis' AI Supermodel, Aiming To Advance Cancer Treatment And Precision Medicine", "summary": "", "symbols": ["TEM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42873581/tempus-partners-with-genialis-to-develop-rna-based-biomarker-algorithms-using-tempus-multimodal-data", "tags": ["contract"]}
{"id": 42873593, "time": "2025-01-08 08:52:13", "headline": "Matthews International To Sell SGK Brand Solutions For $350M Upfront, Retains 40% Stake In $900M New Entity With SGS Affiliates; Proceeds To Repay Debt, New Entity Targets $50M+ Annual Cost Synergies", "summary": "", "symbols": ["MATW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42873593/matthews-international-to-sell-sgk-brand-solutions-for-350m-upfront-retains-40-stake-in-900m-new-ent", "tags": []}
{"id": 42873597, "time": "2025-01-08 08:52:34", "headline": "Shake Shack, Morgan Stanley, Synovus Financial And A Communication Services Stock On CNBC's 'Final Trades'", "summary": "On CNBC&#39;s &#34;Halftime Report Final Trades,&#34; Joshua Brown of Ritholtz Wealth Management named Shake Shack Inc. as his final trade.", "symbols": ["CMCSA", "MS", "PARA", "SHAK", "SNV"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/trading-ideas/long-ideas/25/01/42873597/shake-shack-morgan-stanley-synovus-financial-and-a-communication-services-stock-on-cnbcs-final-trades", "tags": []}
{"id": 42873633, "time": "2025-01-08 08:55:04", "headline": "Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times", "summary": "", "symbols": ["ACCD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/01/42873633/trading-halt-halt-status-updated-at-8-55-00-am-et-quotation-resumption-news-and-resumption-times", "tags": []}
{"id": 42873657, "time": "2025-01-08 08:56:25", "headline": "Albertsons CEO Says Over Next 3 Years Co Plans To Deliver $1.5B In Savings, Invest In Customer Value Proposition & Growth Initiatives; Food And Beverage Sector Slowed Down In December", "summary": "", "symbols": ["ACI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42873657/albertsons-ceo-says-over-next-3-years-co-plans-to-deliver-1-5b-in-savings-invest-in-customer-value-p", "tags": ["management"]}
{"id": 42873669, "time": "2025-01-08 08:56:53", "headline": "Radius Recycling Q1 Adj $(1.33) Misses $(0.43) Estimate, Sales $656.54M Miss $665.90M Estimate", "summary": "", "symbols": ["RDUS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/01/42873669/radius-recycling-q1-adj-1-33-misses-0-43-estimate-sales-656-54m-miss-665-90m-estimate", "tags": []}
{"id": 42873709, "time": "2025-01-08 08:58:48", "headline": "Scotiabank Maintains Sector Outperform on Rogers Communications, Lowers Price Target to C$64", "summary": "", "symbols": ["TSX:RCI", "TSX:RCI/B"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42873709/scotiabank-maintains-sector-outperform-on-rogers-communications-lowers-price-target-to-c-64", "tags": ["analyst_other", "price_target_down"]}
{"id": 42873724, "time": "2025-01-08 08:59:54", "headline": "Red Cat Secures FAA Authorization To Operate Unmanned Drones Without Remote ID For Aeronautical Research", "summary": "", "symbols": ["RCAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42873724/red-cat-secures-faa-authorization-to-operate-unmanned-drones-without-remote-id-for-aeronautical-rese", "tags": []}
{"id": 42873762, "time": "2025-01-08 09:00:05", "headline": "Trading Halt: Halt status updated at 9:00:00 AM ET: Quotation Resumption: News and Resumption Times", "summary": "", "symbols": ["CEROW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/01/42873762/trading-halt-halt-status-updated-at-9-00-00-am-et-quotation-resumption-news-and-resumption-times", "tags": []}
{"id": 42873838, "time": "2025-01-08 09:00:16", "headline": "Oppenheimer Maintains Outperform on iRhythm Technologies, Raises Price Target to $120", "summary": "", "symbols": ["IRTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42873838/oppenheimer-maintains-outperform-on-irhythm-technologies-raises-price-target-to-120", "tags": ["analyst_other", "price_target_up"]}
{"id": 42873938, "time": "2025-01-08 09:00:50", "headline": "Bit Origin Receives Nasdaq Noncompliance Notification", "summary": "", "symbols": ["BTOG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42873938/bit-origin-receives-nasdaq-noncompliance-notification", "tags": []}
{"id": 42873977, "time": "2025-01-08 09:01:26", "headline": "Pfizer And GSK's RSV Vaccines Safety Labels Updated, FDA Adds Warning For Rare Neurological Disorder", "summary": "FDA updates safety labels for Pfizer&#39;s Abrysvo and GSK&#39;s Arexvy RSV vaccines, citing increased Guillain-Barr\u00e9 syndrome risk. Study estimates 7-9 excess GBS cases per million doses.", "symbols": ["GSK", "PFE"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/25/01/42873977/safety-labels-updated-for-pfizer-and-gsks-rsv-vaccines-fda-adds-warning-for-rare-neurological-disorder", "tags": ["fda"]}
{"id": 42874005, "time": "2025-01-08 09:02:08", "headline": "NeurAxis Sees Q4 Revenues ~$800K, Up 50% YoY", "summary": "", "symbols": ["NRXS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42874005/neuraxis-sees-q4-revenues-800k-up-50-yoy", "tags": []}
{"id": 42874009, "time": "2025-01-08 09:02:16", "headline": "3 E Network Technology Group Announces Pricing Of Nasdaq Initial Public Offering Of 1.25M Shares At A Price Of $4/Share", "summary": "", "symbols": ["MASK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42874009/3-e-network-technology-group-announces-pricing-of-nasdaq-initial-public-offering-of-1-25m-shares-at", "tags": ["offering"]}
{"id": 42874017, "time": "2025-01-08 09:02:45", "headline": "'Meta Ad Changes Threaten Telehealth's Weight Loss Boom' - The Information", "summary": "", "symbols": ["DRIO", "HIMS", "META", "TDOC", "ZM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42874017/meta-ad-changes-threaten-telehealths-weight-loss-boom-the-information", "tags": []}
{"id": 42874028, "time": "2025-01-08 09:03:16", "headline": "Freight Technologies Signs New Logistics Services Contract With A Toy Industry Brand, Terms Not Disclosed", "summary": "", "symbols": ["FRGT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42874028/freight-technologies-signs-new-logistics-services-contract-with-a-toy-industry-brand-terms-not-discl", "tags": ["contract"]}
{"id": 42874038, "time": "2025-01-08 09:03:59", "headline": "Starbox Launches AI-Driven StarboxAI-IntelliDistribute System To Transform Advertising For 180 Degrees Brandcom With Smart Distribution, Real-Time Analytics, And Personalized Content", "summary": "", "symbols": ["STBX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42874038/starbox-launches-ai-driven-starboxai-intellidistribute-system-to-transform-advertising-for-180-degre", "tags": []}
{"id": 42874042, "time": "2025-01-08 09:04:08", "headline": "Sandia Area Federal Credit Union Selects Upstart For Personal Lending", "summary": "", "symbols": ["UPST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42874042/sandia-area-federal-credit-union-selects-upstart-for-personal-lending", "tags": []}
{"id": 42874054, "time": "2025-01-08 09:04:59", "headline": "Grocery Giant Albertsons Q3 Sales Grow As Pharmacy Products Shine; Boosts Annual Earnings Outlook", "summary": "Albertsons Companies reported a 1.2% increase in sales for Q3, totaling $18.774 billion, slightly missing estimates. Identical sales grew 2%, with pharmacy sales driving growth. Despite an 8% drop in operating income, adjusted EPS of $0.71 beat expectations.", "symbols": ["ACI"], "source": "benzinga", "author": "Shivani Kumaresan", "url": "https://www.benzinga.com/25/01/42874054/grocery-giant-albertsons-q3-sales-grow-as-pharmacy-products-shine", "tags": ["earnings", "guidance"]}
{"id": 42874069, "time": "2025-01-08 09:05:40", "headline": "Bitcoin Could Drop As Low As $75,000 If It Fills This Liquidity Gap, Expert Warns", "summary": "A significant gap in the Chicago Mercantile Exchange (NASDAQ:CME) Bitcoin futures contract near $75,000, suggests a potential downside move for Bitcoin (CRYP", "symbols": ["BTCUSD", "CME"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/25/01/42874069/bitcoin-could-drop-as-low-as-75000-if-it-fills-this-liquidity-gap-expert-warns", "tags": ["contract"]}
{"id": 42874074, "time": "2025-01-08 09:06:02", "headline": "Avidity Biosciences To File First BLA For Del-Zota By End Of 2025, Accelerates Global Commercialization Plans For Three Rare Muscle Disease Programs, And Strengthens Leadership Team To Support Pipeline Expansion And Multiple Product Launches", "summary": "", "symbols": ["RNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/01/42874074/avidity-biosciences-to-file-first-bla-for-del-zota-by-end-of-2025-accelerates-global-commercializ", "tags": []}
{"id": 42874153, "time": "2025-01-08 09:06:53", "headline": "Goldman Sachs Maintains Buy on Amer Sports, Raises Price Target to $31", "summary": "", "symbols": ["AS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42874153/goldman-sachs-maintains-buy-on-amer-sports-raises-price-target-to-31", "tags": ["analyst_other", "price_target_up"]}
{"id": 42874154, "time": "2025-01-08 09:06:54", "headline": "MicroStrategy and STACKIT Form Strategic Partnership To Leverage MicroStrategy One To Facilitate Data-Driven Decision Making Throught Organizations", "summary": "", "symbols": ["MSTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42874154/microstrategy-and-stackit-form-strategic-partnership-to-leverage-microstrategy-one-to-facilitate-dat", "tags": ["contract"]}
{"id": 42874155, "time": "2025-01-08 09:06:58", "headline": "Nvidia Teams Up With MediaTek to Challenge Intel and AMD in Desktop CPU Market", "summary": "Nvidia CEO Jensen Huang says MediaTek could sell desktop processor chip co-developed with Nvidia, showcased at CES 2025. AMD and Intel are key competitors.", "symbols": ["AMD", "DELL", "INTC", "MSFT", "NVDA", "TSM"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/media/25/01/42874155/nvidia-teams-up-with-mediatek-to-challenge-intel-and-amd-in-desktop-cpu-market", "tags": ["management"]}
{"id": 42874157, "time": "2025-01-08 09:07:01", "headline": "iHeartMedia And NFL ExtendNFL Podcast Network Partnership", "summary": "", "symbols": ["IHRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/social-media/25/01/42874157/iheartmedia-and-nfl-extendnfl-podcast-network-partnership", "tags": ["contract"]}
{"id": 42874162, "time": "2025-01-08 09:07:13", "headline": "RCI Hospitality Reports Q1 2025 Sales, Nightclubs $61.3M; Bombshells $9.6M; Combined Total Sales Of $70.9M", "summary": "", "symbols": ["RICK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/01/42874162/rci-hospitality-reports-q1-2025-sales-nightclubs-61-3m-bombshells-9-6m-combined-total-sales-of-70-9", "tags": []}
{"id": 42874183, "time": "2025-01-08 09:07:53", "headline": "Neo-Concept International Granted Second 180-Day Grace Period By Nasdaq To Regain $1 Minimum Bid Price Compliance By July 7, 2025, With Delisting Risk If Compliance Is Not Met", "summary": "", "symbols": ["NCI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42874183/neo-concept-international-granted-second-180-day-grace-period-by-nasdaq-to-regain-1-minimum-bid-pric", "tags": []}
{"id": 42874195, "time": "2025-01-08 09:08:58", "headline": "Innventure's Refinity Acquires Exclusive Rights From VTT Technical Research Centre Of Finland For Its Fluidized Bed Advanced Plastic Waste Conversion Technology; Amount Not Disclosed", "summary": "", "symbols": ["INV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/01/42874195/innventures-refinity-acquires-exclusive-rights-from-vtt-technical-research-centre-of-finland-for-its", "tags": ["merger"]}
{"id": 42874199, "time": "2025-01-08 09:09:20", "headline": "Goldman Sachs Downgrades Comerica to Neutral, Lowers Price Target to $71", "summary": "", "symbols": ["CMA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42874199/goldman-sachs-downgrades-comerica-to-neutral-lowers-price-target-to-71", "tags": ["analyst_down", "price_target_down"]}
{"id": 42874202, "time": "2025-01-08 09:09:42", "headline": "D. Boral Capital Maintains Buy on Compass Therapeutics, Maintains $32 Price Target", "summary": "", "symbols": ["CMPX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42874202/d-boral-capital-maintains-buy-on-compass-therapeutics-maintains-32-price-target", "tags": ["analyst_other"]}
{"id": 42874207, "time": "2025-01-08 09:10:36", "headline": "Ridgewood Infrastructure Announces The Sale Of Its 80% Interest In Sienergy To Northwest Natural Holding Company; No Financial Terms Disclosed", "summary": "", "symbols": ["NWN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/01/42874207/ridgewood-infrastructure-announces-the-sale-of-its-80-interest-in-sienergy-to-northwest-natural-hold", "tags": []}
{"id": 42874380, "time": "2025-01-08 09:11:20", "headline": "PacBio Ships First Vega Systems To Berry Genomics For Clinical Assay Development In Asian Markets, With Plans For NMPA Regulatory Approval And Over 50 Additional Units Committed", "summary": "", "symbols": ["PACB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42874380/pacbio-ships-first-vega-systems-to-berry-genomics-for-clinical-assay-development-in-asian-markets-wi", "tags": ["fda"]}
{"id": 42874384, "time": "2025-01-08 09:11:57", "headline": "HC Wainwright & Co. Maintains Buy on Genmab, Maintains $50 Price Target", "summary": "", "symbols": ["GMAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42874384/hc-wainwright-co-maintains-buy-on-genmab-maintains-50-price-target", "tags": ["analyst_other"]}
{"id": 42874398, "time": "2025-01-08 09:12:12", "headline": "Ulta Beauty Partners With Instacart To Launch Nationwide Same-Day Delivery From Over 1,400 Stores", "summary": "", "symbols": ["CART", "ULTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42874398/ulta-beauty-partners-with-instacart-to-launch-nationwide-same-day-delivery-from-over-1-400-stores", "tags": ["contract"]}
{"id": 42874399, "time": "2025-01-08 09:12:15", "headline": "Absci Stock Jumps As AMD Invests $20M To Boost AI Drug Discovery", "summary": "Absci shares are rising after announcing a strategic collaboration with Advanced Micro Devices Inc. The partnership will enhance Absci&#39;s AI drug discovery capabilities using AMD Instinct accelerators and ROCm software. ", "symbols": ["ABSI", "AMD", "INTC", "NVDA"], "source": "benzinga", "author": "Shivani Kumaresan", "url": "https://www.benzinga.com/25/01/42874399/amd-invests-20m-in-absci-to-boost-ai-drug-discovery", "tags": ["contract"]}
{"id": 42874422, "time": "2025-01-08 09:13:08", "headline": "Goldman Sachs Maintains Neutral on Netflix, Raises Price Target to $850", "summary": "", "symbols": ["NFLX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42874422/goldman-sachs-maintains-neutral-on-netflix-raises-price-target-to-850", "tags": ["analyst_other", "price_target_up"]}
{"id": 42874426, "time": "2025-01-08 09:13:36", "headline": "HC Wainwright & Co. Maintains Buy on Sana Biotechnology, Raises Price Target to $11", "summary": "", "symbols": ["SANA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42874426/hc-wainwright-co-maintains-buy-on-sana-biotechnology-raises-price-target-to-11", "tags": ["analyst_other", "price_target_up"]}
{"id": 42874429, "time": "2025-01-08 09:14:59", "headline": "Macquarie Maintains Neutral on Getty Images Holdings, Maintains $3.75 Price Target", "summary": "", "symbols": ["GETY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42874429/macquarie-maintains-neutral-on-getty-images-holdings-maintains-3-75-price-target", "tags": ["analyst_other"]}
{"id": 42874446, "time": "2025-01-08 09:15:41", "headline": "Samsung's Outlook Dims Amid HBM Supply Struggles for Nvidia and Sluggish Consumer Chip Sales", "summary": "Samsung Electronics expects lower operating profit due to R&amp;D costs and weak demand for memory chips. Nvidia approves Samsung&#39;s HBM chips for AI processors.", "symbols": ["BIDU", "MU", "NVDA", "SSNLF"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/news/guidance/25/01/42874446/samsungs-outlook-dims-amid-hbm-supply-struggles-for-nvidia-and-sluggish-consumer-chip-sales", "tags": ["guidance"]}
{"id": 42874466, "time": "2025-01-08 09:16:12", "headline": "Blue Hat Announces Pricing Of $3.9M Registered Direct Offering  Of 55.95M Ordinary Shares At An Offering Price Of $0.07 Per Share", "summary": "", "symbols": ["BHAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42874466/blue-hat-announces-pricing-of-3-9m-registered-direct-offering-of-55-95m-ordinary-shares-at-an-offeri", "tags": ["offering"]}
{"id": 42874523, "time": "2025-01-08 09:16:29", "headline": "Top 10 Trending Stocks On WallStreetBets As Of January 8, 2025 (Via Swaggy Stocks)", "summary": "", "symbols": ["AMD", "CORN", "CVNA", "FUBO", "META", "NVDA", "PLTR", "RGTI", "TSLA", "X"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/01/42874523/top-10-trending-stocks-on-wallstreetbets-as-of-january-8-2025-via-swaggy-stocks", "tags": []}
{"id": 42874542, "time": "2025-01-08 09:17:25", "headline": "Terreno Realty Corporation Sells Property In Union City, CA For $16.9M", "summary": "", "symbols": ["TRNO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42874542/terreno-realty-corporation-sells-property-in-union-city-ca-for-16-9m", "tags": []}
{"id": 42874552, "time": "2025-01-08 09:17:57", "headline": "Goldman Sachs Maintains Buy on Spotify Technology, Raises Price Target to $550", "summary": "", "symbols": ["SPOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42874552/goldman-sachs-maintains-buy-on-spotify-technology-raises-price-target-to-550", "tags": ["analyst_other", "price_target_up"]}
{"id": 42874564, "time": "2025-01-08 09:18:32", "headline": "What's Going On With NIO Stock Today?", "summary": "NIO shares are down in premarket trading despite positive developments in its Onvo sub-brand and strong December sales growth.", "symbols": ["NIO"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/25/01/42874564/whats-going-on-with-nio-stock-today", "tags": ["why_moving"]}
{"id": 42874576, "time": "2025-01-08 09:19:11", "headline": "Vislink Technologies Partners With Radio Television Malaysia To Deploy Advanced Vislink System; Contract Worth Over $1M", "summary": "", "symbols": ["VISL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42874576/vislink-technologies-partners-with-radio-television-malaysia-to-deploy-advanced-vislink-system-contr", "tags": ["contract"]}
{"id": 42874582, "time": "2025-01-08 09:19:55", "headline": "Goldman Sachs Maintains Buy on Synchrony Finl, Raises Price Target to $82", "summary": "", "symbols": ["SYF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42874582/goldman-sachs-maintains-buy-on-synchrony-finl-raises-price-target-to-82", "tags": ["analyst_other", "price_target_up"]}
{"id": 42874587, "time": "2025-01-08 09:20:32", "headline": "Trump Media Stock Climbs 104%: Bullish Technicals, Inauguration Rally Drive Volatility", "summary": "Trump Media &amp; Tech. Group stock has surged 104% in past year on optimism about Trump&#39;s return to the White House, but will the momentum last?", "symbols": ["DJT"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/25/01/42874587/djt-stock-riding-the-trump-inauguration-rally-or-bracing-for-a-turn", "tags": []}
{"id": 42874865, "time": "2025-01-08 09:22:03", "headline": "UBS Upgrades Novo Nordisk to Buy", "summary": "", "symbols": ["NVO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42874865/ubs-upgrades-novo-nordisk-to-buy", "tags": ["analyst_up"]}
{"id": 42874868, "time": "2025-01-08 09:22:06", "headline": "Fed's Waller Says Monetary Rules Are A Good Check On Judgment, But Should Not Be Used Exclusively; Filling Out The December Sep Was A Very Difficult Problem Given Policy Uncertainty", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/01/42874868/feds-waller-says-monetary-rules-are-a-good-check-on-judgment-but-should-not-be-us", "tags": []}
{"id": 42874920, "time": "2025-01-08 09:23:54", "headline": "Chevron CEO Says U.S. Could See A Build Out Of Natural Gas Power Generation To Support Data Center Demand", "summary": "", "symbols": ["CVX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42874920/chevron-ceo-says-u-s-could-see-a-build-out-of-natural-gas-power-generation-to-support-data-center-de", "tags": ["management"]}
{"id": 42875365, "time": "2025-01-08 09:27:09", "headline": "Sana Biotechnology Stock Surges Over 200% On Wednesday - Here's Why", "summary": "Sana Biotechnology&#39;s first-in-human study shows UP421 pancreatic islet cells surviving and functioning in type 1 diabetes without immunosuppression.", "symbols": ["SANA"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/25/01/42875365/sana-biotechnology-stock-surges-over-200-on-data-for-cell-transplantation-study-for-diabetes", "tags": []}
{"id": 42875493, "time": "2025-01-08 09:33:40", "headline": "UBS Maintains Buy on D.R. Horton, Lowers Price Target to $203", "summary": "", "symbols": ["DHI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42875493/ubs-maintains-buy-on-d-r-horton-lowers-price-target-to-203", "tags": ["analyst_other", "price_target_down"]}
{"id": 42875502, "time": "2025-01-08 09:34:59", "headline": "Oil Price Drop To Cut Exxon Mobil's Q4 Upstream Earnings By Up To $0.9 Billion: Details", "summary": "Exxon Mobil anticipates changes in oil and gas prices to impact Q4 earnings, signs agreement with Chart Industries and sues CA AG for defamation.", "symbols": ["GTLS", "VDE", "XLE", "XOM"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/25/01/42875502/oil-price-drop-to-cut-exxon-mobils-q4-upstream-earnings-by-up-to-09-billion", "tags": ["earnings", "contract"]}
{"id": 42875506, "time": "2025-01-08 09:35:06", "headline": "UBS Maintains Buy on KB Home, Lowers Price Target to $100", "summary": "", "symbols": ["KBH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42875506/ubs-maintains-buy-on-kb-home-lowers-price-target-to-100", "tags": ["analyst_other", "price_target_down"]}
{"id": 42875586, "time": "2025-01-08 09:36:29", "headline": "UBS Maintains Buy on Lennar, Lowers Price Target to $192", "summary": "", "symbols": ["LEN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42875586/ubs-maintains-buy-on-lennar-lowers-price-target-to-192", "tags": ["analyst_other", "price_target_down"]}
{"id": 42875596, "time": "2025-01-08 09:36:40", "headline": "Alternus Clean Energy Announced Construction Of 18MW Solar Project In Italy Starting Q2 2025; Expected To Generate $2M Annually, 80% EBITDA Margin; Completion By Mid-2026; Potential $7M Cash Proceeds Upon Sale; Full Portfolio Development By Q4 2025-Q1 2026", "summary": "", "symbols": ["ALCE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42875596/alternus-clean-energy-announced-construction-of-18mw-solar-project-in-italy-starting-q2-2025-expecte", "tags": []}
{"id": 42875681, "time": "2025-01-08 09:38:22", "headline": "HF Sinclair Announces Cash Tender Offer For Up To $900M Aggregate Purchase Price Of Debt Securities, And Subject To The 2027 Notes Tender Cap", "summary": "", "symbols": ["DINO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42875681/hf-sinclair-announces-cash-tender-offer-for-up-to-900m-aggregate-purchase-price-of-debt-securities-a", "tags": []}
{"id": 42875687, "time": "2025-01-08 09:38:32", "headline": "Why Citius Pharmaceuticals (CTXR) Stock Is Down 15%", "summary": "Citius Pharmaceuticals shares are trading lower by 15% during Wednesday&#39;s session. The company announced a\u00a0$3 million\u00a0registered direct offering.", "symbols": ["CTXR"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/25/01/42875687/why-citius-pharmaceuticals-ctxr-stock-is-down-15", "tags": ["why_moving", "offering"]}
{"id": 42875723, "time": "2025-01-08 09:39:02", "headline": "UBS Maintains Buy on Meritage Homes, Lowers Price Target to $118", "summary": "", "symbols": ["MTH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42875723/ubs-maintains-buy-on-meritage-homes-lowers-price-target-to-118", "tags": ["analyst_other", "price_target_down"]}
{"id": 42875750, "time": "2025-01-08 09:40:09", "headline": "SEALSQ Shares Halted On Circuit Breaker To The Downside, Stock Now Down -40%", "summary": "", "symbols": ["LAES"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/01/42875750/sealsq-shares-halted-on-circuit-breaker-to-the-downside-stock-now-down-40", "tags": ["halt"]}
{"id": 42875796, "time": "2025-01-08 09:40:54", "headline": "UBS Maintains Neutral on NVR, Lowers Price Target to $8750", "summary": "", "symbols": ["NVR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42875796/ubs-maintains-neutral-on-nvr-lowers-price-target-to-8750", "tags": ["analyst_other", "price_target_down"]}
{"id": 42875825, "time": "2025-01-08 09:41:37", "headline": "Watching Shares Of AppLovin; Traders Circulate Report From The Captain's Log", "summary": "", "symbols": ["APP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/01/42875825/watching-shares-of-applovin-traders-circulate-report-from-the-captains-log", "tags": []}
{"id": 42875906, "time": "2025-01-08 09:43:31", "headline": "Watching Premier; Jehoshaphat Research Issues Report On Co, Announcing It Is Short On The Stock", "summary": "", "symbols": ["PINC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42875906/watching-premier-jehoshaphat-research-issues-report-on-co-announcing-it-is-short-on-the-stock", "tags": []}
{"id": 42875928, "time": "2025-01-08 09:43:56", "headline": "HSBC Downgrades Advanced Micro Devices to Reduce, Lowers Price Target to $110", "summary": "", "symbols": ["AMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42875928/hsbc-downgrades-advanced-micro-devices-to-reduce-lowers-price-target-to-110", "tags": ["analyst_down", "price_target_down"]}
{"id": 42875952, "time": "2025-01-08 09:44:51", "headline": "eBay Option Alert: Jun 20 $75 Calls Sweep (3) Near The Ask: 500 @ $3.65 Vs 4809 OI; Earnings 2/25 After Close [est] Ref=$69.76", "summary": "", "symbols": ["EBAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42875952/ebay-option-alert-jun-20-75-calls-sweep-3-near-the-ask-500-3-65-vs-4809-oi-earnings-225-after-close", "tags": ["earnings"]}
{"id": 42875977, "time": "2025-01-08 09:45:14", "headline": "Novo Nordisk Seeks to Strengthen Obesity Pipeline With Two Back-To-Back Biobuck Deals", "summary": "Novo Nordisk expands collaboration with Valo Health for cardiometabolic drugs and partners with Variant Bio on metabolic disease targets.", "symbols": ["NVO"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/25/01/42875977/novo-nordisk-seeks-to-strengthen-its-obesity-pipeline-with-back-to-back-two-biobuck-deals", "tags": ["contract"]}
{"id": 42876019, "time": "2025-01-08 09:46:06", "headline": "SEALSQ Shares Resume Trade Then Again Halted On Circuit Breaker To The Downside, Stock Now Down -46.4%", "summary": "", "symbols": ["LAES"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/01/42876019/sealsq-shares-resume-trade-then-again-halted-on-circuit-breaker-to-the-downside-stock-now-down-46-4", "tags": ["halt"]}
{"id": 42876040, "time": "2025-01-08 09:46:40", "headline": "XChange TEC.INC Shares Halted On Circuit Breaker To The Upside, Stock Now Up 56.3%", "summary": "", "symbols": ["XHG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/01/42876040/xchange-tec-inc-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-56-3", "tags": ["halt"]}
{"id": 42876117, "time": "2025-01-08 09:48:26", "headline": "MSC Industrial Beats Q1 Estimates, Eyes Long-Term Growth Amid Near-Term Challenges", "summary": "MSC Industrial reported Q1 results with net sales of $928.48M, beating consensus. CEO is confident in long-term growth despite soft conditions.", "symbols": ["MSM"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/25/01/42876117/msc-industrial-beats-q1-estimates-eyes-long-term-growth-amid-near-term-challenges", "tags": ["earnings", "management"]}
{"id": 42876362, "time": "2025-01-08 09:51:25", "headline": "Biofrontera Announces Achievement Of Key Milestone In Phase 3 Study Of Ameluz-Photodynamic Therapy In The Treatment Of Superficial Basal Cell Carcinoma Was Met With The Last Patient Completing The 1 Year Follow-Up Visit In December Of 2024", "summary": "", "symbols": ["BFRI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/01/42876362/biofrontera-announces-achievement-of-key-milestone-in-phase-3-study-of-ameluz-photodynamic-therap", "tags": ["fda"]}
{"id": 42876373, "time": "2025-01-08 09:51:41", "headline": "'GSK nears $1B deal for biotech developing drug for rare tumour' - Financial Times", "summary": "", "symbols": ["GSK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/01/42876373/gsk-nears-1bn-deal-for-biotech-developing-drug-for-rare-tumour-financial-times", "tags": ["contract"]}
{"id": 42876489, "time": "2025-01-08 09:53:57", "headline": "US Stocks Down; Acuity Brands Posts Weak Revenue", "summary": " ", "symbols": ["AYI", "CURR", "DATS", "JSPR", "SANA", "SILO", "XTIA"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/01/42876489/us-stocks-down-acuity-brands-posts-weak-revenue", "tags": ["earnings"]}
{"id": 42876503, "time": "2025-01-08 09:54:26", "headline": "UBS Maintains Buy on Toll Brothers, Lowers Price Target to $185", "summary": "", "symbols": ["TOL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42876503/ubs-maintains-buy-on-toll-brothers-lowers-price-target-to-185", "tags": ["analyst_other", "price_target_down"]}
{"id": 42876504, "time": "2025-01-08 09:54:28", "headline": "Biofrontera Shares Halted On Circuit Breaker To The Upside, Stock Now Up 17.1%", "summary": "", "symbols": ["BFRI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/01/42876504/biofrontera-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-17-1", "tags": ["halt"]}
{"id": 42876518, "time": "2025-01-08 09:54:43", "headline": "SEALSQ Shares Resume Trade Then Again Halted On Circuit Breaker To The Downside, Stock Now Down -53.3%", "summary": "", "symbols": ["LAES"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/01/42876518/sealsq-shares-resume-trade-then-again-halted-on-circuit-breaker-to-the-downside-stock-now-down-53-3", "tags": ["halt"]}
{"id": 42876525, "time": "2025-01-08 09:54:55", "headline": "TD Cowen Downgrades WK Kellogg to Sell, Lowers Price Target to $16", "summary": "", "symbols": ["KLG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42876525/td-cowen-downgrades-wk-kellogg-to-sell-lowers-price-target-to-16", "tags": ["analyst_down", "price_target_down"]}
{"id": 42876561, "time": "2025-01-08 09:55:49", "headline": "Biofrontera Shares Resume Trade", "summary": "", "symbols": ["BFRI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/01/42876561/biofrontera-shares-resume-trade", "tags": []}
{"id": 42876569, "time": "2025-01-08 09:56:14", "headline": "Mill City Ventures III Shares Halted On Circuit Breaker To The Downside, Stock Now Down -33.8%", "summary": "", "symbols": ["MCVT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/01/42876569/mill-city-ventures-iii-shares-halted-on-circuit-breaker-to-the-downside-stock-now-down-33-8", "tags": ["halt"]}
{"id": 42876612, "time": "2025-01-08 09:57:49", "headline": "Susquehanna Maintains Neutral on Canadian National Railway, Lowers Price Target to $115", "summary": "", "symbols": ["CNI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42876612/susquehanna-maintains-neutral-on-canadian-national-railway-lowers-price-target-to-115", "tags": ["analyst_other", "price_target_down"]}
{"id": 42876615, "time": "2025-01-08 09:57:52", "headline": "UBS Maintains Buy on Merck & Co, Lowers Price Target to $120", "summary": "", "symbols": ["MRK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42876615/ubs-maintains-buy-on-merck-co-lowers-price-target-to-120", "tags": ["analyst_other", "price_target_down"]}
{"id": 42876650, "time": "2025-01-08 09:58:56", "headline": "UBS Maintains Neutral on Pfizer, Lowers Price Target to $29", "summary": "", "symbols": ["PFE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42876650/ubs-maintains-neutral-on-pfizer-lowers-price-target-to-29", "tags": ["analyst_other", "price_target_down"]}
{"id": 42876660, "time": "2025-01-08 09:59:32", "headline": "Susquehanna Maintains Positive on Canadian Pacific Kansas, Lowers Price Target to $90", "summary": "", "symbols": ["CP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42876660/susquehanna-maintains-positive-on-canadian-pacific-kansas-lowers-price-target-to-90", "tags": ["analyst_other", "price_target_down"]}
{"id": 42876673, "time": "2025-01-08 10:00:00", "headline": "Reviva Pharmaceuticals Option Alert: 1,491 Jul $2.50 Calls Swept Near Ask At $0.451 With 2.5K OI; Stock Trading Around $1.95", "summary": "", "symbols": ["RVPH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/01/42876673/reviva-pharmaceuticals-option-alert-1-491-jul-2-50-calls-swept-near-ask-at-0-451-with-2-5k-oi-stock", "tags": []}
{"id": 42876728, "time": "2025-01-08 10:00:15", "headline": "UBS Maintains Buy on United Therapeutics, Raises Price Target to $475", "summary": "", "symbols": ["UTHR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42876728/ubs-maintains-buy-on-united-therapeutics-raises-price-target-to-475", "tags": ["analyst_other", "price_target_up"]}
{"id": 42876751, "time": "2025-01-08 10:00:41", "headline": "USA Wholesale Inventories (MoM) For November -0.2% Vs -0.2% Est.; -0.2% Prior", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/01/42876751/usa-wholesale-inventories-mom-for-november-0-2-vs-0-2-est-0-2-prior", "tags": []}
{"id": 42874541, "time": "2025-01-08 09:17:24", "headline": "Ondas Holdings shares are trading higher after the company announced it secured an order from a major defense company for its AI-driven iron drone raider system.", "summary": "", "symbols": ["ONDS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/25/01/42874541/ondas-holdings-shares-are-trading-higher-after-the-company-announced-it-secured-an-order-from-a-majo", "tags": ["why_moving"]}
{"id": 42874457, "time": "2025-01-08 09:16:07", "headline": "Moleculin Biotech shares are trading higher after the company announced it received U.S. institutional review board approval for its Phase 3 clinical trial.", "summary": "", "symbols": ["MBRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/25/01/42874457/moleculin-biotech-shares-are-trading-higher-after-the-company-announced-it-received-u-s-institutiona", "tags": ["why_moving", "fda"]}
{"id": 42874041, "time": "2025-01-08 09:04:08", "headline": "Freight Technologies shares are trading higher after the company announced it signed a new logistics services contract with a toy industry brand.", "summary": "", "symbols": ["FRGT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/25/01/42874041/freight-technologies-shares-are-trading-higher-after-the-company-announced-it-signed-a-new-logistics", "tags": ["why_moving", "contract"]}
{"id": 42873231, "time": "2025-01-08 08:48:01", "headline": "60 Degrees Pharmaceuticals shares are trading higher after the company announced the first patient enrollment for its Tafenoquine expanded access study for persistent babesiosis.", "summary": "", "symbols": ["SXTP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/25/01/42873231/60-degrees-pharmaceuticals-shares-are-trading-higher-after-the-company-announced-the-first-patient-e", "tags": ["why_moving"]}
{"id": 42873102, "time": "2025-01-08 08:43:17", "headline": "MMA inc shares are trading higher after the company announced an expansion of its collaborative programs with the UFC Gym Group.", "summary": "", "symbols": ["MMA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/25/01/42873102/mma-inc-shares-are-trading-higher-after-the-company-announced-an-expansion-of-its-collaborative-prog", "tags": ["why_moving"]}
{"id": 42876865, "time": "2025-01-08 10:02:59", "headline": "UBS Maintains Buy on Neurocrine Biosciences, Raises Price Target to $162", "summary": "", "symbols": ["NBIX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42876865/ubs-maintains-buy-on-neurocrine-biosciences-raises-price-target-to-162", "tags": ["analyst_other", "price_target_up"]}
{"id": 42876879, "time": "2025-01-08 10:03:30", "headline": "GM Collaborating With EVgo To Build Total Of 2,850 DC Public Charging Stalls Across U.S.; Teamed Up With Pilot Travel Centers & EVgo To Add Up To 2,000 DC Fast Charging Stalls At Up To 500 Pilot & Flying J Travel Centers Across U.S.", "summary": "", "symbols": ["EVGO", "GM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42876879/gm-collaborating-with-evgo-to-build-total-of-2-850-dc-public-charging-stalls-across-u-s-teamed-up-wi", "tags": []}
{"id": 42876882, "time": "2025-01-08 10:03:41", "headline": "Susquehanna Maintains Positive on DraftKings, Lowers Price Target to $54", "summary": "", "symbols": ["DKNG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42876882/susquehanna-maintains-positive-on-draftkings-lowers-price-target-to-54", "tags": ["analyst_other", "price_target_down"]}
{"id": 42872560, "time": "2025-01-08 08:26:10", "headline": "MBX Biosciences shares are trading higher on possible continued strength after the company announced results from its Phase 1 single ascending dose and multiple ascending dose trial of MBX 1416 yesterday.", "summary": "", "symbols": ["MBX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/25/01/42872560/mbx-biosciences-shares-are-trading-higher-after-the-company-announced-results-from-its-phase-1-singl", "tags": ["why_moving", "fda"]}
{"id": 42876906, "time": "2025-01-08 10:04:55", "headline": "La Rosa Holdings Shares Halted On Circuit Breaker To The Downside, Stock Now Up 7.89%", "summary": "", "symbols": ["LRHC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/01/42876906/la-rosa-holdings-shares-halted-on-circuit-breaker-to-the-downside-stock-now-up-7-89", "tags": ["halt"]}
{"id": 42876908, "time": "2025-01-08 10:04:57", "headline": "UBS Maintains Buy on Moderna, Lowers Price Target to $96", "summary": "", "symbols": ["MRNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42876908/ubs-maintains-buy-on-moderna-lowers-price-target-to-96", "tags": ["analyst_other", "price_target_down"]}
{"id": 42876923, "time": "2025-01-08 10:05:14", "headline": "Susquehanna Maintains Positive on Flutter Entertainment, Lowers Price Target to $317", "summary": "", "symbols": ["FLUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42876923/susquehanna-maintains-positive-on-flutter-entertainment-lowers-price-target-to-317", "tags": ["analyst_other", "price_target_down"]}
{"id": 42876926, "time": "2025-01-08 10:05:18", "headline": "XChange TEC.INC Shares Halted On Circuit Breaker To The Downside, Stock Now Up 80.5%", "summary": "", "symbols": ["XHG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/01/42876926/xchange-tec-inc-shares-halted-on-circuit-breaker-to-the-downside-stock-now-up-80-5", "tags": ["halt"]}
{"id": 42876938, "time": "2025-01-08 10:05:36", "headline": "HP Positions Itself As Front-Runner In AI PC Race, Analyst Says", "summary": "HP Inc. (NYSE:HPQ) focuses on AI-powered PCs and print market consolidation for growth. Bullish outlook with new lineup of AI-enhanced PCs.", "symbols": ["HP", "HPQ", "XRX"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/25/01/42876938/hp-sees-bigger-opportunity-to-differentiate-as-ai-pcs-drive-optimism-analyst", "tags": ["guidance"]}
{"id": 42876937, "time": "2025-01-08 10:05:36", "headline": "Solana Down 6% As Expert Touts 'Relatively Cheap' Price: What Is Going On?", "summary": "Solana (CRYPTO: SOL) has dropped below the $200 mark, down 6% on the day as the wider cryptocurrency market continues its slide.", "symbols": ["BTCUSD", "ETHUSD", "SOLUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/25/01/42876937/solana-down-6-as-expert-touts-relatively-cheap-price-what-is-going-on", "tags": []}
{"id": 42876979, "time": "2025-01-08 10:06:44", "headline": "Radius Recycling's Q1 Revenue Falls Short, Declines in Ferrous Sales Weigh on Results", "summary": "Radius Recycling reported lower first-quarter revenue of $656.54 million, missing consensus of $665.6 million. Nonferrous prices rose, offsetting weaker domestic steel conditions. Adjusted loss per share was $(1.33), missing consensus. The company declared a dividend of $0.1875 per share. ", "symbols": ["RDUS"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/25/01/42876979/radius-recyclings-q1-fy25-revenue-falls-short-declines-in-ferrous-sales-weigh-on-results", "tags": ["earnings", "dividend"]}
{"id": 42876981, "time": "2025-01-08 10:06:46", "headline": "Caesars Entertainment In Partnership With Evolution Gaming Launches Its First Branded Online Casino Live Dealer Studio In Pennsylvania", "summary": "", "symbols": ["CZR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42876981/caesars-entertainment-in-partnership-with-evolution-gaming-launches-its-first-branded-online-casino", "tags": ["contract"]}
{"id": 42876988, "time": "2025-01-08 10:06:52", "headline": "Susquehanna Maintains Positive on General Dynamics, Lowers Price Target to $315", "summary": "", "symbols": ["GD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42876988/susquehanna-maintains-positive-on-general-dynamics-lowers-price-target-to-315", "tags": ["analyst_other", "price_target_down"]}
{"id": 42876998, "time": "2025-01-08 10:07:02", "headline": "Bitcoin Drops 5% to $95K Amid Market Uncertainty; Nippon Steel Defends $15B US Merger, Criticizes Tariffs as Weak Policy; Micron Invests $7B In Singapore AI Memory Facility  \u2013 Top Headlines While the U.S. Slept", "summary": " ", "symbols": ["BTCUSD", "ETHUSD", "SPY"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/25/01/42876998/bitcoin-drops-5-to-95k-amid-market-uncertainty-nippon-steel-defends-15b-us-merger-criticizes-tariffs-as-weak-policy-micron-invests-7b-in-singapore-ai-memory-facility-to-drive-innovation-and-growth-top-headlines-while-the-us-slept", "tags": ["merger"]}
{"id": 42877008, "time": "2025-01-08 10:07:11", "headline": "AAR Posts Upbeat Results, Joins AngioDynamics, eBay, Cal-Maine Foods And Other Big Stocks Moving Higher On Wednesday", "summary": " ", "symbols": ["ABSI", "ADTN", "AIR", "ALTM", "ANGO", "BSX", "CALM", "EBAY", "MATW", "SANA", "UNF", "VIR"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/01/42877008/aar-posts-upbeat-results-joins-angiodynamics-ebay-cal-maine-foods-and-other-big-stocks-moving-higher-on-wednesday", "tags": ["why_moving"]}
{"id": 42877020, "time": "2025-01-08 10:07:16", "headline": "UBS Maintains Buy on Revolution Medicines, Raises Price Target to $71", "summary": "", "symbols": ["RVMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42877020/ubs-maintains-buy-on-revolution-medicines-raises-price-target-to-71", "tags": ["analyst_other", "price_target_up"]}
{"id": 42877044, "time": "2025-01-08 10:07:25", "headline": "Biofrontera Shares Halted On Circuit Breaker To The Downside, Stock Now Up 20.7%", "summary": "", "symbols": ["BFRI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/01/42877044/biofrontera-shares-halted-on-circuit-breaker-to-the-downside-stock-now-up-20-7", "tags": ["halt"]}
{"id": 42877054, "time": "2025-01-08 10:07:39", "headline": "XChange TEC.INC Shares Resume Trade", "summary": "", "symbols": ["XHG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/01/42877054/xchange-tec-inc-shares-resume-trade", "tags": []}
{"id": 42877101, "time": "2025-01-08 10:08:36", "headline": "Wells Fargo Maintains Equal-Weight on Array Technologies, Lowers Price Target to $7", "summary": "", "symbols": ["ARRY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42877101/wells-fargo-maintains-equal-weight-on-array-technologies-lowers-price-target-to-7", "tags": ["analyst_other", "price_target_down"]}
{"id": 42877115, "time": "2025-01-08 10:09:04", "headline": "Susquehanna Maintains Positive on L3Harris Technologies, Lowers Price Target to $258", "summary": "", "symbols": ["LHX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42877115/susquehanna-maintains-positive-on-l3harris-technologies-lowers-price-target-to-258", "tags": ["analyst_other", "price_target_down"]}
{"id": 42877136, "time": "2025-01-08 10:09:46", "headline": "Wells Fargo Maintains Equal-Weight on Canadian Solar, Lowers Price Target to $10", "summary": "", "symbols": ["CSIQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42877136/wells-fargo-maintains-equal-weight-on-canadian-solar-lowers-price-target-to-10", "tags": ["analyst_other", "price_target_down"]}
{"id": 42877259, "time": "2025-01-08 10:10:25", "headline": "Reported Earlier, Amplify ETFs To Liquidate The Amplify U.S. Alternative Harvest ETF; The Fund Will No Longer Accept Creation Orders After The Close Of Business On January 20, 2025. Shareholders May Sell Their Shares In The Fund Prior To The End Of Trading On January 27, 2025; Liquidated And A Final Distribution To Shareholders Of The Fund Is Expected To Occur On Or Around January 30, 2025", "summary": "", "symbols": ["MJUS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42877259/reported-earlier-amplify-etfs-to-liquidate-the-amplify-u-s-alternative-harvest-etf-the-fund-will-no", "tags": []}
{"id": 42877270, "time": "2025-01-08 10:11:00", "headline": "Susquehanna Maintains Positive on Lockheed Martin, Lowers Price Target to $590", "summary": "", "symbols": ["LMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42877270/susquehanna-maintains-positive-on-lockheed-martin-lowers-price-target-to-590", "tags": ["analyst_other", "price_target_down"]}
{"id": 42877278, "time": "2025-01-08 10:11:39", "headline": "Wells Fargo Maintains Overweight on Enphase Energy, Lowers Price Target to $83", "summary": "", "symbols": ["ENPH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42877278/wells-fargo-maintains-overweight-on-enphase-energy-lowers-price-target-to-83", "tags": ["analyst_other", "price_target_down"]}
{"id": 42877383, "time": "2025-01-08 10:12:23", "headline": "Biofrontera Shares Resume Trading", "summary": "", "symbols": ["BFRI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/01/42877383/biofrontera-shares-resume-trading", "tags": []}
{"id": 42877393, "time": "2025-01-08 10:12:39", "headline": "La Rosa Holdings Shares Resume Trade", "summary": "", "symbols": ["LRHC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/01/42877393/la-rosa-holdings-shares-resume-trade", "tags": []}
{"id": 42877397, "time": "2025-01-08 10:12:53", "headline": "Susquehanna Maintains Positive on Northrop Grumman, Lowers Price Target to $557", "summary": "", "symbols": ["NOC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42877397/susquehanna-maintains-positive-on-northrop-grumman-lowers-price-target-to-557", "tags": ["analyst_other", "price_target_down"]}
{"id": 42877413, "time": "2025-01-08 10:13:53", "headline": "Wells Fargo Maintains Overweight on First Solar, Lowers Price Target to $209", "summary": "", "symbols": ["FSLR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42877413/wells-fargo-maintains-overweight-on-first-solar-lowers-price-target-to-209", "tags": ["analyst_other", "price_target_down"]}
{"id": 42877416, "time": "2025-01-08 10:14:17", "headline": "Crown LNG Shares Halted On Circuit Breaker To The Downside, Stock Now Up 39.6%", "summary": "", "symbols": ["CGBS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/01/42877416/crown-lng-shares-halted-on-circuit-breaker-to-the-downside-stock-now-up-39-6", "tags": ["halt"]}
{"id": 42877421, "time": "2025-01-08 10:14:37", "headline": "Susquehanna Maintains Neutral on Norfolk Southern, Lowers Price Target to $265", "summary": "", "symbols": ["NSC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42877421/susquehanna-maintains-neutral-on-norfolk-southern-lowers-price-target-to-265", "tags": ["analyst_other", "price_target_down"]}
{"id": 42877426, "time": "2025-01-08 10:14:44", "headline": "BlackRock Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call", "summary": " ", "symbols": ["BLK"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-ratings/price-target/25/01/42877426/blackrock-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call", "tags": ["earnings"]}
{"id": 42877486, "time": "2025-01-08 10:16:11", "headline": "Susquehanna Maintains Positive on RTX, Lowers Price Target to $139", "summary": "", "symbols": ["RTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42877486/susquehanna-maintains-positive-on-rtx-lowers-price-target-to-139", "tags": ["analyst_other", "price_target_down"]}
{"id": 42877492, "time": "2025-01-08 10:16:35", "headline": "Wells Fargo Maintains Overweight on NEXTracker, Lowers Price Target to $69", "summary": "", "symbols": ["NXT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42877492/wells-fargo-maintains-overweight-on-nextracker-lowers-price-target-to-69", "tags": ["analyst_other", "price_target_down"]}
{"id": 42877536, "time": "2025-01-08 10:17:42", "headline": "La Rosa Holdings Shares Halted On Circuit Breaker To The Downside, Stock Now Down -23.7%", "summary": "", "symbols": ["LRHC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/01/42877536/la-rosa-holdings-shares-halted-on-circuit-breaker-to-the-downside-stock-now-down-23-7", "tags": ["halt"]}
{"id": 42877543, "time": "2025-01-08 10:17:55", "headline": "Matinas BioPharma Shares Halted To The Downside; Stock Now Up 3.15%", "summary": "", "symbols": ["MTNB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/01/42877543/matinas-biopharma-shares-halted-to-the-downside-stock-now-up-3-15", "tags": ["halt"]}
{"id": 42877553, "time": "2025-01-08 10:18:19", "headline": "Susquehanna Maintains Positive on Textron, Lowers Price Target to $90", "summary": "", "symbols": ["TXT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42877553/susquehanna-maintains-positive-on-textron-lowers-price-target-to-90", "tags": ["analyst_other", "price_target_down"]}
{"id": 42877614, "time": "2025-01-08 10:19:47", "headline": "Wells Fargo Maintains Equal-Weight on SolarEdge Technologies, Lowers Price Target to $15", "summary": "", "symbols": ["SEDG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42877614/wells-fargo-maintains-equal-weight-on-solaredge-technologies-lowers-price-target-to-15", "tags": ["analyst_other", "price_target_down"]}
{"id": 42877648, "time": "2025-01-08 10:20:14", "headline": "eBay Stock Surges After Meta Launches Integration Test For Facebook Marketplace", "summary": "Meta Platforms is testing the integration of eBay listings into Facebook Marketplace in select regions. This partnership enhances eBay sellers&#39; exposure and provides Marketplace users with a wider range of products. ", "symbols": ["EBAY", "META"], "source": "benzinga", "author": "Shivani Kumaresan", "url": "https://www.benzinga.com/25/01/42877648/ebay-shares-surge-after-meta-launches-integration-test-for-facebook-marketplace", "tags": ["contract"]}
{"id": 42877738, "time": "2025-01-08 10:21:08", "headline": "Wells Fargo Maintains Equal-Weight on Sunnova Energy Intl, Lowers Price Target to $4", "summary": "", "symbols": ["NOVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42877738/wells-fargo-maintains-equal-weight-on-sunnova-energy-intl-lowers-price-target-to-4", "tags": ["analyst_other", "price_target_down"]}
{"id": 42877857, "time": "2025-01-08 10:22:02", "headline": "Wells Fargo Maintains Overweight on Sunrun, Lowers Price Target to $12", "summary": "", "symbols": ["RUN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42877857/wells-fargo-maintains-overweight-on-sunrun-lowers-price-target-to-12", "tags": ["analyst_other", "price_target_down"]}
{"id": 42877890, "time": "2025-01-08 10:22:48", "headline": "Watching DoubleVerify; Traders Circulate Stifel Note Saying \"We've Learned That DoubleVerify Is Raising Prices By Roughly 5% On Average (Pricing Ranges From Unchanged To +8 To +10%, Depending On The Product), Effective February 1st\"", "summary": "", "symbols": ["DV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42877890/watching-doubleverify-traders-circulate-stifel-note-saying-weve-learned-that-doubleverify-is-raising", "tags": []}
{"id": 42877903, "time": "2025-01-08 10:23:07", "headline": "Matinas Biopharma Shares Resume Trade", "summary": "", "symbols": ["MTNB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/01/42877903/matinas-biopharma-shares-resume-trade", "tags": []}
{"id": 42877913, "time": "2025-01-08 10:23:29", "headline": "Jasper Therapeutics Skin Disorder Candidate Data Fails To Cheer Investors", "summary": "Jasper Therapeutics reports strong briquilimab efficacy in CSU with UAS7 reductions, dose-dependent responses, and Phase 2b plans by late 2025.", "symbols": ["CLDX", "JSPR"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/25/01/42877913/jasper-therapeutics-skin-disorder-candidate-data-fails-to-cheer-investors", "tags": []}
{"id": 42877960, "time": "2025-01-08 10:24:06", "headline": "Why DatChat (DATS) Stock Is Getting Hammered", "summary": "DatChat shares are trading lower by 63% during Wednesday&#39;s session. The company announced the pricing of a\u00a0$5.1 million\u00a0registered direct offering.", "symbols": ["DATS"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/25/01/42877960/why-datchat-dats-stock-is-getting-hammered", "tags": ["why_moving", "offering"]}
{"id": 42877950, "time": "2025-01-08 10:23:52", "headline": "Mexico President Says We Are Going To Collaborate With Trump Government, When Asked About Bilateral Relationship After Trump Comments", "summary": "", "symbols": ["EWW", "SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/01/42877950/mexico-president-says-we-are-going-to-collaborate-with-trump-government-when-aske", "tags": []}
{"id": 42877983, "time": "2025-01-08 10:24:48", "headline": "Wells Fargo Maintains Equal-Weight on General Dynamics, Lowers Price Target to $279", "summary": "", "symbols": ["GD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42877983/wells-fargo-maintains-equal-weight-on-general-dynamics-lowers-price-target-to-279", "tags": ["analyst_other", "price_target_down"]}
{"id": 42878018, "time": "2025-01-08 10:26:33", "headline": "Wells Fargo Maintains Equal-Weight on Lockheed Martin, Lowers Price Target to $500", "summary": "", "symbols": ["LMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42878018/wells-fargo-maintains-equal-weight-on-lockheed-martin-lowers-price-target-to-500", "tags": ["analyst_other", "price_target_down"]}
{"id": 42878041, "time": "2025-01-08 10:27:14", "headline": "XChange TEC.INC Shares Halted On Circuit Breaker To The Upside, Stock Now Up 118.4%", "summary": "", "symbols": ["XHG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/01/42878041/xchange-tec-inc-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-118-4", "tags": ["halt"]}
{"id": 42878112, "time": "2025-01-08 10:28:26", "headline": "Truist Securities Maintains Buy on Shake Shack, Raises Price Target to $149", "summary": "", "symbols": ["SHAK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42878112/truist-securities-maintains-buy-on-shake-shack-raises-price-target-to-149", "tags": ["analyst_other", "price_target_up"]}
{"id": 42878117, "time": "2025-01-08 10:28:38", "headline": "What's Going On With Robinhood Markets Stock?", "summary": "Robinhood Markets shares are trading lower by 1.9% Wednesday. The stock is falling after the latest employment data signaled a cooling U.S. labor market.", "symbols": ["HOOD"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/25/01/42878117/whats-going-on-with-robinhood-markets-stock", "tags": ["why_moving"]}
{"id": 42878135, "time": "2025-01-08 10:29:15", "headline": "'JPMorgan Files Two Lawsuits in Greece and UK Over Viva Wallet' - Bloomberg News", "summary": "", "symbols": ["JPM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42878135/jpmorgan-files-two-lawsuits-in-greece-and-uk-over-viva-wallet-bloomberg-news", "tags": []}
{"id": 42878139, "time": "2025-01-08 10:29:44", "headline": "Peter Schiff Doesn't 'Hate Bitcoin' But Warns 'Millions' Will Lose More Than They Can Afford In 'Speculative Mania'", "summary": "Economist and market commentator Peter Schiff has issued a stark warning about the current speculative frenzy surrounding Bitcoin (CRYPTO: ", "symbols": ["BTCUSD", "MSTR"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/25/01/42878139/peter-schiff-doesnt-hate-bitcoin-but-warns-millions-will-lose-more-than-they-can-afford-in-speculative-mania", "tags": []}
{"id": 42878141, "time": "2025-01-08 10:29:49", "headline": "Dovish ECB Drives 7% EURUSD Drop in Q4", "summary": " ", "symbols": [], "source": "benzinga", "author": "European Capital Insights", "url": "https://www.benzinga.com/markets/eurozone/25/01/42878141/dovish-ecb-drives-7-eurusd-drop-in-q4", "tags": []}
{"id": 42878172, "time": "2025-01-08 10:30:18", "headline": "Trump Asks Supreme Court To Block Hush Money Sentencing: Lawyers Call It 'Constitutionally Intolerable Risk'", "summary": "Trump asks Supreme Court to block sentencing in NY hush money case, argues it would disrupt presidency and national security.", "symbols": [], "source": "benzinga", "author": "Hayden Buckfire", "url": "https://www.benzinga.com/25/01/42878172/trump-asks-supreme-court-to-block-hush-money-sentencing-constitutionally-intolerable-risk-trump-lawyers-say", "tags": ["legal"]}
{"id": 42878177, "time": "2025-01-08 10:30:24", "headline": "USA Crude Oil Inventories 0.959M Barrel Draw Vs 1.800M Barrel Draw Est.; 1.178M Barrel Draw Prior", "summary": "", "symbols": ["SPY", "USO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/01/42878177/usa-crude-oil-inventories-0-959m-barrel-draw-vs-1-800m-barrel-draw-est-1-178m-bar", "tags": []}
{"id": 42878197, "time": "2025-01-08 10:30:44", "headline": "Wells Fargo Maintains Overweight on RTX, Raises Price Target to $151", "summary": "", "symbols": ["RTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42878197/wells-fargo-maintains-overweight-on-rtx-raises-price-target-to-151", "tags": ["analyst_other", "price_target_up"]}
{"id": 42878198, "time": "2025-01-08 10:30:48", "headline": "EIA Weekly Distillates Stocks 6.071M Barrel Build Vs 0.500M Barrel Build Est.; 6.406M Barrel Build Prior", "summary": "", "symbols": ["SPY", "UNG", "USO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/01/42878198/eia-weekly-distillates-stocks-6-071m-barrel-build-vs-0-500m-barrel-build-est-6-40", "tags": []}
{"id": 42878208, "time": "2025-01-08 10:31:03", "headline": "USA Gasoline Inventories 6.330M Barrel Build Vs 0.500M Barrel Build Est.; 7.717M Barrel Build Prior", "summary": "", "symbols": ["SPY", "UNG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/01/42878208/usa-gasoline-inventories-6-330m-barrel-build-vs-0-500m-barrel-build-est-7-717m-ba", "tags": []}
{"id": 42878213, "time": "2025-01-08 10:31:06", "headline": "Market Clubhouse Morning Memo - January 8th, 2025 (Trade Strategy For SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META and TSLA)", "summary": " ", "symbols": [], "source": "benzinga", "author": "RIPS", "url": "https://www.benzinga.com/trading-ideas/25/01/42878213/market-clubhouse-morning-memo-january-8th-2025-trade-strategy-for-spy-qqq-aapl-msft-nvda-googl-meta", "tags": []}
{"id": 42878235, "time": "2025-01-08 10:31:30", "headline": "Truist Securities Maintains Buy on Texas Roadhouse, Raises Price Target to $209", "summary": "", "symbols": ["TXRH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42878235/truist-securities-maintains-buy-on-texas-roadhouse-raises-price-target-to-209", "tags": ["analyst_other", "price_target_up"]}
{"id": 42878268, "time": "2025-01-08 10:32:21", "headline": "Wells Fargo Maintains Equal-Weight on Woodward, Lowers Price Target to $193", "summary": "", "symbols": ["WWD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42878268/wells-fargo-maintains-equal-weight-on-woodward-lowers-price-target-to-193", "tags": ["analyst_other", "price_target_down"]}
{"id": 42878286, "time": "2025-01-08 10:32:46", "headline": "Failed Nvidia Breakout Burns Momo Crowd, Interest Rates Rise On Strong Economic Data", "summary": " ", "symbols": ["NVDA", "SMH"], "source": "benzinga", "author": "The Arora Report", "url": "https://www.benzinga.com/trading-ideas/25/01/42878286/failed-nvidia-breakout-burns-momo-crowd-interest-rates-rise-on-strong-economic-data", "tags": []}
{"id": 42878295, "time": "2025-01-08 10:33:20", "headline": "Quantum Stocks Tumble: Why Rigetti, IonQ and D-Wave Are Falling", "summary": "Quantum-related stocks are tumbling after Nvidia CEO Jensen Huang expressed skepticism about the near-term usefulness of quantum computers.", "symbols": ["IONQ", "NVDA", "QBTS", "RGTI"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/25/01/42878295/quantum-stocks-tumble-why-rigetti-ionq-and-d-wave-are-falling", "tags": ["management"]}
{"id": 42878317, "time": "2025-01-08 10:33:40", "headline": "Wells Fargo Maintains Overweight on Booz Allen Hamilton, Lowers Price Target to $171", "summary": "", "symbols": ["BAH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42878317/wells-fargo-maintains-overweight-on-booz-allen-hamilton-lowers-price-target-to-171", "tags": ["analyst_other", "price_target_down"]}
{"id": 42878337, "time": "2025-01-08 10:34:59", "headline": "Wells Fargo Maintains Overweight on CACI International, Lowers Price Target to $503", "summary": "", "symbols": ["CACI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42878337/wells-fargo-maintains-overweight-on-caci-international-lowers-price-target-to-503", "tags": ["analyst_other", "price_target_down"]}
{"id": 42878339, "time": "2025-01-08 10:35:04", "headline": "Trading Halt: Halt status updated at 10:35:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation", "summary": "", "symbols": ["MASK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/01/42878339/trading-halt-halt-status-updated-at-10-35-00-am-et-quotation-resumption-ipo-security-released-for-qu", "tags": []}
{"id": 42878350, "time": "2025-01-08 10:35:48", "headline": "Truist Securities Reiterates Buy on Verona Pharma, Raises Price Target to $57", "summary": "", "symbols": ["VRNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42878350/truist-securities-reiterates-buy-on-verona-pharma-raises-price-target-to-57", "tags": ["analyst_other", "price_target_up"]}
{"id": 42878357, "time": "2025-01-08 10:36:28", "headline": "Wells Fargo Maintains Overweight on Leidos Holdings, Lowers Price Target to $199", "summary": "", "symbols": ["LDOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42878357/wells-fargo-maintains-overweight-on-leidos-holdings-lowers-price-target-to-199", "tags": ["analyst_other", "price_target_down"]}
{"id": 42878368, "time": "2025-01-08 10:36:53", "headline": "XRP ETF 'Very Soon,' Likely Next After Bitcoin And Ethereum, Ripple President Says", "summary": "Ripple President Monica Long has stated that an XRP spot exchange-traded fund (ETF) is likely to be approved \u201cvery soon,\u201d and is expected to be next in line after the", "symbols": ["BTCUSD", "ETHUSD", "XRPUSD"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/25/01/42878368/xrp-etf-very-soon-likely-next-after-bitcoin-and-ethereum-ripple-president-says", "tags": []}
{"id": 42878430, "time": "2025-01-08 10:37:44", "headline": "Wells Fargo Maintains Overweight on Science Applications Intl, Lowers Price Target to $149", "summary": "", "symbols": ["SAIC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42878430/wells-fargo-maintains-overweight-on-science-applications-intl-lowers-price-target-to-149", "tags": ["analyst_other", "price_target_down"]}
{"id": 42878466, "time": "2025-01-08 10:39:42", "headline": "Wildfire Rips Through LA's Pacific Palisades Neighborhood Destroying Homes: 3,000 Acres Burned As 30,000 Residents Evacuate", "summary": "A destructive wildfire is raging through the Pacific Palisades section of Los Angeles on Wednesday and more than 30,000 people have been forced to evacuate the area.\u00a0", "symbols": ["AAL", "ALL", "DAL", "PCG", "SRE", "TRV", "UAL"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/25/01/42878466/wildfire-rips-through-las-pacific-palisades-neighborhood-3000-acres-burned-30000-evacuated-homes-destroyed", "tags": []}
{"id": 42878530, "time": "2025-01-08 10:41:57", "headline": "Cintas-Targeted Uniform Supplier UniFirst Reports Mixed Q1 Results; Adjusts Annual Revenue Outlook", "summary": "UniFirst reported Q1 2025 results with sales of $604.91M, operating income of $55.5M, and adjusted EPS of $2.40. Cintas offered to acquire UniFirst for $275/share.", "symbols": ["BSMC", "CTAS", "UNF"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/25/01/42878530/unifirst-reports-q1-results-adjusted-eps-beats-estimates-despite-sales-miss", "tags": ["earnings", "guidance", "merger"]}
{"id": 42878612, "time": "2025-01-08 10:45:38", "headline": "Keefe, Bruyette & Woods Maintains Outperform on Enact Holdings, Lowers Price Target to $41", "summary": "", "symbols": ["ACT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42878612/keefe-bruyette-woods-maintains-outperform-on-enact-holdings-lowers-price-target-to-41", "tags": ["analyst_other", "price_target_down"]}
{"id": 42878625, "time": "2025-01-08 10:45:59", "headline": "3 E Network Technology Group IPO Shares Open For Trade At $3.85/Share; IPO Priced At $4/Share On 1.25M Shares", "summary": "", "symbols": ["MASK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/01/42878625/3-e-network-technology-group-ipo-shares-open-for-trade-at-3-85share-ipo-priced-at-4share-on-1-25m-s", "tags": []}
{"id": 42878646, "time": "2025-01-08 10:47:03", "headline": "Keefe, Bruyette & Woods Maintains Outperform on Essent Group, Lowers Price Target to $72", "summary": "", "symbols": ["ESNT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42878646/keefe-bruyette-woods-maintains-outperform-on-essent-group-lowers-price-target-to-72", "tags": ["analyst_other", "price_target_down"]}
{"id": 42878782, "time": "2025-01-08 10:49:13", "headline": "Keefe, Bruyette & Woods Maintains Market Perform on First American Financial, Lowers Price Target to $74", "summary": "", "symbols": ["FAF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42878782/keefe-bruyette-woods-maintains-market-perform-on-first-american-financial-lowers-price-target-to-74", "tags": ["analyst_other", "price_target_down"]}
{"id": 42878791, "time": "2025-01-08 10:49:41", "headline": "XChange TEC.INC Shares Halted On Circuit Breaker To The Upside, Stock Now Up 196.6%", "summary": "", "symbols": ["XHG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/01/42878791/xchange-tec-inc-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-196-6", "tags": ["halt"]}
{"id": 42878797, "time": "2025-01-08 10:50:45", "headline": "Autodesk Could Return Capital More Aggressively In 2025: Analyst", "summary": "Piper Sandler analyst upgrades Autodesk (ADSK) from Neutral to Overweight with a raised price target, citing attractive stock price and potential for growth in 2025.", "symbols": ["ADSK"], "source": "benzinga", "author": "Priya Nigam", "url": "https://www.benzinga.com/25/01/42878797/autodesk-could-return-capital-more-aggressively-in-2025-says-bullish-analyst", "tags": ["analyst_up"]}
{"id": 42878798, "time": "2025-01-08 10:50:48", "headline": "Keefe, Bruyette & Woods Maintains Market Perform on Fidelity National Finl, Lowers Price Target to $63", "summary": "", "symbols": ["FNF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42878798/keefe-bruyette-woods-maintains-market-perform-on-fidelity-national-finl-lowers-price-target-to-63", "tags": ["analyst_other", "price_target_down"]}
{"id": 42878885, "time": "2025-01-08 10:51:55", "headline": "Keefe, Bruyette & Woods Maintains Market Perform on MGIC Investment, Lowers Price Target to $28", "summary": "", "symbols": ["MTG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42878885/keefe-bruyette-woods-maintains-market-perform-on-mgic-investment-lowers-price-target-to-28", "tags": ["analyst_other", "price_target_down"]}
{"id": 42878896, "time": "2025-01-08 10:52:30", "headline": "Dollar Hits 14-Month High, 30-Year Yields Near Critical Threshold As Trump Reportedly Mulls Economic Emergency Tariffs", "summary": "USD reaches 14-month high, 30-year yields near 5% as Trump considers emergency powers, tariffs, and inflation fears. Market volatility expected.", "symbols": ["TLT", "UUP"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/economics/macro-economic-events/25/01/42878896/dollar-jumps-to-14-month-highs-30-year-yields-near-danger-zone-as-trump-mulls-national-economic-emergency-to-set-tariffs", "tags": []}
{"id": 42878927, "time": "2025-01-08 10:53:18", "headline": "Keefe, Bruyette & Woods Maintains Market Perform on NMI Holdings, Lowers Price Target to $43", "summary": "", "symbols": ["NMIH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42878927/keefe-bruyette-woods-maintains-market-perform-on-nmi-holdings-lowers-price-target-to-43", "tags": ["analyst_other", "price_target_down"]}
{"id": 42878954, "time": "2025-01-08 10:54:28", "headline": "XChange TEC.INC Shares Resume Trading", "summary": "", "symbols": ["XHG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/01/42878954/xchange-tec-inc-shares-resume-trading", "tags": []}
{"id": 42878963, "time": "2025-01-08 10:54:42", "headline": "Watching Shares Of Richtech Robotics; Company Post On X, \"We are thrilled to announce that Richtech Robotics and our beverage-making robot, ADAM, were featured in @nvidia's \"The AI Factory\" video\u2026\"", "summary": "", "symbols": ["NVDA", "RR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42878963/watching-shares-of-richtech-robotics-company-post-on-x-we-are-thrilled-to-announce-that-richtech-rob", "tags": []}
{"id": 42878982, "time": "2025-01-08 10:56:02", "headline": "Keefe, Bruyette & Woods Maintains Outperform on Radian Group, Lowers Price Target to $40", "summary": "", "symbols": ["RDN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42878982/keefe-bruyette-woods-maintains-outperform-on-radian-group-lowers-price-target-to-40", "tags": ["analyst_other", "price_target_down"]}
{"id": 42879007, "time": "2025-01-08 10:57:16", "headline": "Keefe, Bruyette & Woods Maintains Market Perform on Stewart Information Servs, Lowers Price Target to $74", "summary": "", "symbols": ["STC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42879007/keefe-bruyette-woods-maintains-market-perform-on-stewart-information-servs-lowers-price-target-to-74", "tags": ["analyst_other", "price_target_down"]}
{"id": 42879172, "time": "2025-01-08 11:00:52", "headline": "B of A Securities Maintains Neutral on Reddit, Raises Price Target to $180", "summary": "", "symbols": ["RDDT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42879172/b-of-a-securities-maintains-neutral-on-reddit-raises-price-target-to-180", "tags": ["analyst_other", "price_target_up"]}
{"id": 42879216, "time": "2025-01-08 11:03:14", "headline": "B of A Securities Maintains Neutral on Canadian National Railway, Lowers Price Target to $112", "summary": "", "symbols": ["CNI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42879216/b-of-a-securities-maintains-neutral-on-canadian-national-railway-lowers-price-target-to-112", "tags": ["analyst_other", "price_target_down"]}
{"id": 42879239, "time": "2025-01-08 11:04:00", "headline": "Li Auto Achieves 200,000 Units Of Li L6 SUV Production: Report", "summary": "Li Auto has reportedly reached a major milestone with the production of its 200,000th Li L6 SUV. The Li L6, an affordable extended-range electric vehicle (EREV), was launched in April 2024 and is available in Pro and Max trims. ", "symbols": ["LI"], "source": "benzinga", "author": "Shivani Kumaresan", "url": "https://www.benzinga.com/markets/equities/25/01/42879239/li-auto-achieves-200000-units-of-li-l6-suv-production-report", "tags": []}
{"id": 42879251, "time": "2025-01-08 11:04:38", "headline": "Craig-Hallum Initiates Coverage On Adtran Holdings with Buy Rating, Announces Price Target of $15", "summary": "", "symbols": ["ADTN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42879251/craig-hallum-initiates-coverage-on-adtran-holdings-with-buy-rating-announces-price-target-of-15", "tags": ["analyst_init"]}
{"id": 42879317, "time": "2025-01-08 11:07:09", "headline": "Florida Congresswoman Laurel Lee Has Disclosed A Small Purchase Of TuHURA Biosicences In The Amount Between $1,001-$15,000", "summary": "", "symbols": ["HURA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42879317/florida-congresswoman-laurel-lee-has-disclosed-a-small-purchase-of-tuhura-biosicences-in-the-amount", "tags": []}
{"id": 42879390, "time": "2025-01-08 11:08:31", "headline": "Morgan Stanley Maintains Underweight on Carnival, Raises Price Target to $22", "summary": "", "symbols": ["CCL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42879390/morgan-stanley-maintains-underweight-on-carnival-raises-price-target-to-22", "tags": ["analyst_other", "price_target_up"]}
{"id": 42879422, "time": "2025-01-08 11:10:09", "headline": "Morgan Stanley Maintains Equal-Weight on Royal Caribbean Gr, Raises Price Target to $210", "summary": "", "symbols": ["RCL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42879422/morgan-stanley-maintains-equal-weight-on-royal-caribbean-gr-raises-price-target-to-210", "tags": ["analyst_other", "price_target_up"]}
{"id": 42879460, "time": "2025-01-08 11:11:17", "headline": "Honda, Amazon Collaborate On EV Development With Generative AI And IoT", "summary": "Honda partnered with Amazon Web Services (AWS) to transition its automobiles into software-defined vehicles (SDVs).", "symbols": ["AMZN", "GMOI", "HAIL", "HMC"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/contracts/25/01/42879460/honda-amazon-collaborate-on-ev-development-with-generative-ai-and-iot", "tags": []}
{"id": 42879469, "time": "2025-01-08 11:11:31", "headline": "Mizuho Maintains Outperform on Valero Energy, Lowers Price Target to $158", "summary": "", "symbols": ["VLO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42879469/mizuho-maintains-outperform-on-valero-energy-lowers-price-target-to-158", "tags": ["analyst_other", "price_target_down"]}
{"id": 42879542, "time": "2025-01-08 11:13:24", "headline": "Mizuho Maintains Outperform on RPM Intl, Lowers Price Target to $140", "summary": "", "symbols": ["RPM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42879542/mizuho-maintains-outperform-on-rpm-intl-lowers-price-target-to-140", "tags": ["analyst_other", "price_target_down"]}
{"id": 42879566, "time": "2025-01-08 11:14:30", "headline": "Mizuho Maintains Neutral on Paycor HCM, Raises Price Target to $22.5", "summary": "", "symbols": ["PYCR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42879566/mizuho-maintains-neutral-on-paycor-hcm-raises-price-target-to-22-5", "tags": ["analyst_other", "price_target_up"]}
{"id": 42879571, "time": "2025-01-08 11:15:00", "headline": "eXp World Holdings Reaches $34M Nationwide Settlement Agreement Resolving Class Action Lawsuit, Commits To Business Practice Changes Including Transparent Compensation Disclosure And Training Initiatives; Settlement Pending Court Approval", "summary": "", "symbols": ["EXPI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42879571/exp-world-holdings-reaches-34m-nationwide-settlement-agreement-resolving-class-action-lawsuit-commit", "tags": ["contract", "legal"]}
{"id": 42879588, "time": "2025-01-08 11:15:58", "headline": "Mizuho Maintains Neutral on Agree Realty, Lowers Price Target to $74", "summary": "", "symbols": ["ADC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42879588/mizuho-maintains-neutral-on-agree-realty-lowers-price-target-to-74", "tags": ["analyst_other", "price_target_down"]}
{"id": 42879612, "time": "2025-01-08 11:17:00", "headline": "Mizuho Maintains Neutral on American Tower, Lowers Price Target to $204", "summary": "", "symbols": ["AMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42879612/mizuho-maintains-neutral-on-american-tower-lowers-price-target-to-204", "tags": ["analyst_other", "price_target_down"]}
{"id": 42879671, "time": "2025-01-08 11:18:19", "headline": "Mizuho Maintains Neutral on Lineage, Lowers Price Target to $67", "summary": "", "symbols": ["LINE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42879671/mizuho-maintains-neutral-on-lineage-lowers-price-target-to-67", "tags": ["analyst_other", "price_target_down"]}
{"id": 42879690, "time": "2025-01-08 11:19:30", "headline": "Mizuho Maintains Outperform on Netstreit, Lowers Price Target to $15", "summary": "", "symbols": ["NTST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42879690/mizuho-maintains-outperform-on-netstreit-lowers-price-target-to-15", "tags": ["analyst_other", "price_target_down"]}
{"id": 42879718, "time": "2025-01-08 11:20:34", "headline": "Mizuho Maintains Neutral on Realty Income, Lowers Price Target to $54", "summary": "", "symbols": ["O"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42879718/mizuho-maintains-neutral-on-realty-income-lowers-price-target-to-54", "tags": ["analyst_other", "price_target_down"]}
{"id": 42879720, "time": "2025-01-08 11:20:43", "headline": "MicroStrategy Launches Sovereign European Cloud With STACKIT: Details", "summary": "MicroStrategy partners with STACKIT to launch Sovereign European Cloud, meeting EU regulations and offering AI solutions for data-driven decisions.", "symbols": ["CRPT", "MSTR", "MSTU"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/large-cap/25/01/42879720/microstrategy-launches-sovereign-european-cloud-with-stackit-details", "tags": ["offering", "contract"]}
{"id": 42879725, "time": "2025-01-08 11:20:57", "headline": "Nvidia CEO Sends Quantum Stocks Lower: Poll Finds Over 50% Pick Rigetti Or Skip For 2025", "summary": "Benzinga readers pick their favorite quantum computing stock among QUBT, QBTS, RGTI and INOD for 2025.", "symbols": ["INOD", "QBTS", "QUBT", "RGTI"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/tech/25/01/42879725/nvidia-ceo-sends-quantum-stocks-lower-poll-finds-over-50-pick-rigetti-or-skip-for-2025", "tags": ["management"]}
{"id": 42879801, "time": "2025-01-08 11:21:31", "headline": "HC Wainwright & Co. Maintains Buy on BiomX, Maintains $2 Price Target", "summary": "", "symbols": ["PHGE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42879801/hc-wainwright-co-maintains-buy-on-biomx-maintains-2-price-target", "tags": ["analyst_other"]}
{"id": 42879826, "time": "2025-01-08 11:21:35", "headline": "Mizuho Maintains Neutral on Prologis, Lowers Price Target to $117", "summary": "", "symbols": ["PLD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42879826/mizuho-maintains-neutral-on-prologis-lowers-price-target-to-117", "tags": ["analyst_other", "price_target_down"]}
{"id": 42879850, "time": "2025-01-08 11:22:54", "headline": "Mizuho Maintains Outperform on Regency Centers, Raises Price Target to $80", "summary": "", "symbols": ["REG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42879850/mizuho-maintains-outperform-on-regency-centers-raises-price-target-to-80", "tags": ["analyst_other", "price_target_up"]}
{"id": 42879863, "time": "2025-01-08 11:22:57", "headline": "HC Wainwright & Co. Maintains Buy on Absci, Maintains $7 Price Target", "summary": "", "symbols": ["ABSI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42879863/hc-wainwright-co-maintains-buy-on-absci-maintains-7-price-target", "tags": ["analyst_other"]}
{"id": 42879906, "time": "2025-01-08 11:24:20", "headline": "U.S. Treasury's Yellen Says Speniding On Covid May Have Contributed A Little Bit To Inflation; Main Factor In Inflation Was Shortages; We Haven't Seen Too Much Progress On Inflation During Past Couple Of Months; Labor Market Has Cooled But Is In Good State; Recent Data Suggests Path Of Interest Rates May Be Higher Than People Expected; Term Premium On Long Term Rates Has Begun To Normalize; Fiscal Policy Needs To Be Put On Sustainable Course", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/01/42879906/u-s-treasurys-yellen-says-speniding-on-covid-may-have-contributed-a-little-bit-to", "tags": []}
{"id": 42879910, "time": "2025-01-08 11:24:31", "headline": "Mizuho Maintains Neutral on Rexford Industrial Realty, Lowers Price Target to $45", "summary": "", "symbols": ["REXR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42879910/mizuho-maintains-neutral-on-rexford-industrial-realty-lowers-price-target-to-45", "tags": ["analyst_other", "price_target_down"]}
{"id": 42879912, "time": "2025-01-08 11:24:33", "headline": "HC Wainwright & Co. Maintains Buy on Compass Therapeutics, Maintains $10 Price Target", "summary": "", "symbols": ["CMPX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42879912/hc-wainwright-co-maintains-buy-on-compass-therapeutics-maintains-10-price-target", "tags": ["analyst_other"]}
{"id": 42879930, "time": "2025-01-08 11:25:38", "headline": "U.S. Treasury Secretary Yellen Says Will Be Important To Keep Irs Modernization On Track; If IRS Funding Is Repealed, Could Be $800B Hit To Deficit; Disappointed That Biden Administration Has Not Been Able To Work With Congress For More Deficit Reduction", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42879930/u-s-treasury-secretary-yellen-says-will-be-important-to-keep-irs-modernization-on-track-if-irs-fundi", "tags": []}
{"id": 42879940, "time": "2025-01-08 11:26:17", "headline": "Phillips Edison Stock Is Up Wednesday After CEO Comments On $300M Deal Activity", "summary": "Phillips Edison &amp; Company stock is falling after announcing over $300 million in acquisitions, with no significant dispositions", "symbols": ["HAPS", "PECO"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/25/01/42879940/why-phillips-edison-company-stock-is-falling-today", "tags": ["contract", "management"]}
{"id": 42879954, "time": "2025-01-08 11:26:36", "headline": "Mizuho Maintains Outperform on VICI Props, Lowers Price Target to $30", "summary": "", "symbols": ["VICI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42879954/mizuho-maintains-outperform-on-vici-props-lowers-price-target-to-30", "tags": ["analyst_other", "price_target_down"]}
{"id": 42879968, "time": "2025-01-08 11:26:57", "headline": "HC Wainwright & Co. Maintains Buy on Viking Therapeutics, Maintains $102 Price Target", "summary": "", "symbols": ["VKTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42879968/hc-wainwright-co-maintains-buy-on-viking-therapeutics-maintains-102-price-target", "tags": ["analyst_other"]}
{"id": 42880009, "time": "2025-01-08 11:28:18", "headline": "Stifel Maintains Hold on Lindsay, Raises Price Target to $130", "summary": "", "symbols": ["LNN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42880009/stifel-maintains-hold-on-lindsay-raises-price-target-to-130", "tags": ["analyst_other", "price_target_up"]}
{"id": 42880028, "time": "2025-01-08 11:28:57", "headline": "HC Wainwright & Co. Maintains Buy on Sensei Biotherapeutics, Maintains $4 Price Target", "summary": "", "symbols": ["SNSE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42880028/hc-wainwright-co-maintains-buy-on-sensei-biotherapeutics-maintains-4-price-target", "tags": ["analyst_other"]}
{"id": 42880031, "time": "2025-01-08 11:29:09", "headline": "Stifel Maintains Buy on Rocket Lab USA, Raises Price Target to $31", "summary": "", "symbols": ["RKLB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42880031/stifel-maintains-buy-on-rocket-lab-usa-raises-price-target-to-31", "tags": ["analyst_other", "price_target_up"]}
{"id": 42880052, "time": "2025-01-08 11:30:12", "headline": "Stifel Maintains Buy on Realty Income, Lowers Price Target to $66.5", "summary": "", "symbols": ["O"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42880052/stifel-maintains-buy-on-realty-income-lowers-price-target-to-66-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 42880125, "time": "2025-01-08 11:31:41", "headline": "D. Boral Capital Maintains Buy on VolitionRX, Maintains $5 Price Target", "summary": "", "symbols": ["VNRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42880125/d-boral-capital-maintains-buy-on-volitionrx-maintains-5-price-target", "tags": ["analyst_other"]}
{"id": 42880169, "time": "2025-01-08 11:33:05", "headline": "Carvana Stock Soars As Atlanta 'Megasite' Integration Boosts Auction, Reconditioning Capacity", "summary": "Carvana stock rises as the company integrates an auction and reconditioning &#39;Megasite&#39; in Atlanta, expanding capacity and improving services.", "symbols": ["CVNA"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/trading-ideas/movers/25/01/42880169/carvana-stock-soars-as-atlanta-megasite-integration-boosts-auction-reconditioning-capacity", "tags": []}
{"id": 42880173, "time": "2025-01-08 11:33:17", "headline": "'FTC Finalizes Order with H&R Block Requiring Them to Pay $7 Million and Overhaul Advertising and Customer Service Practices for 2025 and 2026 Tax Seasons' - FTC", "summary": "", "symbols": ["HRB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42880173/ftc-finalizes-order-with-h-r-block-requiring-them-to-pay-7-million-and-overhaul-advertising-and-cust", "tags": []}
{"id": 42880174, "time": "2025-01-08 11:33:18", "headline": "GE Aerospace Received An Order For 210 T700 Engines To Power The 96 Boeing AH-64E Apache Guardian Helicopters For The Polish Armed Forces; No Financial Terms Disclosed", "summary": "", "symbols": ["EPOL", "GE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42880174/ge-aerospace-received-an-order-for-210-t700-engines-to-power-the-96-boeing-ah-64e-apache-guardian-he", "tags": []}
{"id": 42880196, "time": "2025-01-08 11:35:03", "headline": "U.S. Treasury's Yellen Says China-Sponsored Hack Of Treasury Workstations Is Of Tremendous Concern; China Hack Of Treasury Does Not Help U.S.-China Relations; Necessary For U.S., China To Cooperate In Some Areas", "summary": "", "symbols": ["FXI", "SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42880196/u-s-treasurys-yellen-says-china-sponsored-hack-of-treasury-workstations-is-of-tremendous-concern-chi", "tags": []}
{"id": 42880309, "time": "2025-01-08 11:42:08", "headline": "Instacart Grows Stronger: S&P MidCap 400 Inclusion, Ulta Partnership Boosts Stock", "summary": "Instacart gains as it is set to join S&amp;P MidCap 400. The company also partners with Ulta Beauty for same-day delivery, boosting stock value.", "symbols": ["ARCH", "CART", "ENOV", "NBCC", "RVER", "ULTA"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/25/01/42880309/instacart-grows-stronger-sp-midcap-400-inclusion-and-ulta-partnership-boosts-stock", "tags": ["contract"]}
{"id": 42880362, "time": "2025-01-08 11:44:00", "headline": "Anthropic Navigates Legal Hurdles While Pushing AI Innovation In Enterprise Sector", "summary": "Court orders measures to protect copyrights for Anthropic&#39;s AI. Anthropic&#39;s rapid growth and partnership with AWS show potential, but legal challenges must be navigated for success.", "symbols": [], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/trading-ideas/long-ideas/25/01/42880362/anthropic-navigates-legal-hurdles-while-pushing-ai-innovation-in-enterprise-sector", "tags": ["contract", "legal"]}
{"id": 42868377, "time": "2025-01-08 11:44:32", "headline": "Man Behind Tesla Cybertruck Blast Outside Trump Hotel Used ChatGPT For Planning, Says Las Vegas Police (UPDATED)", "summary": "The incident has raised significant concerns about the potential misuse of AI technologies like ChatGPT. ", "symbols": ["TSLA"], "source": "benzinga", "author": "Pooja Rajkumari", "url": "https://www.benzinga.com/news/25/01/42868377/man-behind-tesla-cybertruck-blast-outside-trump-hotel-used-chatgpt-for-planning-says-las-vegas-police", "tags": []}
{"id": 42880385, "time": "2025-01-08 11:44:42", "headline": "Leerink Partners Downgrades Accolade to Market Perform", "summary": "", "symbols": ["ACCD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42880385/leerink-partners-downgrades-accolade-to-market-perform", "tags": ["analyst_down"]}
{"id": 42880409, "time": "2025-01-08 11:47:31", "headline": "Bernstein Upgrades L3Harris Technologies to Outperform, Lowers Price Target to $267", "summary": "", "symbols": ["LHX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42880409/bernstein-upgrades-l3harris-technologies-to-outperform-lowers-price-target-to-267", "tags": ["analyst_up", "price_target_down"]}
{"id": 42880535, "time": "2025-01-08 11:52:12", "headline": "What's Going On With Inovio Pharmaceuticals (INO) Stock?", "summary": "Shares of Inovio Pharmaceuticals pulled back by 5.3% during Wednesday&#39;s session. The decline may be attributed to profit-taking, as investors assess renewed focus on respiratory illnesses.", "symbols": ["INO"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/25/01/42880535/whats-going-on-with-inovio-pharmaceuticals-ino-stock", "tags": ["why_moving"]}
{"id": 42880549, "time": "2025-01-08 11:52:45", "headline": "Nvidia CEO Jensen Huang Wants To Congratulate Trump At Mar-A-Lago, But Hasn't Been Invited Yet", "summary": "Nvidia CEO Jensen Huang is a leader in the tech and AI fields. While other tech leaders have met with Donald Trump at Mar-A-Lago, Huang hasn&#39;t been invited.", "symbols": ["NVDA"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/news/management/25/01/42880549/nvidia-ceo-jensen-huang-wants-to-congratulate-trump-at-mar-a-lago-but-hasnt-been-invited-yet", "tags": ["management"]}
{"id": 42880721, "time": "2025-01-08 11:56:27", "headline": "What's Going On With FuboTV Stock After Disney Deal?", "summary": "FuboTV shares are trading lower by 5.5% during Wednesday&#39;s session. The stock is pulling back after a 300% surge driven by the announcement of its new partnership with Walt Disney.", "symbols": ["DIS", "FUBO"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/25/01/42880721/whats-going-on-with-fubotv-stock-after-disney-deal", "tags": ["why_moving", "contract"]}
{"id": 42880773, "time": "2025-01-08 11:58:26", "headline": "Benchmark Initiates Coverage On Lithia Motors with Buy Rating, Announces Price Target of $400", "summary": "", "symbols": ["LAD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42880773/benchmark-initiates-coverage-on-lithia-motors-with-buy-rating-announces-price-target-of-400", "tags": ["analyst_init"]}
{"id": 42880786, "time": "2025-01-08 11:59:10", "headline": "Arthur J. Gallagher To Benefit From AssuredPartners Acquisition In 2025, Says Bullish Analyst", "summary": "Piper Sandler analyst upgrades Arthur J. Gallagher and raises price target to $315. The AssuredPartners acquisition to boost earnings.", "symbols": ["AJG"], "source": "benzinga", "author": "Priya Nigam", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/25/01/42880786/arthur-j-gallagher-to-benefit-from-assuredpartners-acquisition-in-2025-says-bullish-analyst", "tags": ["analyst_up", "price_target_up", "earnings"]}
{"id": 42880922, "time": "2025-01-08 12:00:37", "headline": "Benchmark Initiates Coverage On Gambling.com Gr with Buy Rating, Announces Price Target of $16", "summary": "", "symbols": ["GAMB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42880922/benchmark-initiates-coverage-on-gambling-com-gr-with-buy-rating-announces-price-target-of-16", "tags": ["analyst_init"]}
{"id": 42880937, "time": "2025-01-08 12:00:46", "headline": "USA Natural Gas Storage -40B Vs -39B Est.; -116B Prior", "summary": "", "symbols": ["SPY", "UNG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/01/42880937/usa-natural-gas-storage-40b-vs-39b-est-116b-prior", "tags": []}
{"id": 42881050, "time": "2025-01-08 12:03:52", "headline": "BTIG Downgrades Inari Medical to Neutral", "summary": "", "symbols": ["NARI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42881050/btig-downgrades-inari-medical-to-neutral", "tags": ["analyst_down"]}
{"id": 42881072, "time": "2025-01-08 12:05:16", "headline": "BTIG Downgrades Palo Alto Networks to Neutral", "summary": "", "symbols": ["PANW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42881072/btig-downgrades-palo-alto-networks-to-neutral", "tags": ["analyst_down"]}
{"id": 42881085, "time": "2025-01-08 12:06:34", "headline": "Is Labor Market Cooling Or Raising Fed Concerns? What To Watch In Friday's Jobs Report", "summary": "The December 2024 jobs report is expected to show slower hiring, easing pressure on the Fed amid inflation concerns and uncertainty under Trump. ADP&#39;s private-sector report already reveals slower growth.", "symbols": [], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/economics/macro-economic-events/25/01/42881085/is-labor-market-cooling-or-raising-fed-concerns-what-to-watch-in-fridays-jobs-report", "tags": []}
{"id": 42881109, "time": "2025-01-08 12:07:32", "headline": "Bitcoin Is Suffering From A Shift In Macro Expectations, Analyst Says: Here's What That Means", "summary": "Economist and prominent macro trader Alex Kr\u00fcger shared his outlook on Bitcoin&#39;s (CRYPTO: BTC) trajectory and market dynamics for 2025, emphasizing the potential for short-term trading opportunities as ", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/25/01/42881109/bitcoin-is-suffering-from-a-shift-in-macro-expectations-analyst-says-heres-what-that-means", "tags": ["guidance"]}
{"id": 42881112, "time": "2025-01-08 12:07:48", "headline": "'BlackRock to Cut About 1% of Its Employees, Staff Memo Says' - Bloomberg News", "summary": "", "symbols": ["BLK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42881112/blackrock-to-cut-about-1-of-its-employees-staff-memo-says-bloomberg-news", "tags": []}
{"id": 42881131, "time": "2025-01-08 12:08:26", "headline": "Flowers Foods Expands Snacking Segment With $795 Million Simple Mills Acquisition", "summary": "Flowers Foods (FLO) to acquire Simple Mills for $795 million in cash. The deal is expected to boost growth and margins, pending regulatory approval.", "symbols": ["CSB", "FLO", "FXG"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/global/25/01/42881131/flowers-foods-expands-snacking-segment-with-795-million-simple-mills-acquisition", "tags": ["merger", "contract"]}
{"id": 42881164, "time": "2025-01-08 12:09:13", "headline": "Crude Oil Down 1%; US Weekly Jobless Claims Decline", "summary": " ", "symbols": ["ANGO", "DATS", "JSPR", "SANA", "SILO", "XTIA"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/01/42881164/crude-oil-down-1-us-weekly-jobless-claims-decline", "tags": []}
{"id": 42873711, "time": "2025-01-08 08:58:49", "headline": "Sensei Biotherapeutics shares are trading higher after the company announced it's advancing its SNS-101 study and is expecting to present key data milestones in 2025.", "summary": "", "symbols": ["SNSE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/25/01/42873711/sensei-biotherapeutics-shares-are-trading-higher-after-the-company-announced-its-advancing-its-sns-1", "tags": ["why_moving"]}
{"id": 42881180, "time": "2025-01-08 12:10:18", "headline": "Live On CNBC, Steve Weiss Announces Sold INDA & SMIN India ETFs", "summary": "", "symbols": ["INDA", "SMIN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42881180/live-on-cnbc-steve-weiss-announces-sold-inda-smin-india-etfs", "tags": []}
{"id": 42881185, "time": "2025-01-08 12:10:54", "headline": "CBRE Initiates Coverage On Ryman Hospitality Props with Buy Rating, Announces Price Target of $130", "summary": "", "symbols": ["RHP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42881185/cbre-initiates-coverage-on-ryman-hospitality-props-with-buy-rating-announces-price-target-of-130", "tags": ["analyst_init"]}
{"id": 42881186, "time": "2025-01-08 12:11:08", "headline": "Quantum Stocks Face Reality Check After Nvidia CEO's Comments: What Do The Charts Show?", "summary": "Nvidia Corp. CEO Jensen Huang spoke at Nvidia&#39;s Analyst Day and made it clear: &#34;very useful&#34; quantum computers are likely decades away.", "symbols": ["IONQ", "QBTS", "RGTI"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/trading-ideas/technicals/25/01/42881186/quantum-stocks-face-reality-check-after-nvidia-ceos-comments-what-do-the-charts-show", "tags": ["management"]}
{"id": 42881260, "time": "2025-01-08 12:13:36", "headline": "Benzinga Market Summary: Quantum Stocks Slide On NVIDIA CEO Huang's Comments On Sector, Goldman Upgrades Spotify, US Dollar Index rises", "summary": "", "symbols": ["IONQ", "RGTI", "SPOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/01/42881260/benzinga-market-summary-quantum-stocks-slide-on-nvidia-ceo-huangs-comments-on-sec", "tags": ["analyst_up", "management"]}
{"id": 42881308, "time": "2025-01-08 12:17:10", "headline": "CIBC Downgrades TransAlta to Neutral, Raises Price Target to C$23", "summary": "", "symbols": ["TSX:TA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42881308/cibc-downgrades-transalta-to-neutral-raises-price-target-to-c-23", "tags": ["analyst_down", "price_target_up"]}
{"id": 42881350, "time": "2025-01-08 12:19:09", "headline": "Safety Shot Merges With Plant-Based Beverage Maker Yerba\u00e9 In $19.7 Million Deal", "summary": "Safety Shot Inc. (NASDAQ: SHOT) and Yerba\u00e9 Brands Corp. (OTC: YERBF) have completed a merger agreement that aims to combine wellness products with plant-based energy drinks.", "symbols": ["SHOT", "YERBF"], "source": "benzinga", "author": "Shivani Kumaresan", "url": "https://www.benzinga.com/news/25/01/42881350/safety-shot-merges-with-plant-based-beverage-maker-yerbae-in-19-7-million-deal", "tags": ["merger", "contract"]}
{"id": 42881352, "time": "2025-01-08 12:19:11", "headline": "CIBC Maintains Outperformer on Brookfield Renewable, Lowers Price Target to $32", "summary": "", "symbols": ["BEP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42881352/cibc-maintains-outperformer-on-brookfield-renewable-lowers-price-target-to-32", "tags": ["analyst_other", "price_target_down"]}
{"id": 42881462, "time": "2025-01-08 12:21:37", "headline": "CIBC Maintains Neutral on Fortis, Raises Price Target to C$64", "summary": "", "symbols": ["TSX:FTS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42881462/cibc-maintains-neutral-on-fortis-raises-price-target-to-c-64", "tags": ["analyst_other", "price_target_up"]}
{"id": 42881507, "time": "2025-01-08 12:23:11", "headline": "Live On CNBC, Joe Terranova Announces Bought Teradyne", "summary": "", "symbols": ["TER"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42881507/live-on-cnbc-joe-terranova-announces-bought-teradyne", "tags": []}
{"id": 42881546, "time": "2025-01-08 12:23:57", "headline": "Brazil Potash Stock Could Double: Analyst Bets On Autazes' Strategic Role In Potash Rebound", "summary": "Roth MKM analyst initiates coverage on Brazil Potash Corp. with Buy rating and $17 price target, citing undervalued Autazes project and potential for strong growth in Brazil&#39;s potash market.", "symbols": ["GRO"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/25/01/42881546/brazil-potash-stock-could-double-analyst-bets-on-autazes-strategic-role-in-potash-rebound", "tags": ["analyst_init"]}
{"id": 42881567, "time": "2025-01-08 12:24:28", "headline": "What's Going On With Arcadium Lithium Stock Wednesday?", "summary": "Arcadium Lithium shares are trading higher on Wednesday after the company announced that it secured Committee on Foreign Investment in\u00a0the United States clearance regarding Rio Tinto&#39;s proposed acquisition.", "symbols": ["ALTM"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/25/01/42881567/whats-going-on-with-arcadium-lithium-stock-wednesday", "tags": ["why_moving"]}
{"id": 42881585, "time": "2025-01-08 12:25:10", "headline": "Boston Scientific Expands Cardiovascular Treatment Portfolio With $440 Million+ Bolt Medical Deal", "summary": "Boston Scientific to acquire Bolt Medical for $600 million upfront plus milestones. Bolt&#39;s IVL platform addresses coronary and peripheral artery disease.", "symbols": ["BSX"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/health-care/25/01/42881585/boston-scientific-expands-cardiovascular-treatment-portfolio-with-440-million-bolt-medical-deal", "tags": ["merger", "contract"]}
{"id": 42881586, "time": "2025-01-08 12:25:11", "headline": "Trading Halt: Halted at 12:25:07 p.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["CPRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/01/42881586/trading-halt-halted-at-12-25-07-p-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 42881590, "time": "2025-01-08 12:25:16", "headline": "Live On CNBC, Trian Says Solventum Trades At A Discount To Its Peers And 3M Itself", "summary": "", "symbols": ["SOLV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42881590/live-on-cnbc-trian-says-solventum-trades-at-a-discount-to-its-peers-and-3m-itself", "tags": []}
{"id": 42881609, "time": "2025-01-08 12:26:45", "headline": "CIBC Maintains Neutral on NextEra Energy Partners, Lowers Price Target to $21", "summary": "", "symbols": ["NEP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42881609/cibc-maintains-neutral-on-nextera-energy-partners-lowers-price-target-to-21", "tags": ["analyst_other", "price_target_down"]}
{"id": 42881652, "time": "2025-01-08 12:28:22", "headline": "Vir Biotechnology Stock Soars On Prostate Cancer Trial Data - Here's Why", "summary": "Vir Biotechnology&#39;s Phase 1 trials reveal promising safety and efficacy for dual-masked T-cell engagers targeting HER2 and PSMA in cancer therapies.", "symbols": ["VIR"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/25/01/42881652/vir-biotechnology-stock-jumps-after-prostate-cancer-trial-data", "tags": ["fda"]}
{"id": 42881698, "time": "2025-01-08 12:30:18", "headline": "Here's Why Phreesia's Average Revenue Per Client Will Accelerate: Analyst", "summary": "Analyst predicts Phreesia&#39;s revenue per client will accelerate, as company shifts focus to monetizing existing clients. Upgraded rating and PT raised.", "symbols": ["PHR"], "source": "benzinga", "author": "Priya Nigam", "url": "https://www.benzinga.com/25/01/42881698/heres-why-phreesias-average-revenue-per-client-will-accelerate-says-bullish-analyst", "tags": ["analyst_up", "earnings"]}
{"id": 42881721, "time": "2025-01-08 12:31:12", "headline": "TD Cowen Upgrades McCormick & Co to Buy, Raises Price Target to $90", "summary": "", "symbols": ["MKC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42881721/td-cowen-upgrades-mccormick-co-to-buy-raises-price-target-to-90", "tags": ["analyst_up", "price_target_up"]}
{"id": 42881723, "time": "2025-01-08 12:31:26", "headline": "'Constellation Energy Nears $30B Deal For Calpine' - Bloomberg News", "summary": "", "symbols": ["CEG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/01/42881723/constellation-energy-nears-30b-deal-for-calpine-bloomberg-news", "tags": ["contract"]}
{"id": 42881732, "time": "2025-01-08 12:32:56", "headline": "Catalyst Pharmaceuticals Announces Settlement Of FIRDAPSE Patent Litigation With Teva Pharmaceuticals; Teva Will Not Market Its Generic Version Of FIRDAPSE In The U.S. Any Earlier Than February 25, 2035, If Approved By The FDA", "summary": "", "symbols": ["CPRX", "TEVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42881732/catalyst-pharmaceuticals-announces-settlement-of-firdapse-patent-litigation-with-teva-pharmaceutical", "tags": ["fda", "legal"]}
{"id": 42881735, "time": "2025-01-08 12:33:09", "headline": "Verizon Hits 5.5 Gbps 5G Speeds, Lands Air Force Deal to Upgrade Base Networks Nationwide", "summary": "Verizon announced 5.5 Gbps download speeds using carrier aggregation and virtualized 5G tech. Also selected by USAF for 5G and network upgrades.", "symbols": ["NVDA", "SSNLF", "VZ"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/25/01/42881735/verizon-hits-55-gbps-5g-speeds-lands-air-force-deal-to-upgrade-base-networks-nationwide", "tags": ["analyst_up", "contract"]}
{"id": 42881790, "time": "2025-01-08 12:34:34", "headline": "TD Cowen Upgrades Coca-Cola to Buy, Announces $75 Price Target", "summary": "", "symbols": ["KO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42881790/td-cowen-upgrades-coca-cola-to-buy-announces-75-price-target", "tags": ["analyst_up"]}
{"id": 42881794, "time": "2025-01-08 12:35:11", "headline": "10 Information Technology Stocks With Whale Alerts In Today's Session", "summary": " ", "symbols": ["AAPL", "AMD", "APP", "CSCO", "MARA", "MSTR", "NVDA", "PLTR", "QBTS", "RGTI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/01/42881794/10-information-technology-stocks-with-whale-alerts-in-todays-session", "tags": []}
{"id": 42881797, "time": "2025-01-08 12:35:17", "headline": "8 Consumer Discretionary Stocks Whale Activity In Today's Session", "summary": " ", "symbols": ["AMZN", "BABA", "BKNG", "ETSY", "GME", "MELI", "PDD", "TSLA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/01/42881797/8-consumer-discretionary-stocks-whale-activity-in-todays-session", "tags": []}
{"id": 42881798, "time": "2025-01-08 12:35:22", "headline": "8 Health Care Stocks Whale Activity In Today's Session", "summary": " ", "symbols": ["ABBV", "ABT", "CAPR", "CVS", "GEHC", "JNJ", "SOLV", "VEEV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/01/42881798/8-health-care-stocks-whale-activity-in-todays-session", "tags": []}
{"id": 42881804, "time": "2025-01-08 12:35:56", "headline": "Lake Street Initiates Coverage On Strawberry Fields REIT with Buy Rating, Announces Price Target of $13.5", "summary": "", "symbols": ["STRW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42881804/lake-street-initiates-coverage-on-strawberry-fields-reit-with-buy-rating-announces-price-target-of-1", "tags": ["analyst_init"]}
{"id": 42881818, "time": "2025-01-08 12:36:41", "headline": "SEALSQ Expands Reach With DigiKey Launch: Details", "summary": "SEALSQ stock drops after NVIDIA CEO&#39;s comments on quantum computing delays, despite progress in secure chip distribution.", "symbols": ["LAES"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/markets/equities/25/01/42881818/sealsq-expands-reach-with-digikey-launch-details", "tags": ["management"]}
{"id": 42881835, "time": "2025-01-08 12:37:11", "headline": "Lake Street Initiates Coverage On Anteris Technologies with Buy Rating, Announces Price Target of $20", "summary": "", "symbols": ["AVR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42881835/lake-street-initiates-coverage-on-anteris-technologies-with-buy-rating-announces-price-target-of-20", "tags": ["analyst_init"]}
{"id": 42881849, "time": "2025-01-08 12:37:42", "headline": "TD Cowen Downgrades JM Smucker to Hold, Lowers Price Target to $121", "summary": "", "symbols": ["SJM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42881849/td-cowen-downgrades-jm-smucker-to-hold-lowers-price-target-to-121", "tags": ["analyst_down", "price_target_down"]}
{"id": 42881889, "time": "2025-01-08 12:39:45", "headline": "Uber, Nvidia Partnership To Unlock Value By Leveraging AI To Advance Ridesharing, Autonomous Tech: Analyst", "summary": "Analyst maintains Buy rating on Uber with $96 price target after its partnership with Nvidia to develop AVs, leveraging Uber&#39;s data and Nvidia&#39;s AI platform.", "symbols": ["AMZN", "AUR", "GOOG", "GOOGL", "NVDA", "TM", "TSLA", "UBER"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/analyst-ratings/price-target/25/01/42881889/uber-nvidia-partnership-to-unlock-value-by-leveraging-ai-to-advance-ridesharing-autonomous-tech-analyst", "tags": ["analyst_other", "contract"]}
{"id": 42881904, "time": "2025-01-08 12:41:17", "headline": "TD Cowen Downgrades Kimberly-Clark to Hold, Announces $145 Price Target", "summary": "", "symbols": ["KMB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42881904/td-cowen-downgrades-kimberly-clark-to-hold-announces-145-price-target", "tags": ["analyst_down"]}
{"id": 42881940, "time": "2025-01-08 12:44:28", "headline": "Lake Street Maintains Buy on Personalis, Raises Price Target to $9", "summary": "", "symbols": ["PSNL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42881940/lake-street-maintains-buy-on-personalis-raises-price-target-to-9", "tags": ["analyst_other", "price_target_up"]}
{"id": 42881951, "time": "2025-01-08 12:45:38", "headline": "TD Cowen Downgrades Science Applications Intl to Hold, Lowers Price Target to $120", "summary": "", "symbols": ["SAIC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42881951/td-cowen-downgrades-science-applications-intl-to-hold-lowers-price-target-to-120", "tags": ["analyst_down", "price_target_down"]}
{"id": 42881958, "time": "2025-01-08 12:46:04", "headline": "Costco Wholesale's Options Frenzy: What You Need to Know", "summary": " ", "symbols": ["COST"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/01/42881958/costco-wholesales-options-frenzy-what-you-need-to-know", "tags": []}
{"id": 42881959, "time": "2025-01-08 12:46:10", "headline": "Spotlight on Pfizer: Analyzing the Surge in Options Activity", "summary": " ", "symbols": ["PFE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/01/42881959/spotlight-on-pfizer-analyzing-the-surge-in-options-activity", "tags": []}
{"id": 42881961, "time": "2025-01-08 12:46:17", "headline": "Shell Awards Schlumberger Three-Year, Multi-Region Deepwater Contracts: Details", "summary": "Schlumberger secured major contracts from Shell for energy development in various locations, leveraging its AI and ultra-deepwater expertise.", "symbols": ["IEZ", "OIH", "SHEL", "SLB"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/contracts/25/01/42881961/shell-awards-schlumberger-three-year-multi-region-deepwater-contracts-details", "tags": []}
{"id": 42882005, "time": "2025-01-08 12:47:28", "headline": "Lake Street Maintains Hold on Kura Sushi USA, Raises Price Target to $103", "summary": "", "symbols": ["KRUS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42882005/lake-street-maintains-hold-on-kura-sushi-usa-raises-price-target-to-103", "tags": ["analyst_other", "price_target_up"]}
{"id": 42882016, "time": "2025-01-08 12:47:43", "headline": "TD Cowen Initiates Coverage On Axon Enterprise with Buy Rating, Announces Price Target of $700", "summary": "", "symbols": ["AXON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42882016/td-cowen-initiates-coverage-on-axon-enterprise-with-buy-rating-announces-price-target-of-700", "tags": ["analyst_init"]}
{"id": 42882089, "time": "2025-01-08 12:49:50", "headline": "Lake Street Maintains Buy on AVITA Medical, Lowers Price Target to $14", "summary": "", "symbols": ["RCEL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42882089/lake-street-maintains-buy-on-avita-medical-lowers-price-target-to-14", "tags": ["analyst_other", "price_target_down"]}
{"id": 42882098, "time": "2025-01-08 12:51:09", "headline": "Maxim Group Initiates Coverage On NioCorp Developments with Buy Rating, Announces Price Target of $4", "summary": "", "symbols": ["NB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42882098/maxim-group-initiates-coverage-on-niocorp-developments-with-buy-rating-announces-price-target-of-4", "tags": ["analyst_init"]}
{"id": 42882099, "time": "2025-01-08 12:51:11", "headline": "TD Cowen Upgrades Cardinal Health to Buy, Raises Price Target to $144", "summary": "", "symbols": ["CAH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42882099/td-cowen-upgrades-cardinal-health-to-buy-raises-price-target-to-144", "tags": ["analyst_up", "price_target_up"]}
{"id": 42882191, "time": "2025-01-08 12:52:32", "headline": "'Hershey Seeks CFTC Help To Take Huge Cocoa Position In New York' - Bloomberg News", "summary": "", "symbols": ["HSY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42882191/hershey-seeks-cftc-help-to-take-huge-cocoa-position-in-new-york-bloomberg-news", "tags": []}
{"id": 42882230, "time": "2025-01-08 12:53:54", "headline": "Craig-Hallum Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $18", "summary": "", "symbols": ["ETON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42882230/craig-hallum-maintains-buy-on-eton-pharmaceuticals-raises-price-target-to-18", "tags": ["analyst_other", "price_target_up"]}
{"id": 42882231, "time": "2025-01-08 12:54:05", "headline": "TD Cowen Maintains Buy on BellRing Brands, Raises Price Target to $86", "summary": "", "symbols": ["BRBR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42882231/td-cowen-maintains-buy-on-bellring-brands-raises-price-target-to-86", "tags": ["analyst_other", "price_target_up"]}
{"id": 42882233, "time": "2025-01-08 12:54:21", "headline": "Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies", "summary": "Bird flu has severely impacted poultry farms and cattle herds across 16 states, marking the worst outbreak of its kind.", "symbols": ["CVAC", "FTXH", "GSK", "IDNA", "MRNA", "NVAX", "PFE", "SNY", "XBI"], "source": "benzinga", "author": "Chandrima Sanyal", "url": "https://www.benzinga.com/general/biotech/25/01/42882233/bird-flu-sparks-vaccine-stock-surge-etfs-to-watch-as-h5n1-outbreak-intensifies", "tags": []}
{"id": 42882268, "time": "2025-01-08 12:55:08", "headline": "Trading Halt: Halt status updated at 12:55:00 PM ET: Quotation Resumption: News and Resumption Times", "summary": "", "symbols": ["CPRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/01/42882268/trading-halt-halt-status-updated-at-12-55-00-pm-et-quotation-resumption-news-and-resumption-times", "tags": []}
{"id": 42882279, "time": "2025-01-08 12:55:39", "headline": "Blackstone Invests Big In Citrin Cooperman: Private Equity Fuels Growth In Tax and Advisory", "summary": "Blackstone agreed to invest in Citrin Cooperman Advisors LLC, aiming to expand services &amp; tech.", "symbols": ["BX", "GK", "LBO"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/25/01/42882279/whats-going-on-with-blackstone-stock-on-wednesday", "tags": []}
{"id": 42882298, "time": "2025-01-08 12:56:49", "headline": "TD Cowen Maintains Hold on Anheuser-Busch InBev, Lowers Price Target to $55", "summary": "", "symbols": ["BUD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42882298/td-cowen-maintains-hold-on-anheuser-busch-inbev-lowers-price-target-to-55", "tags": ["analyst_other", "price_target_down"]}
{"id": 42882330, "time": "2025-01-08 12:59:28", "headline": "TD Cowen Maintains Buy on Colgate-Palmolive, Lowers Price Target to $100", "summary": "", "symbols": ["CL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42882330/td-cowen-maintains-buy-on-colgate-palmolive-lowers-price-target-to-100", "tags": ["analyst_other", "price_target_down"]}
{"id": 42882349, "time": "2025-01-08 13:00:18", "headline": "Demystifying Netstreit: Insights From 5 Analyst Reviews", "summary": " ", "symbols": ["NTST"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42882349/demystifying-netstreit-insights-from-5-analyst-reviews", "tags": []}
{"id": 42882353, "time": "2025-01-08 13:00:28", "headline": "Demystifying Nasdaq: Insights From 14 Analyst Reviews", "summary": " ", "symbols": ["NDAQ"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42882353/demystifying-nasdaq-insights-from-14-analyst-reviews", "tags": []}
{"id": 42882369, "time": "2025-01-08 13:00:35", "headline": "What Analysts Are Saying About Booz Allen Hamilton Stock", "summary": " ", "symbols": ["BAH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42882369/what-analysts-are-saying-about-booz-allen-hamilton-stock", "tags": []}
{"id": 42882376, "time": "2025-01-08 13:00:44", "headline": "The Analyst Verdict: Eton Pharmaceuticals In The Eyes Of 5 Experts", "summary": " ", "symbols": ["ETON"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42882376/the-analyst-verdict-eton-pharmaceuticals-in-the-eyes-of-5-experts", "tags": []}
{"id": 42882375, "time": "2025-01-08 13:00:44", "headline": "$92,000 Is Bitcoin's Key Support \u2014 Here's What Top Analyst Says Will Happen If It Fails", "summary": "Pseudonymous cryptocurrency analyst Ali Martinez has cautioned that Bitcoin (CRYPTO: BTC) is vulnerable to a steep decline, citing a lack of substantial support ", "symbols": ["ADAUSD", "BTCUSD", "DOGEUSD", "SOLUSD"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/25/01/42882375/92000-is-bitcoins-key-support-heres-what-top-analyst-says-will-happen-if-it-fails", "tags": []}
{"id": 42882386, "time": "2025-01-08 13:00:53", "headline": "CNBC Halftime Report Final Trades: Apollo Global Management, UnitedHealth Group, iShares U.S. Financial ETF, Boston Scientific", "summary": "", "symbols": ["APO", "BSX", "IYF", "UNH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42882386/cnbc-halftime-report-final-trades-apollo-global-management-unitedhealth-group-ishares-u-s-financial", "tags": []}
{"id": 42882387, "time": "2025-01-08 13:00:55", "headline": "Expert Outlook: First Solar Through The Eyes Of 23 Analysts", "summary": " ", "symbols": ["FSLR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42882387/expert-outlook-first-solar-through-the-eyes-of-23-analysts", "tags": ["guidance"]}
{"id": 42882389, "time": "2025-01-08 13:01:03", "headline": "Smart Money Is Betting Big In SOUN Options", "summary": " ", "symbols": ["SOUN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/01/42882389/smart-money-is-betting-big-in-soun-options", "tags": []}
{"id": 42882391, "time": "2025-01-08 13:01:06", "headline": "Where Science Applications Intl Stands With Analysts", "summary": " ", "symbols": ["SAIC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42882391/where-science-applications-intl-stands-with-analysts", "tags": []}
{"id": 42882394, "time": "2025-01-08 13:01:14", "headline": "Broadcom's Options: A Look at What the Big Money is Thinking", "summary": " ", "symbols": ["AVGO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/01/42882394/broadcoms-options-a-look-at-what-the-big-money-is-thinking", "tags": []}
{"id": 42882431, "time": "2025-01-08 13:03:03", "headline": "Wall Street Mixed Ahead Of Fed Minutes, Dollar Bolsters Strength, Bitcoin Falls Below $95,000: What's Driving Markets Wednesday?", "summary": "Wall Street began Wednesday with muted trading, as investors braced for the release of the December Federal Open Market Committee meeting minutes.", "symbols": ["AMD", "BTCUSD", "DIA", "EBAY", "IONQ", "IWM", "META", "NVDA", "QBTS", "QQQ", "QUBT", "RGTI", "SPY", "XLC", "XLE", "XLK", "XLV"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/economics/macro-economic-events/25/01/42882431/wall-street-mixed-ahead-of-fed-minutes-dollar-bolsters-strength-bitcoin-falls-below-95000-whats-driving-markets-wednesday", "tags": []}
{"id": 42882484, "time": "2025-01-08 13:06:05", "headline": "Avita Medical Cuts Annual Sales Forecast On Softer Demand From Hospitals", "summary": "AVITA Medical revises 2024 revenue guidance to $64.3 million, citing year-end inventory adjustments, and forecasts 2025 revenue growth of 55%-65% with new product launches.", "symbols": ["RCEL"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/health-care/25/01/42882484/avita-medical-cuts-annual-sales-forecast-on-softer-demand-from-hospitals", "tags": ["earnings", "guidance"]}
{"id": 42882522, "time": "2025-01-08 13:07:45", "headline": "TD Cowen Maintains Hold on Diageo, Raises Price Target to $129", "summary": "", "symbols": ["DEO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42882522/td-cowen-maintains-hold-on-diageo-raises-price-target-to-129", "tags": ["analyst_other", "price_target_up"]}
{"id": 42882596, "time": "2025-01-08 13:10:45", "headline": "TD Cowen Maintains Hold on Hershey, Lowers Price Target to $172", "summary": "", "symbols": ["HSY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42882596/td-cowen-maintains-hold-on-hershey-lowers-price-target-to-172", "tags": ["analyst_other", "price_target_down"]}
{"id": 42882638, "time": "2025-01-08 13:14:15", "headline": "Simply Good Foods Reports 10.6% Revenue Growth In Q1, CEO Highlights Rise In Popularity Of Nutritional Snacking", "summary": "Simply Good Foods reports Q1 earnings beat but revenue misses estimates, with strong growth expected in FY25 and a focus on nutritional snacking.", "symbols": ["SMPL"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/news/earnings/25/01/42882638/simply-good-foods-reports-10-6-revenue-growth-in-q1-ceo-highlights-rise-in-popularity-of-nutritional-snacking", "tags": ["earnings", "management"]}
{"id": 42882657, "time": "2025-01-08 13:15:06", "headline": "TD Cowen Maintains Hold on Keurig Dr Pepper, Lowers Price Target to $36", "summary": "", "symbols": ["KDP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42882657/td-cowen-maintains-hold-on-keurig-dr-pepper-lowers-price-target-to-36", "tags": ["analyst_other", "price_target_down"]}
{"id": 42882659, "time": "2025-01-08 13:15:41", "headline": "A Closer Look at Bank of America's Options Market Dynamics", "summary": " ", "symbols": ["BAC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/01/42882659/a-closer-look-at-bank-of-americas-options-market-dynamics", "tags": []}
{"id": 42882660, "time": "2025-01-08 13:15:46", "headline": "Looking At Caterpillar's Recent Unusual Options Activity", "summary": " ", "symbols": ["CAT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/01/42882660/looking-at-caterpillars-recent-unusual-options-activity", "tags": []}
{"id": 42882698, "time": "2025-01-08 13:17:38", "headline": "What's Going On With Currenc Group Shares Wednesday?", "summary": "Currenc shares are trading higher on Wednesday after the company announced the launch of its SEAMLESS AI Call Center.", "symbols": ["CURR"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/25/01/42882698/whats-going-on-with-currenc-group-shares-wednesday", "tags": ["why_moving"]}
{"id": 42882766, "time": "2025-01-08 13:21:09", "headline": "DEA Accused Of Bias In Cannabis Rescheduling Hearings: Weed Stocks Plummeted In 2024 As Process Drags On", "summary": "DEA judge orders agency to respond to allegations of opposing marijuana rescheduling and improper communication with opponents. Cannabis stocks declined in 2024 due to concerns about DEA review.", "symbols": ["AAWH", "CGC", "CRLBF", "CURLF", "GTBIF", "MSOS", "OGI", "TCNNF", "TLRY", "TSNDF", "VRNOF"], "source": "benzinga", "author": "Maureen Meehan", "url": "https://www.benzinga.com/government/regulations/25/01/42882766/dea-accused-of-bias-in-cannabis-rescheduling-hearings-weed-stocks-plummeted-in-2024-as-process-drags-on", "tags": []}
{"id": 42882886, "time": "2025-01-08 13:24:01", "headline": "TD Cowen Maintains Hold on Kraft Heinz, Lowers Price Target to $32", "summary": "", "symbols": ["KHC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42882886/td-cowen-maintains-hold-on-kraft-heinz-lowers-price-target-to-32", "tags": ["analyst_other", "price_target_down"]}
{"id": 42882898, "time": "2025-01-08 13:24:42", "headline": "Reported Earlier, Microbot Medical Entered Into Definitive Agreements For The Purchase And Sale Of 3,788,550 Shares Of Common Stock At A Purchase Price Of $2.27 Per Share In A Registered Direct Offering", "summary": "", "symbols": ["MBOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42882898/microbot-medical-entered-into-definitive-agreements-for-the-purchase-and-sale-of-3-788-550-shares-of", "tags": ["offering"]}
{"id": 42882919, "time": "2025-01-08 13:26:57", "headline": "Netflix Q4 To Show Advertising, Live Sports Strength, Analyst Says: 'Multiyear Narrative Of Compounded Growth'", "summary": "A Netflix analyst expects most investors to be focused on the streaming company&#39;s live sports and advertising efforts in Q4 earnings results.", "symbols": ["NFLX"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/general/sports/25/01/42882919/netflix-q4-to-show-advertising-live-sports-strength-analyst-says-multiyear-narrative-of-compounded-growth", "tags": ["earnings"]}
{"id": 42882920, "time": "2025-01-08 13:26:57", "headline": "What's Going On With Accolade Stock Wednesday?", "summary": "Accolade shares are trading higher on Wednesday after it announced that Transcarent will acquire the company.", "symbols": ["ACCD"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/25/01/42882920/whats-going-on-with-accolade-stock-wednesday", "tags": ["why_moving", "merger"]}
{"id": 42882921, "time": "2025-01-08 13:27:05", "headline": "TD Cowen Maintains Hold on PepsiCo, Lowers Price Target to $160", "summary": "", "symbols": ["PEP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42882921/td-cowen-maintains-hold-on-pepsico-lowers-price-target-to-160", "tags": ["analyst_other", "price_target_down"]}
{"id": 42882959, "time": "2025-01-08 13:28:18", "headline": "Intel Partners with Amazon Cloud to Drive Next-Gen Smart Vehicle Tech, Wins Stellantis, Karma Auto As Clients", "summary": "Intel showcased its expanded product portfolio and partnerships for electric and software-defined vehicles at CES 2025, targeting cost reductions and performance improvements.", "symbols": ["AMD", "AMZN", "INTC", "NVDA", "SMH", "SOXX", "STLA", "TSM"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/25/01/42882959/intel-partners-with-amazon-cloud-to-drive-next-gen-smart-vehicle-tech", "tags": ["contract"]}
{"id": 42882997, "time": "2025-01-08 13:29:20", "headline": "TD Cowen Maintains Hold on Constellation Brands, Lowers Price Target to $260", "summary": "", "symbols": ["STZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42882997/td-cowen-maintains-hold-on-constellation-brands-lowers-price-target-to-260", "tags": ["analyst_other", "price_target_down"]}
{"id": 42883003, "time": "2025-01-08 13:30:00", "headline": "Hoth Therapeutics Addresses Market Rumors, Confirms No Plans For Offering, Strong Financial Position With $10M Cash And No Debt; Reports Steady Progress In HT-001 Clinical Trial Enrollment", "summary": "", "symbols": ["HOTH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42883003/hoth-therapeutics-addresses-market-rumors-confirms-no-plans-for-offering-strong-financial-position-w", "tags": ["offering", "fda"]}
{"id": 42883011, "time": "2025-01-08 13:30:26", "headline": "Price Over Earnings Overview: PennantPark Floating Rate", "summary": " ", "symbols": ["PFLT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/01/42883011/price-over-earnings-overview-pennantpark-floating-rate", "tags": ["earnings"]}
{"id": 42883025, "time": "2025-01-08 13:31:23", "headline": "TD Cowen Maintains Buy on Utz Brands, Lowers Price Target to $17", "summary": "", "symbols": ["UTZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42883025/td-cowen-maintains-buy-on-utz-brands-lowers-price-target-to-17", "tags": ["analyst_other", "price_target_down"]}
{"id": 42883027, "time": "2025-01-08 13:31:47", "headline": "CIMG Shares Halted On Circuit Breaker To The Upside, Stock Now Up 75.7%", "summary": "", "symbols": ["IMG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/01/42883027/cimg-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-75-7", "tags": ["halt"]}
{"id": 42883035, "time": "2025-01-08 13:33:00", "headline": "Why Is Accolade Stock Trading Over 100% On Tuesday?", "summary": "Transcarent to acquire Accolade Inc. for $7.03 per share, combining AI-driven care solutions with personalized healthcare expertise. Deal closes Q2 2025.", "symbols": ["ACCD"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/health-care/25/01/42883035/why-is-accolade-stock-trading-over-100-on-tuesday", "tags": ["why_moving", "merger", "contract"]}
{"id": 42883046, "time": "2025-01-08 13:33:50", "headline": "TD Cowen Maintains Buy on Vital Farms, Raises Price Target to $45", "summary": "", "symbols": ["VITL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42883046/td-cowen-maintains-buy-on-vital-farms-raises-price-target-to-45", "tags": ["analyst_other", "price_target_up"]}
{"id": 42883080, "time": "2025-01-08 13:37:53", "headline": "Weak sentiment may leave Auntea Jenny thirsty for better valuation", "summary": "Key Takeaways:\n\n\n\tAuntea Jenny has revived its Hong Kong listing plan, reporting its profit fell 12% in the first half of last year while its revenue rose just 6.4%\n\tThe bubble tea chain operator had nearly 8,500 stores in its network at the middle of last year\n\n\n\u00a0\u00a0\n\nBy Cheng Shui Tong", "symbols": [], "source": "benzinga", "author": "The Bamboo Works", "url": "https://www.benzinga.com/25/01/42883080/weak-sentiment-may-leave-auntea-jenny-thirsty-for-better-valuation", "tags": ["earnings"]}
{"id": 42883087, "time": "2025-01-08 13:38:27", "headline": "TD Cowen Downgrades Leidos Holdings to Hold, Lowers Price Target to $165", "summary": "", "symbols": ["LDOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42883087/td-cowen-downgrades-leidos-holdings-to-hold-lowers-price-target-to-165", "tags": ["analyst_down", "price_target_down"]}
{"id": 42883117, "time": "2025-01-08 13:39:10", "headline": "In an Unpredictable Market Here Are Some Potential Winners and Losers for the First Quarter", "summary": "Every year, analysts discuss the stocks and sectors they favor for the coming year, often providing price targets for where major indexes might land by year-end. I believe both of these practices are futile. The market is dynamic and ever-changing; the environment can shift on a dime, so don\u2019t get attached to a one-year playbook. Focusing on quarterly trends is a better approach.", "symbols": ["BKR", "CVX", "GLNG", "HON", "KBR", "LNG", "TTE", "XOM"], "source": "benzinga", "author": "Kevin Green", "url": "https://www.benzinga.com/25/01/42883117/in-an-unpredictable-market-here-are-some-potential-winners-and-losers-for-the-first-quarter", "tags": []}
{"id": 42883118, "time": "2025-01-08 13:39:40", "headline": "Why CureVac (CVAC) Stock Is Moving", "summary": "Shares of CureVac fell by 12.3% Wednesday afternoon. The pullback may stem from profit-taking after Tuesday&#39;s strong gains driven by rising concerns over U.S. respiratory illnesses.", "symbols": ["CVAC"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/25/01/42883118/why-curevac-cvac-stock-is-moving", "tags": []}
{"id": 42883122, "time": "2025-01-08 13:40:02", "headline": "Nike's Getting Back To Being Nike", "summary": "Nike Inc (NYSE: NKE) ended 2023 by reporting declining revenue and profit despite beating both top and bottom line estimates with its latest quarter results.\n\nFiscal second quarter highlights", "symbols": ["DKS", "FL", "NKE"], "source": "benzinga", "author": "Upwallstreet", "url": "https://www.benzinga.com/news/small-cap/25/01/42883122/nikes-getting-back-to-being-nike", "tags": ["earnings"]}
{"id": 42883139, "time": "2025-01-08 13:40:26", "headline": "TD Cowen Maintains Buy on Booz Allen Hamilton, Lowers Price Target to $155", "summary": "", "symbols": ["BAH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42883139/td-cowen-maintains-buy-on-booz-allen-hamilton-lowers-price-target-to-155", "tags": ["analyst_other", "price_target_down"]}
{"id": 42883167, "time": "2025-01-08 13:44:06", "headline": "TD Cowen Maintains Buy on CACI International, Lowers Price Target to $480", "summary": "", "symbols": ["CACI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42883167/td-cowen-maintains-buy-on-caci-international-lowers-price-target-to-480", "tags": ["analyst_other", "price_target_down"]}
{"id": 42883207, "time": "2025-01-08 13:45:27", "headline": "TradePulse Power Inflow Alert: GE Vernova (GEV) Receives Alert and Moves 3.3% Higher In The Session", "summary": " ", "symbols": [], "source": "benzinga", "author": "Finit", "url": "https://www.benzinga.com/trading-ideas/25/01/42883207/tradepulse-power-inflow-alert-ge-vernova-gev-receives-alert-and-moves-3-3-higher-in-the-session", "tags": []}
{"id": 42883218, "time": "2025-01-08 13:45:57", "headline": "A Look Into Arbor Realty Trust Inc's Price Over Earnings", "summary": " ", "symbols": ["ABR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/01/42883218/a-look-into-arbor-realty-trust-incs-price-over-earnings", "tags": ["earnings"]}
{"id": 42883232, "time": "2025-01-08 13:46:27", "headline": "RBC Capital Maintains Outperform on Celestica, Raises Price Target to $115", "summary": "", "symbols": ["CLS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42883232/rbc-capital-maintains-outperform-on-celestica-raises-price-target-to-115", "tags": ["analyst_other", "price_target_up"]}
{"id": 42883252, "time": "2025-01-08 13:48:32", "headline": "Pinterest Headwinds See BofA Lower Estimates, But Analyst Optimistic About AI Solutions", "summary": "The BofA Securities analyst lowers estimates for Pinterest, while maintaining a Buy rating and $39 price target.", "symbols": ["PINS", "RVER", "SOCL"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/general/social-media/25/01/42883252/pinterest-headwinds-see-bofa-lower-estimates-but-analyst-optimistic-about-ai-solutions", "tags": []}
{"id": 42883379, "time": "2025-01-08 13:51:44", "headline": "TD Cowen Maintains Hold on KBR, Lowers Price Target to $64", "summary": "", "symbols": ["KBR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42883379/td-cowen-maintains-hold-on-kbr-lowers-price-target-to-64", "tags": ["analyst_other", "price_target_down"]}
{"id": 42883442, "time": "2025-01-08 13:54:32", "headline": "TD Cowen Maintains Buy on Parsons, Lowers Price Target to $105", "summary": "", "symbols": ["PSN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42883442/td-cowen-maintains-buy-on-parsons-lowers-price-target-to-105", "tags": ["analyst_other", "price_target_down"]}
{"id": 42883460, "time": "2025-01-08 13:55:44", "headline": "TD Cowen Maintains Buy on Amer Sports, Raises Price Target to $33", "summary": "", "symbols": ["AS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42883460/td-cowen-maintains-buy-on-amer-sports-raises-price-target-to-33", "tags": ["analyst_other", "price_target_up"]}
{"id": 42883468, "time": "2025-01-08 13:57:27", "headline": "TD Cowen Maintains Hold on Academy Sports, Raises Price Target to $61", "summary": "", "symbols": ["ASO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42883468/td-cowen-maintains-hold-on-academy-sports-raises-price-target-to-61", "tags": ["analyst_other", "price_target_up"]}
{"id": 42883477, "time": "2025-01-08 13:58:21", "headline": "Amplify To Liquidate Cannabis-Focused MJUS ETF As Regulatory Uncertainty Weighs On Sector", "summary": "Amplify ETFs plans to liquidate MJUS, a cannabis-related ETF, due to regulatory issues. Other cannabis ETFs also struggling with DEA&#39;s indecisiveness.", "symbols": ["CURLF", "GTBIF", "MJUS", "MSOS", "TOKE", "VICE", "WEED"], "source": "benzinga", "author": "Chandrima Sanyal", "url": "https://www.benzinga.com/etfs/specialty-etfs/25/01/42883477/amplify-to-liquidate-cannabis-focused-mjus-etf-as-regulatory-uncertainty-weighs-on-sector", "tags": []}
{"id": 42883487, "time": "2025-01-08 13:59:05", "headline": "TD Cowen Maintains Buy on Dick's Sporting Goods, Raises Price Target to $294", "summary": "", "symbols": ["DKS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42883487/td-cowen-maintains-buy-on-dicks-sporting-goods-raises-price-target-to-294", "tags": ["analyst_other", "price_target_up"]}
{"id": 42883513, "time": "2025-01-08 14:00:13", "headline": "The Analyst Verdict: Beacon Roofing Supply In The Eyes Of 7 Experts", "summary": " ", "symbols": ["BECN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42883513/the-analyst-verdict-beacon-roofing-supply-in-the-eyes-of-7-experts", "tags": []}
{"id": 42883516, "time": "2025-01-08 14:00:22", "headline": "A Glimpse Into The Expert Outlook On Workday Through 14 Analysts", "summary": " ", "symbols": ["WDAY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42883516/a-glimpse-into-the-expert-outlook-on-workday-through-14-analysts", "tags": ["guidance"]}
{"id": 42883517, "time": "2025-01-08 14:00:28", "headline": "TD Cowen Maintains Buy on On Holding, Raises Price Target to $66", "summary": "", "symbols": ["ONON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42883517/td-cowen-maintains-buy-on-on-holding-raises-price-target-to-66", "tags": ["analyst_other", "price_target_up"]}
{"id": 42883518, "time": "2025-01-08 14:00:31", "headline": "Demystifying Kennametal: Insights From 5 Analyst Reviews", "summary": " ", "symbols": ["KMT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42883518/demystifying-kennametal-insights-from-5-analyst-reviews", "tags": []}
{"id": 42883519, "time": "2025-01-08 14:00:39", "headline": "Wall Street Bullish on Nvidia Following Advanced AI Development Announcement at CES 2025", "summary": "Wall Street analysts upgraded Nvidia (NVDA) after CES 2025. CEO Jensen Huang envisions a future of advanced AI, requiring massive data centers.", "symbols": ["NVDA"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/25/01/42883519/nvidias-push-into-advanced-ai-and-data-centers-fuels-analyst-optimism", "tags": ["analyst_up", "management"]}
{"id": 42883520, "time": "2025-01-08 14:00:41", "headline": "What 5 Analyst Ratings Have To Say About Canadian Solar", "summary": " ", "symbols": ["CSIQ"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42883520/what-5-analyst-ratings-have-to-say-about-canadian-solar", "tags": []}
{"id": 42883521, "time": "2025-01-08 14:00:45", "headline": "JPMorgan Chase Unusual Options Activity For January 08", "summary": " ", "symbols": ["JPM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/01/42883521/jpmorgan-chase-unusual-options-activity-for-january-08", "tags": []}
{"id": 42883524, "time": "2025-01-08 14:00:50", "headline": "Assessing AbbVie: Insights From 17 Financial Analysts", "summary": " ", "symbols": ["ABBV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42883524/assessing-abbvie-insights-from-17-financial-analysts", "tags": []}
{"id": 42883538, "time": "2025-01-08 14:01:00", "headline": "Assessing Texas Roadhouse: Insights From 15 Financial Analysts", "summary": " ", "symbols": ["TXRH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42883538/assessing-texas-roadhouse-insights-from-15-financial-analysts", "tags": []}
{"id": 42883558, "time": "2025-01-08 14:01:57", "headline": "TD Cowen Maintains Buy on Skechers USA, Raises Price Target to $93", "summary": "", "symbols": ["SKX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42883558/td-cowen-maintains-buy-on-skechers-usa-raises-price-target-to-93", "tags": ["analyst_other", "price_target_up"]}
{"id": 42883571, "time": "2025-01-08 14:02:15", "headline": "FOMC Minutes: Fed's Participants Say Fed Was At Or Near Point To Slow Pace Of Easing; If Data Came In As Expected, Appropriate To Gradually Move Toward Neutral Policy Stance; Expected Inflation To Move Toward 2%, But Potential Trade And Immigration Policy Changes Could Slow Process; A Number Of Participants Incorporated 'Placeholder Assumptions' On Policy Changes Into Projections; Vast Majority Supported Lowering Rate Target By 25 Basis Points", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42883571/fomc-minutes-feds-participants-say-fed-was-at-or-near-point-to-slow-pace-of-easing-if-data-came-in-a", "tags": []}
{"id": 42883599, "time": "2025-01-08 14:03:45", "headline": "TD Cowen Maintains Hold on Ulta Beauty, Raises Price Target to $480", "summary": "", "symbols": ["ULTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42883599/td-cowen-maintains-hold-on-ulta-beauty-raises-price-target-to-480", "tags": ["analyst_other", "price_target_up"]}
{"id": 42883638, "time": "2025-01-08 14:05:24", "headline": "TD Cowen Maintains Buy on Baker Hughes, Lowers Price Target to $51", "summary": "", "symbols": ["BKR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42883638/td-cowen-maintains-buy-on-baker-hughes-lowers-price-target-to-51", "tags": ["analyst_other", "price_target_down"]}
{"id": 42883650, "time": "2025-01-08 14:06:10", "headline": "Stock Of The Day: Where Will The GE HealthCare Rally End?", "summary": "Shares of GE HealthCare Technologies are trading higher because of an upgrade. There has been resistance around $94.", "symbols": ["GEHC"], "source": "benzinga", "author": "Mark Putrino", "url": "https://www.benzinga.com/general/health-care/25/01/42883650/stock-of-the-day-where-will-the-ge-healthcare-rally-end", "tags": ["analyst_up"]}
{"id": 42883664, "time": "2025-01-08 14:06:57", "headline": "TD Cowen Maintains Hold on Liberty Energy, Lowers Price Target to $16", "summary": "", "symbols": ["LBRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42883664/td-cowen-maintains-hold-on-liberty-energy-lowers-price-target-to-16", "tags": ["analyst_other", "price_target_down"]}
{"id": 42883679, "time": "2025-01-08 14:07:38", "headline": "Galapagos Unveils 2025 Split To Accelerate Innovation, Sharpen Strategic Focus", "summary": "Galapagos NV plans to split into two entities by mid-2025, focusing on oncology cell therapy and innovative medicines, with \u20ac2.45 billion allocated to SpinCo&#39;s pipeline.", "symbols": ["GILD", "GLPG"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/25/01/42883679/galapagos-unveils-2025-split-to-accelerate-innovation-sharpen-strategic-focus", "tags": []}
{"id": 42882021, "time": "2025-01-08 12:48:07", "headline": "Major indexes are lower amid weakness in chip stocks.", "summary": "", "symbols": ["DIA", "IWM", "QQQ", "SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/01/42882021/major-indexes-are-lower-amid-weakness-in-chip-stocks", "tags": []}
{"id": 42883709, "time": "2025-01-08 14:09:05", "headline": "TD Cowen Maintains Hold on Oceaneering International, Raises Price Target to $27", "summary": "", "symbols": ["OII"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42883709/td-cowen-maintains-hold-on-oceaneering-international-raises-price-target-to-27", "tags": ["analyst_other", "price_target_up"]}
{"id": 42883747, "time": "2025-01-08 14:11:18", "headline": "Goldman Sachs Flags Weak Q4 Guidance For Exxon Amid Weak Upstream And Chemical Results", "summary": "Goldman Sachs analyst expresses views on Exxon Mobil&#39;s Q4 earnings expectations. The company projected impact on upstream earnings due to changes in oil and gas prices.", "symbols": ["VDE", "XLE", "XOM"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/25/01/42883747/goldman-sachs-cuts-exxon-mobils-q4-eps-forecast-cites-weakness-across-segments", "tags": ["earnings", "guidance"]}
{"id": 42883748, "time": "2025-01-08 14:11:24", "headline": "TD Cowen Maintains Hold on Transocean, Lowers Price Target to $5.5", "summary": "", "symbols": ["RIG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42883748/td-cowen-maintains-hold-on-transocean-lowers-price-target-to-5-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 42883782, "time": "2025-01-08 14:13:15", "headline": "TD Cowen Maintains Buy on Schlumberger, Lowers Price Target to $53", "summary": "", "symbols": ["SLB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42883782/td-cowen-maintains-buy-on-schlumberger-lowers-price-target-to-53", "tags": ["analyst_other", "price_target_down"]}
{"id": 42883808, "time": "2025-01-08 14:15:03", "headline": "DA Davidson Maintains Neutral on Apogee Enterprises, Lowers Price Target to $62", "summary": "", "symbols": ["APOG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42883808/da-davidson-maintains-neutral-on-apogee-enterprises-lowers-price-target-to-62", "tags": ["analyst_other", "price_target_down"]}
{"id": 42883811, "time": "2025-01-08 14:15:16", "headline": "(UPS) - Analyzing United Parcel Service's Short Interest", "summary": " ", "symbols": ["UPS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/01/42883811/ups-analyzing-united-parcel-services-short-interest", "tags": []}
{"id": 42883812, "time": "2025-01-08 14:15:21", "headline": "Peering Into Essential Props Realty's Recent Short Interest", "summary": " ", "symbols": ["EPRT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/01/42883812/peering-into-essential-props-realtys-recent-short-interest", "tags": []}
{"id": 42883813, "time": "2025-01-08 14:15:26", "headline": "How Is The Market Feeling About Pinterest?", "summary": " ", "symbols": ["PINS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/01/42883813/how-is-the-market-feeling-about-pinterest", "tags": []}
{"id": 42883933, "time": "2025-01-08 14:20:42", "headline": "USDA Says 15 Additional States Onboard With National Milk Testing Strategy For H5N1; Not Imminently Implementing Vaccination For H5N1 In Animals; Intends Soon To Move Forward With Contract For Currently Licensed Vaccine For H5N1 In Animals To Establish A Stockpile; At Least 7 Candidates Approved For Field Safety Trials For Vaccine Candidates To Protect Dairy Cows From H5N1", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42883933/usda-says-15-additional-states-onboard-with-national-milk-testing-strategy-for-h5n1-not-imminently-i", "tags": ["contract"]}
{"id": 42883991, "time": "2025-01-08 14:21:42", "headline": "Gordon Haskett Upgrades Shake Shack to Buy, Announces $154 Price Target", "summary": "", "symbols": ["SHAK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42883991/gordon-haskett-upgrades-shake-shack-to-buy-announces-154-price-target", "tags": ["analyst_up"]}
{"id": 42884076, "time": "2025-01-08 14:23:17", "headline": "Gordon Haskett Upgrades BJ's Restaurants to Hold, Announces $36 Price Target", "summary": "", "symbols": ["BJRI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42884076/gordon-haskett-upgrades-bjs-restaurants-to-hold-announces-36-price-target", "tags": ["analyst_up"]}
{"id": 42884098, "time": "2025-01-08 14:24:40", "headline": "Gordon Haskett Downgrades Texas Roadhouse to Hold, Announces $192 Price Target", "summary": "", "symbols": ["TXRH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42884098/gordon-haskett-downgrades-texas-roadhouse-to-hold-announces-192-price-target", "tags": ["analyst_down"]}
{"id": 42884119, "time": "2025-01-08 14:26:47", "headline": "Guggenheim Initiates Coverage On Primoris Services with Buy Rating, Announces Price Target of $102", "summary": "", "symbols": ["PRIM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42884119/guggenheim-initiates-coverage-on-primoris-services-with-buy-rating-announces-price-target-of-102", "tags": ["analyst_init"]}
{"id": 42884120, "time": "2025-01-08 14:26:50", "headline": "Is The Bitcoin Top In? 75% Chance, Says Prominent Trader, But There's A Caveat", "summary": "Bitcoin\u2019s sudden course reversal from $102,000 to $95,000 has kickstarted a discussion among cryptocurrency traders and analysts about whether the Bitcoin (CRYPTO: BTC) ", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/25/01/42884120/is-the-bitcoin-top-in-75-chance-says-prominent-trader-but-theres-a-caveat", "tags": []}
{"id": 42884171, "time": "2025-01-08 14:29:06", "headline": "Guggenheim Initiates Coverage On Quanta Services with Neutral Rating", "summary": "", "symbols": ["PWR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42884171/guggenheim-initiates-coverage-on-quanta-services-with-neutral-rating", "tags": ["analyst_init"]}
{"id": 42884221, "time": "2025-01-08 14:31:07", "headline": "Behind the Scenes of Cisco Systems's Latest Options Trends", "summary": " ", "symbols": ["CSCO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/01/42884221/behind-the-scenes-of-cisco-systemss-latest-options-trends", "tags": []}
{"id": 42884222, "time": "2025-01-08 14:31:09", "headline": "Guggenheim Initiates Coverage On MasTec with Buy Rating, Announces Price Target of $195", "summary": "", "symbols": ["MTZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42884222/guggenheim-initiates-coverage-on-mastec-with-buy-rating-announces-price-target-of-195", "tags": ["analyst_init"]}
{"id": 42884223, "time": "2025-01-08 14:31:13", "headline": "Market Whales and Their Recent Bets on CVS Options", "summary": " ", "symbols": ["CVS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/01/42884223/market-whales-and-their-recent-bets-on-cvs-options", "tags": []}
{"id": 42884245, "time": "2025-01-08 14:32:07", "headline": "Alger Launches Russell Innovation ETF To Capitalize On Emerging Innovators", "summary": "Alger launched its INVN ETF, with holdings including BioMarin, Teradata, and Bristol-Myers Squibb.", "symbols": ["BMRN", "BMY", "FRTY", "INVN", "TDC"], "source": "benzinga", "author": "Chandrima Sanyal", "url": "https://www.benzinga.com/etfs/new-etfs/25/01/42884245/alger-launches-russell-innovation-etf-to-capitalize-on-emerging-innovators", "tags": []}
{"id": 42884252, "time": "2025-01-08 14:32:22", "headline": "Guggenheim Maintains Buy on Warner Music Gr, Lowers Price Target to $40", "summary": "", "symbols": ["WMG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42884252/guggenheim-maintains-buy-on-warner-music-gr-lowers-price-target-to-40", "tags": ["analyst_other", "price_target_down"]}
{"id": 42884303, "time": "2025-01-08 14:34:08", "headline": "Fed Minutes Reveal Inflation Jitters, Policymakers Signal Slower Interest Rate Easing Path Ahead", "summary": "Fed cautious on inflation and interest rates, with policymakers divided on future adjustments and uncertainty about Trump&#39;s policies.", "symbols": ["SPY", "UUP"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/news/econ-s/25/01/42884303/fed-minutes-reveal-inflation-jitters-policymakers-signal-slower-interest-rate-easing-path-ahead", "tags": []}
{"id": 42884312, "time": "2025-01-08 14:34:41", "headline": "Guggenheim Maintains Buy on SpringWorks Therapeutics, Lowers Price Target to $78", "summary": "", "symbols": ["SWTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42884312/guggenheim-maintains-buy-on-springworks-therapeutics-lowers-price-target-to-78", "tags": ["analyst_other", "price_target_down"]}
{"id": 42884351, "time": "2025-01-08 14:37:54", "headline": "Jefferies Maintains Buy on AppLovin, Raises Price Target to $425", "summary": "", "symbols": ["APP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42884351/jefferies-maintains-buy-on-applovin-raises-price-target-to-425", "tags": ["analyst_other", "price_target_up"]}
{"id": 42884375, "time": "2025-01-08 14:40:16", "headline": "Jefferies Initiates Coverage On MDU Resources Gr with Hold Rating, Announces Price Target of $18", "summary": "", "symbols": ["MDU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42884375/jefferies-initiates-coverage-on-mdu-resources-gr-with-hold-rating-announces-price-target-of-18", "tags": ["analyst_init"]}
{"id": 42884401, "time": "2025-01-08 14:44:10", "headline": "JP Morgan Maintains Neutral on American Eagle Outfitters, Lowers Price Target to $20", "summary": "", "symbols": ["AEO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42884401/jp-morgan-maintains-neutral-on-american-eagle-outfitters-lowers-price-target-to-20", "tags": ["analyst_other", "price_target_down"]}
{"id": 42884416, "time": "2025-01-08 14:45:15", "headline": "Looking Into SharkNinja's Recent Short Interest", "summary": " ", "symbols": ["SN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/01/42884416/looking-into-sharkninjas-recent-short-interest", "tags": []}
{"id": 42884420, "time": "2025-01-08 14:45:22", "headline": "How Is The Market Feeling About Candel Therapeutics?", "summary": " ", "symbols": ["CADL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/01/42884420/how-is-the-market-feeling-about-candel-therapeutics", "tags": []}
{"id": 42884422, "time": "2025-01-08 14:45:21", "headline": "JP Morgan Maintains Overweight on Boot Barn Holdings, Raises Price Target to $188", "summary": "", "symbols": ["BOOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42884422/jp-morgan-maintains-overweight-on-boot-barn-holdings-raises-price-target-to-188", "tags": ["analyst_other", "price_target_up"]}
{"id": 42884425, "time": "2025-01-08 14:45:26", "headline": "Looking Into American Intl Gr's Recent Short Interest", "summary": " ", "symbols": ["AIG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/01/42884425/looking-into-american-intl-grs-recent-short-interest", "tags": []}
{"id": 42884467, "time": "2025-01-08 14:47:18", "headline": "JP Morgan Maintains Underweight on Five Below, Lowers Price Target to $107", "summary": "", "symbols": ["FIVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42884467/jp-morgan-maintains-underweight-on-five-below-lowers-price-target-to-107", "tags": ["analyst_other", "price_target_down"]}
{"id": 42884503, "time": "2025-01-08 14:49:17", "headline": "JP Morgan Maintains Neutral on Urban Outfitters, Raises Price Target to $54", "summary": "", "symbols": ["URBN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42884503/jp-morgan-maintains-neutral-on-urban-outfitters-raises-price-target-to-54", "tags": ["analyst_other", "price_target_up"]}
{"id": 42884538, "time": "2025-01-08 14:51:03", "headline": "JP Morgan Maintains Overweight on Macy's, Lowers Price Target to $20", "summary": "", "symbols": ["M"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42884538/jp-morgan-maintains-overweight-on-macys-lowers-price-target-to-20", "tags": ["analyst_other", "price_target_down"]}
{"id": 42884581, "time": "2025-01-08 14:52:07", "headline": "JP Morgan Maintains Overweight on Lululemon Athletica, Raises Price Target to $428", "summary": "", "symbols": ["LULU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42884581/jp-morgan-maintains-overweight-on-lululemon-athletica-raises-price-target-to-428", "tags": ["analyst_other", "price_target_up"]}
{"id": 42884587, "time": "2025-01-08 14:53:01", "headline": "JP Morgan Maintains Neutral on RPM Intl, Lowers Price Target to $124", "summary": "", "symbols": ["RPM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42884587/jp-morgan-maintains-neutral-on-rpm-intl-lowers-price-target-to-124", "tags": ["analyst_other", "price_target_down"]}
{"id": 42884604, "time": "2025-01-08 14:53:59", "headline": "Analyst Predicts Strong Earnings For Brokers Amid Solid Retail Engagement: Virtu Financial, Robinhood, And BlackRock Under The Spotlight", "summary": "BofA Securities analyst predicts strong earnings for brokers like Virtu Financial, Robinhood, and BlackRock, driven by retail engagement and market conditions.", "symbols": ["BLK", "COIN", "HOOD", "VIRT"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/25/01/42884604/analyst-predicts-strong-earnings-for-brokers-amid-solid-retail-engagement-virtu-financial-robinhood-and-blackrock-under-the-spotlight", "tags": ["earnings"]}
{"id": 42884722, "time": "2025-01-08 15:00:15", "headline": "The Analyst Verdict: Lithia Motors In The Eyes Of 8 Experts", "summary": " ", "symbols": ["LAD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42884722/the-analyst-verdict-lithia-motors-in-the-eyes-of-8-experts", "tags": []}
{"id": 42884723, "time": "2025-01-08 15:00:21", "headline": "Here's How Much $100 Invested In Microsoft 5 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["MSFT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/01/42884723/heres-how-much-100-invested-in-microsoft-5-years-ago-would-be-worth-today", "tags": []}
{"id": 42884724, "time": "2025-01-08 15:00:23", "headline": "Where JELD-WEN Holding Stands With Analysts", "summary": " ", "symbols": ["JELD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42884724/where-jeld-wen-holding-stands-with-analysts", "tags": []}
{"id": 42884729, "time": "2025-01-08 15:00:37", "headline": "Where Boot Barn Holdings Stands With Analysts", "summary": " ", "symbols": ["BOOT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42884729/where-boot-barn-holdings-stands-with-analysts", "tags": []}
{"id": 42884733, "time": "2025-01-08 15:00:45", "headline": "Breaking Down MercadoLibre: 10 Analysts Share Their Views", "summary": " ", "symbols": ["MELI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42884733/breaking-down-mercadolibre-10-analysts-share-their-views", "tags": []}
{"id": 42884735, "time": "2025-01-08 15:00:52", "headline": "What 7 Analyst Ratings Have To Say About Skechers USA", "summary": " ", "symbols": ["SKX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42884735/what-7-analyst-ratings-have-to-say-about-skechers-usa", "tags": []}
{"id": 42884743, "time": "2025-01-08 15:01:01", "headline": "Deep Dive Into Phreesia Stock: Analyst Perspectives (5 Ratings)", "summary": " ", "symbols": ["PHR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42884743/deep-dive-into-phreesia-stock-analyst-perspectives-5-ratings", "tags": []}
{"id": 42884764, "time": "2025-01-08 15:01:46", "headline": "How Trump Could Impact China's Role In Emerging Greenland Mining Frontier", "summary": "Trump&#39;s interest in acquiring Greenland sparks renewed global competition for its resources. China and Biden administration also eyeing it.", "symbols": [], "source": "benzinga", "author": "Stjepan Kalinic", "url": "https://www.benzinga.com/news/global/25/01/42884764/how-trump-could-impact-chinas-role-in-emerging-greenland-mining-frontier", "tags": ["merger"]}
{"id": 42884823, "time": "2025-01-08 15:04:16", "headline": "Quantum Corp Says The Co's Senior Lenders Recently Exercised Previously Issued Warrants To Purchase Shares Of Quantum's Common Stock; These Transactions Had Been Incorrectly Reported By Certain News Outlets As A Disposition Of Shares. Co Wants Reiterate That The Associated Parties Are Currently Restricted From Selling Common Stock As A Result Of The Co's Quarterly And Financial Results Calendar", "summary": "", "symbols": ["QMCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42884823/quantum-corp-says-the-cos-senior-lenders-recently-exercised-previously-issued-warrants-to-purchase-s", "tags": ["analyst_other"]}
{"id": 42884862, "time": "2025-01-08 15:07:17", "headline": "SoundHound AI Shares Are Falling Today: What's Going On?", "summary": "SoundHound AI Inc.&#39;s (NASDAQ: SOUN) shares are trading lower today potentially from continued momentum due to sector-wide challenges. ", "symbols": ["NVDA", "SOUN"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/25/01/42884862/soundhound-ai-shares-are-falling-today-whats-going-on", "tags": ["why_moving"]}
{"id": 42884929, "time": "2025-01-08 15:14:45", "headline": "Goldman Sachs Raises Spotify's Forecast Ahead of Q4", "summary": "\nGoldman Sachs analyst maintained Buy on Spotify stock, raising price target to $550 from $490 and previewing industry data and financial implications of creator economy offerings for 2025.", "symbols": ["SPOT"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/25/01/42884929/spotifys-creator-economy-expansion-and-rising-engagement-drive-analyst-optimism-ahead-of-q4-earnings", "tags": ["guidance"]}
{"id": 42884970, "time": "2025-01-08 15:16:08", "headline": "Silo Pharma Shares Are Surging Today: What's Going On?", "summary": "Silo Pharma Inc.&#39;s stock (NASDAQ: SILO) is on the the rise Wednesday following the company&#39;s announcement that it has been awarded a U.S. patent for its PTSD treatment titled &#34;Pharmacological Prophylactics Against Stress-Induced Affective Disorders in Females.&#34;", "symbols": ["SILO"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/25/01/42884970/silo-pharma-shares-are-surging-today-whats-going-on", "tags": ["why_moving", "contract"]}
{"id": 42884993, "time": "2025-01-08 15:17:55", "headline": "Keybanc Upgrades Health Catalyst to Overweight, Announces $9 Price Target", "summary": "", "symbols": ["HCAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42884993/keybanc-upgrades-health-catalyst-to-overweight-announces-9-price-target", "tags": ["analyst_up"]}
{"id": 42885004, "time": "2025-01-08 15:19:36", "headline": "Keybanc Upgrades Winnebago Industries to Overweight, Announces $58 Price Target", "summary": "", "symbols": ["WGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42885004/keybanc-upgrades-winnebago-industries-to-overweight-announces-58-price-target", "tags": ["analyst_up"]}
{"id": 42885028, "time": "2025-01-08 15:20:09", "headline": "Gary Gensler Says 10,000-15,000 Projects Won't Survive, Crypto Market Is 'Wrapped Up In Sentiment'", "summary": "SEC Chair Gensler warns of highly speculative nature of crypto, says majority of projects won&#39;t survive. Role is to protect public from fraud.", "symbols": [], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/25/01/42885028/gary-gensler-says-10000-15000-projects-wont-survive-crypto-market-is-wrapped-up-in-sentiment", "tags": []}
{"id": 42885081, "time": "2025-01-08 15:21:56", "headline": "Keybanc Downgrades Polaris to Sector Weight", "summary": "", "symbols": ["PII"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42885081/keybanc-downgrades-polaris-to-sector-weight", "tags": ["analyst_down"]}
{"id": 42885145, "time": "2025-01-08 15:25:15", "headline": "$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["HON"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/01/42885145/100-invested-in-this-stock-20-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 42884959, "time": "2025-01-08 15:15:27", "headline": "Detroit Lions Take Bite Out Of Sportsbooks: Analyst Advises Patience After Flutter Cuts Guidance", "summary": "The Detroit Lions and other NFL betting favorites hurt revenue and profits for sportsbooks. Here&#39;s what one analyst says could happen next.", "symbols": ["FLUT"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/general/sports/25/01/42884959/detroit-lions-take-a-bite-out-of-sportsbooks-analyst-advises-patience-after-flutter-cuts-guidance", "tags": ["earnings", "guidance"]}
{"id": 42885158, "time": "2025-01-08 15:25:42", "headline": "Keybanc Maintains Overweight on AbCellera Biologics, Lowers Price Target to $4", "summary": "", "symbols": ["ABCL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42885158/keybanc-maintains-overweight-on-abcellera-biologics-lowers-price-target-to-4", "tags": ["analyst_other", "price_target_down"]}
{"id": 42885177, "time": "2025-01-08 15:26:39", "headline": "Keybanc Maintains Overweight on Absci, Lowers Price Target to $5", "summary": "", "symbols": ["ABSI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42885177/keybanc-maintains-overweight-on-absci-lowers-price-target-to-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 42885189, "time": "2025-01-08 15:27:59", "headline": "Keybanc Maintains Overweight on AECOM, Lowers Price Target to $121", "summary": "", "symbols": ["ACM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42885189/keybanc-maintains-overweight-on-aecom-lowers-price-target-to-121", "tags": ["analyst_other", "price_target_down"]}
{"id": 42883730, "time": "2025-01-08 15:28:03", "headline": "Solid Biosciences Outpaces Competitors In Duchenne Gene Therapy Development (CORRECTED)", "summary": "Solid Biosciences advances gene therapies for muscular and cardiac diseases, gaining FDA clearance for SGT-212 and targeting key 2025 milestones.", "symbols": ["NVS", "SLDB", "SRPT"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/25/01/42883730/solid-biosciences-outpaces-competitors-in-duchenne-gene-therapy-development", "tags": ["fda"]}
{"id": 42885203, "time": "2025-01-08 15:29:38", "headline": "Keybanc Maintains Overweight on Doximity, Lowers Price Target to $65", "summary": "", "symbols": ["DOCS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42885203/keybanc-maintains-overweight-on-doximity-lowers-price-target-to-65", "tags": ["analyst_other", "price_target_down"]}
{"id": 42885237, "time": "2025-01-08 15:30:22", "headline": "Price Over Earnings Overview: Capital One Finl", "summary": " ", "symbols": ["COF"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/01/42885237/price-over-earnings-overview-capital-one-finl", "tags": ["earnings"]}
{"id": 42885262, "time": "2025-01-08 15:31:04", "headline": "Keybanc Maintains Overweight on Dycom Industries, Raises Price Target to $229", "summary": "", "symbols": ["DY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42885262/keybanc-maintains-overweight-on-dycom-industries-raises-price-target-to-229", "tags": ["analyst_other", "price_target_up"]}
{"id": 42885286, "time": "2025-01-08 15:32:27", "headline": "Keybanc Maintains Overweight on Fluor, Raises Price Target to $60", "summary": "", "symbols": ["FLR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42885286/keybanc-maintains-overweight-on-fluor-raises-price-target-to-60", "tags": ["analyst_other", "price_target_up"]}
{"id": 42885288, "time": "2025-01-08 15:32:29", "headline": "'Medicare Can Now Cover Eli Lilly's Zepbound For Sleep Apnea, CMS Says' - CNBC", "summary": "", "symbols": ["LLY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/01/42885288/medicare-can-now-cover-eli-lillys-zepbound-for-sleep-apnea-cms-says-cnbc", "tags": []}
{"id": 42885293, "time": "2025-01-08 15:33:56", "headline": "Keybanc Maintains Overweight on GoodRx Holdings, Lowers Price Target to $6", "summary": "", "symbols": ["GDRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42885293/keybanc-maintains-overweight-on-goodrx-holdings-lowers-price-target-to-6", "tags": ["analyst_other", "price_target_down"]}
{"id": 42885316, "time": "2025-01-08 15:35:50", "headline": "Keybanc Maintains Overweight on KBR, Lowers Price Target to $70", "summary": "", "symbols": ["KBR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42885316/keybanc-maintains-overweight-on-kbr-lowers-price-target-to-70", "tags": ["analyst_other", "price_target_down"]}
{"id": 42885328, "time": "2025-01-08 15:37:13", "headline": "Keybanc Maintains Overweight on LifeMD, Lowers Price Target to $7", "summary": "", "symbols": ["LFMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42885328/keybanc-maintains-overweight-on-lifemd-lowers-price-target-to-7", "tags": ["analyst_other", "price_target_down"]}
{"id": 42885350, "time": "2025-01-08 15:38:32", "headline": "Bitcoin, Ethereum, Dogecoin Lower 'Corrections Are Typically Short-Lived,' Trader Prefers Not Going To $89,000 To $90,000", "summary": "Cryptocurrency markets continued to slide lower on Wednesday.", "symbols": ["BTCUSD", "DOGEUSD", "ETHUSD", "RUNEUSD", "SHIBUSD", "SOLUSD", "XRPUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/25/01/42885350/bitcoin-ethereum-dogecoin-lower-corrections-are-typically-short-lived-trader-prefers-not-going-to-89000-to-90000", "tags": []}
{"id": 42885354, "time": "2025-01-08 15:38:42", "headline": "Keybanc Maintains Overweight on Malibu Boats, Lowers Price Target to $45", "summary": "", "symbols": ["MBUU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42885354/keybanc-maintains-overweight-on-malibu-boats-lowers-price-target-to-45", "tags": ["analyst_other", "price_target_down"]}
{"id": 42885399, "time": "2025-01-08 15:42:04", "headline": "22nd Century Group Shares Halted To The Upside; Stock Now Up 45.57%", "summary": "", "symbols": ["XXII"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/01/42885399/22nd-century-group-shares-halted-to-the-upside-stock-now-up-45-57", "tags": ["halt"]}
{"id": 42885400, "time": "2025-01-08 15:42:06", "headline": "Keybanc Maintains Overweight on MasTec, Raises Price Target to $168", "summary": "", "symbols": ["MTZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42885400/keybanc-maintains-overweight-on-mastec-raises-price-target-to-168", "tags": ["analyst_other", "price_target_up"]}
{"id": 42885436, "time": "2025-01-08 15:44:08", "headline": "Keybanc Maintains Overweight on ODDITY Tech, Raises Price Target to $52", "summary": "", "symbols": ["ODD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42885436/keybanc-maintains-overweight-on-oddity-tech-raises-price-target-to-52", "tags": ["analyst_other", "price_target_up"]}
{"id": 42885454, "time": "2025-01-08 15:45:14", "headline": "Looking Into Doximity's Recent Short Interest", "summary": " ", "symbols": ["DOCS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/01/42885454/looking-into-doximitys-recent-short-interest", "tags": []}
{"id": 42885455, "time": "2025-01-08 15:45:19", "headline": "How Is The Market Feeling About TransMedics Gr?", "summary": " ", "symbols": ["TMDX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/01/42885455/how-is-the-market-feeling-about-transmedics-gr", "tags": []}
{"id": 42885456, "time": "2025-01-08 15:45:24", "headline": "(BRO) - Analyzing Brown & Brown's Short Interest", "summary": " ", "symbols": ["BRO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/01/42885456/bro-analyzing-brown-browns-short-interest", "tags": []}
{"id": 42885477, "time": "2025-01-08 15:45:51", "headline": "Keybanc Maintains Overweight on OneWater Marine, Lowers Price Target to $22", "summary": "", "symbols": ["ONEW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42885477/keybanc-maintains-overweight-on-onewater-marine-lowers-price-target-to-22", "tags": ["analyst_other", "price_target_down"]}
{"id": 42885485, "time": "2025-01-08 15:45:58", "headline": "Options Corner: Trade The Ride, Not The Direction Of SoundHound AI", "summary": "While SoundHound AI&#39;s big drop may tempt value hunters, a potentially smarter proposition calls for a wager on rising volatility.", "symbols": ["NVDA", "SOUN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/movers/25/01/42885485/soundhound-ai-soun-stock-drop-trade-volatility", "tags": []}
{"id": 42885500, "time": "2025-01-08 15:46:47", "headline": "22nd Century Group Shares Resume Trade", "summary": "", "symbols": ["XXII"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/01/42885500/22nd-century-group-shares-resume-trade", "tags": []}
{"id": 42885519, "time": "2025-01-08 15:48:35", "headline": "Keybanc Maintains Overweight on Phreesia, Raises Price Target to $30", "summary": "", "symbols": ["PHR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42885519/keybanc-maintains-overweight-on-phreesia-raises-price-target-to-30", "tags": ["analyst_other", "price_target_up"]}
{"id": 42885558, "time": "2025-01-08 15:50:34", "headline": "Keybanc Maintains Overweight on Parsons, Lowers Price Target to $102", "summary": "", "symbols": ["PSN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42885558/keybanc-maintains-overweight-on-parsons-lowers-price-target-to-102", "tags": ["analyst_other", "price_target_down"]}
{"id": 42885626, "time": "2025-01-08 15:52:39", "headline": "Keybanc Maintains Overweight on Recursion Pharmaceuticals, Lowers Price Target to $10", "summary": "", "symbols": ["RXRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42885626/keybanc-maintains-overweight-on-recursion-pharmaceuticals-lowers-price-target-to-10", "tags": ["analyst_other", "price_target_down"]}
{"id": 42885632, "time": "2025-01-08 15:53:39", "headline": "Benzinga Market Summary: S&P Is Slightly Higher, Fed Releases Meeting Minutes, Gold And Silver Rise On Macro Uncertainty", "summary": "", "symbols": ["GLD", "SLV", "SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/01/42885632/benzinga-market-summary-s-p-is-slightly-higher-fed-releases-meeting-minutes-gold-", "tags": []}
{"id": 42885636, "time": "2025-01-08 15:54:29", "headline": "Keybanc Maintains Overweight on Simulations Plus, Lowers Price Target to $35", "summary": "", "symbols": ["SLP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42885636/keybanc-maintains-overweight-on-simulations-plus-lowers-price-target-to-35", "tags": ["analyst_other", "price_target_down"]}
{"id": 42885660, "time": "2025-01-08 15:56:25", "headline": "Keybanc Maintains Overweight on Veeva Systems, Lowers Price Target to $255", "summary": "", "symbols": ["VEEV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42885660/keybanc-maintains-overweight-on-veeva-systems-lowers-price-target-to-255", "tags": ["analyst_other", "price_target_down"]}
{"id": 42885671, "time": "2025-01-08 15:57:56", "headline": "Keybanc Maintains Underweight on YETI Holdings, Lowers Price Target to $35", "summary": "", "symbols": ["YETI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42885671/keybanc-maintains-underweight-on-yeti-holdings-lowers-price-target-to-35", "tags": ["analyst_other", "price_target_down"]}
{"id": 42885711, "time": "2025-01-08 16:00:12", "headline": "A Glimpse Into The Expert Outlook On Allegion Through 5 Analysts", "summary": " ", "symbols": ["ALLE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42885711/a-glimpse-into-the-expert-outlook-on-allegion-through-5-analysts", "tags": ["guidance"]}
{"id": 42885716, "time": "2025-01-08 16:00:15", "headline": "Here's How Much You Would Have Made Owning Canadian Pacific Kansas Stock In The Last 15 Years", "summary": " ", "symbols": ["CP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/01/42885716/heres-how-much-you-would-have-made-owning-canadian-pacific-kansas-stock-in-the-last-15-years", "tags": []}
{"id": 42885719, "time": "2025-01-08 16:00:21", "headline": "What Analysts Are Saying About Vital Farms Stock", "summary": " ", "symbols": ["VITL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42885719/what-analysts-are-saying-about-vital-farms-stock", "tags": []}
{"id": 42885721, "time": "2025-01-08 16:00:31", "headline": "Deep Dive Into Generac Hldgs Stock: Analyst Perspectives (12 Ratings)", "summary": " ", "symbols": ["GNRC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42885721/deep-dive-into-generac-hldgs-stock-analyst-perspectives-12-ratings", "tags": []}
{"id": 42885722, "time": "2025-01-08 16:00:39", "headline": "Analyst Expectations For Reddit's Future", "summary": " ", "symbols": ["RDDT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42885722/analyst-expectations-for-reddits-future", "tags": []}
{"id": 42885723, "time": "2025-01-08 16:00:41", "headline": "Everspin Technologies Appoints William Cooper As CFO, Effective January 6, 2025", "summary": "", "symbols": ["MRAM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42885723/everspin-technologies-appoints-william-cooper-as-cfo-effective-january-6-2025", "tags": ["management"]}
{"id": 42885725, "time": "2025-01-08 16:00:47", "headline": "What 4 Analyst Ratings Have To Say About RPM Intl", "summary": " ", "symbols": ["RPM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42885725/what-4-analyst-ratings-have-to-say-about-rpm-intl", "tags": []}
{"id": 42885763, "time": "2025-01-08 16:00:55", "headline": "Assessing GoodRx Holdings: Insights From 4 Financial Analysts", "summary": " ", "symbols": ["GDRX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42885763/assessing-goodrx-holdings-insights-from-4-financial-analysts", "tags": []}
{"id": 42885882, "time": "2025-01-08 16:02:06", "headline": "Calidi Biotherapeutics Announces Public Offering, Size Not Disclosed", "summary": "", "symbols": ["CLDI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42885882/calidi-biotherapeutics-announces-public-offering-size-not-disclosed", "tags": ["offering"]}
{"id": 42885898, "time": "2025-01-08 16:02:25", "headline": "Scholar Rock Highlights Upcoming Priorities For 2025; Says BLA And MAA Submission For Apitegromab In SMA On Track For Q1", "summary": "", "symbols": ["SRRK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42885898/scholar-rock-highlights-upcoming-priorities-for-2025-says-bla-and-maa-submission-for-apitegromab-in", "tags": []}
{"id": 42885935, "time": "2025-01-08 16:03:44", "headline": "Pure Cycle Q1 EPS $0.16 Up From $0.09 YoY; Revenue $5.8M Up From $5.4M YoY", "summary": "", "symbols": ["PCYO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/01/42885935/pure-cycle-q1-eps-0-16-up-from-0-09-yoy-revenue-5-8m-up-from-5-4m-yoy", "tags": ["earnings"]}
{"id": 42885960, "time": "2025-01-08 16:04:05", "headline": "SEI And Attivo Investments Today Announced A Strategic Partnership,  Leveraging SEI's Co-CIO Solution To Deliver Cutting-Edge, Scalable, And Efficient Investment Services Tailored To Advisers And Their Clients", "summary": "", "symbols": ["SEIC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42885960/sei-and-attivo-investments-today-announced-a-strategic-partnership-leveraging-seis-co-cio-solution-t", "tags": ["contract"]}
{"id": 42885977, "time": "2025-01-08 16:04:40", "headline": "OTR Global Downgrades iQIYI to Negative", "summary": "", "symbols": ["IQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42885977/otr-global-downgrades-iqiyi-to-negative", "tags": ["analyst_down"]}
{"id": 42886079, "time": "2025-01-08 16:05:59", "headline": "The Honest Company Announces CFO Dave Loretta's Planned Retirement In 2025 And Initiates Search For Successor", "summary": "", "symbols": ["HNST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42886079/the-honest-company-announces-cfo-dave-lorettas-planned-retirement-in-2025-and-initiates-search-for-s", "tags": ["management"]}
{"id": 42886080, "time": "2025-01-08 16:06:06", "headline": "Penguin Solutions Q1 2025 Adj EPS $0.49 Beats $0.39 Estimate, Sales $341.10M Beat $320.75M Estimate", "summary": "", "symbols": ["PENG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/01/42886080/penguin-solutions-q1-2025-adj-eps-0-49-beats-0-39-estimate-sales-341-10m-beat-320-75m-estimate", "tags": ["earnings"]}
{"id": 42886081, "time": "2025-01-08 16:06:07", "headline": "12 Industrials Stocks Moving In Wednesday's Pre-Market Session", "summary": " ", "symbols": ["AIR", "AREB", "BAER", "EFSH", "EHGO", "HTCO", "MYNA", "PSHG", "SES", "SGBX", "SPPL", "TYGO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/01/42886081/12-industrials-stocks-moving-in-wednesdays-pre-market-session", "tags": ["why_moving"]}
{"id": 42886087, "time": "2025-01-08 16:06:12", "headline": "12 Health Care Stocks Moving In Wednesday's Pre-Market Session", "summary": " ", "symbols": ["ABSI", "ACCD", "CDT", "DRIO", "HOTH", "JSPR", "MBOT", "QSI", "RCEL", "SANA", "SILO", "VIR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/01/42886087/12-health-care-stocks-moving-in-wednesdays-pre-market-session", "tags": ["why_moving"]}
{"id": 42886088, "time": "2025-01-08 16:06:16", "headline": "Zymeworks Expects $324M Cash Resources, Plus $25M Milestone, To Fund Operations Into 2H-2027", "summary": "", "symbols": ["ZYME"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42886088/zymeworks-expects-324m-cash-resources-plus-25m-milestone-to-fund-operations-into-2h-2027", "tags": []}
{"id": 42886089, "time": "2025-01-08 16:06:17", "headline": "12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session", "summary": " ", "symbols": ["ALUR", "CATO", "EBAY", "FEBO", "NAMI", "RIME", "SPGC", "SRM", "SVMH", "TKLF", "UFI", "XPOF"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/01/42886089/12-consumer-discretionary-stocks-moving-in-wednesdays-pre-market-session", "tags": ["why_moving"]}
{"id": 42886091, "time": "2025-01-08 16:06:22", "headline": "10 Information Technology Stocks Moving In Wednesday's Pre-Market Session", "summary": " ", "symbols": ["AIRG", "AMPG", "DATS", "DOMO", "QBTS", "QUBT", "RGTI", "SATX", "VRME", "XTIA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/01/42886091/10-information-technology-stocks-moving-in-wednesdays-pre-market-session", "tags": ["why_moving"]}
{"id": 42886101, "time": "2025-01-08 16:06:27", "headline": "'No Rate Cuts In Q1 2025,' Strategist Says After Fed's December Minutes", "summary": "Minutes from the Federal Reserve&#39;s December meeting released on Wednesday show officials are uncertain on the path of future rate cuts as President-elect Donald Trump&#39;s policies and how they could affect inflation remains unknown. ", "symbols": ["QQQ", "SPY"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/25/01/42886101/investors-should-expect-no-rate-cuts-in-q1-2025-after-federal-reserves-december-minutes-release-strategist-says", "tags": []}
{"id": 42886154, "time": "2025-01-08 16:07:23", "headline": "Franklin Covey Q1 2025 GAAP EPS $0.09 Misses $0.15 Estimate, Sales $69.10M Miss $70.15M Estimate", "summary": "", "symbols": ["FC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/01/42886154/franklin-covey-q1-2025-gaap-eps-0-09-misses-0-15-estimate-sales-69-10m-miss-70-15m-estimate", "tags": ["earnings"]}
{"id": 42886166, "time": "2025-01-08 16:07:44", "headline": "NeuroPace Sees Prelim. Q4 Revenue $21M-$21.5M vs $20.909M, Sees Prelim. 2024 Revenue $79.4M-$79.9M vs $79.183M Est.", "summary": "", "symbols": ["NPCE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42886166/neuropace-sees-prelim-q4-revenue-21m-21-5m-vs-20-909m-sees-prelim-2024-revenue-79-4m-79-9m-vs-79-183", "tags": ["earnings"]}
{"id": 42885877, "time": "2025-01-08 16:01:52", "headline": "'Liberty Media Taps Sports Veteran Derek Chang As CEO, Seeks to Grow Formula One' - WSJ", "summary": "", "symbols": ["FWONA", "FWONK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42885877/liberty-media-taps-sports-veteran-as-ceo-seeks-to-grow-formula-one-wsj", "tags": ["management"]}
{"id": 42886174, "time": "2025-01-08 16:08:24", "headline": "DBV Technologies Announces  3-Year Results from EPITOPE Phase 3 Open-Label Extension Study; Data Provided Support That Continued Treatment With VIASKIN Peanut Showed Improveemntn Through 36 Months Of Treatment Across All Efficacy Parameters", "summary": "", "symbols": ["DBVT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/01/42886174/dbv-technologies-announces-3-year-results-from-epitope-phase-3-open-label-extension-study-data-pr", "tags": ["fda"]}
{"id": 42886178, "time": "2025-01-08 16:08:41", "headline": "RBC Capital Upgrades Canadian Imperial Bank to Outperform, Raises Price Target to C$103", "summary": "", "symbols": ["TSX:CM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42886178/rbc-capital-upgrades-canadian-imperial-bank-to-outperform-raises-price-target-to-c-103", "tags": ["analyst_up", "price_target_up"]}
{"id": 42886179, "time": "2025-01-08 16:08:42", "headline": "Dyne Therapeutics To Release New Clinical Data From Phase 1/2 ACHIEVE Trial On January 10, 2025; Investor Conference Call And Webcast Scheduled For 8:00 AM ET", "summary": "", "symbols": ["DYN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42886179/dyne-therapeutics-to-release-new-clinical-data-from-phase-12-achieve-trial-on-january-10-2025-invest", "tags": ["fda"]}
{"id": 42886183, "time": "2025-01-08 16:08:53", "headline": "Contineum Therapeutics Completes Enrollment In Phase 2 PIPE-307 VISTA Trial For The Treatment Of Relapsing-Remitting Multiple Sclerosis; The Last Patient Is Expected To Complete The Trial In Q3 2025", "summary": "", "symbols": ["CTNM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/01/42886183/contineum-therapeutics-completes-enrollment-in-phase-2-pipe-307-vista-trial-for-the-treatment-of-", "tags": ["fda"]}
{"id": 42886196, "time": "2025-01-08 16:09:58", "headline": "Penguin Solutions Affirms FY25 Outlook; EPS At $1.30 - $1.70 (Est $1.67), Net Sales Growth At 15% YoY +/- 5%", "summary": "", "symbols": ["PENG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42886196/penguin-solutions-affirms-fy25-outlook-eps-at-1-30-1-70-est-1-67-net-sales-growth-at-15-yoy-5", "tags": ["earnings", "guidance"]}
{"id": 42886250, "time": "2025-01-08 16:10:49", "headline": "RBC Capital Upgrades Bank of Montreal to Outperform, Raises Price Target to C$161", "summary": "", "symbols": ["TSX:BMO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42886250/rbc-capital-upgrades-bank-of-montreal-to-outperform-raises-price-target-to-c-161", "tags": ["analyst_up", "price_target_up"]}
{"id": 42886259, "time": "2025-01-08 16:10:53", "headline": "Siyata Mobile Delays Press Conference Originally Set For January 9, 2025 To Focus On Key Deal; Receives Order For 2,000 SD7 Handsets From Transit Authority, Delivery Expected Q1 2025", "summary": "", "symbols": ["SYTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42886259/siyata-mobile-delays-press-conference-originally-set-for-january-9-2025-to-focus-on-key-deal-receive", "tags": ["contract"]}
{"id": 42886274, "time": "2025-01-08 16:11:14", "headline": "Saratoga Investment Q3 2025 Adj EPS $0.90 Misses $0.94 Estimate, Sales $35.88M Beat $35.26M Estimate", "summary": "", "symbols": ["SAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/01/42886274/saratoga-investment-q3-2025-adj-eps-0-90-misses-0-94-estimate-sales-35-88m-beat-35-26m-estimate", "tags": ["earnings"]}
{"id": 42886290, "time": "2025-01-08 16:11:35", "headline": "Maravai LifeSciences Expects To Report Total 2024 Revenue Near The Mid-point Of Prior Guidance Range Of $255M - $265M, Est $259.773M", "summary": "", "symbols": ["MRVI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42886290/maravai-lifesciences-expects-to-report-total-2024-revenue-near-the-mid-point-of-prior-guidance-range", "tags": ["earnings", "guidance"]}
{"id": 42885897, "time": "2025-01-08 16:02:23", "headline": "Pricesmart Q1 GAAP EPS $1.21 Misses $1.31 Estimate, Sales $1.26B Beat $1.24B Estimate", "summary": "", "symbols": ["PSMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/01/42885897/pricesmart-q1-adj-1-21-misses-1-31-estimate-sales-1-26b-beat-1-24b-estimate", "tags": ["earnings"]}
{"id": 42886312, "time": "2025-01-08 16:12:23", "headline": "Everest Group Announces Leadership Transition; Appoints Jim Williamson Acting Chief Executive Officer; President And CEO Juan C. Andrade Departs Company", "summary": "", "symbols": ["EG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42886312/everest-group-announces-leadership-transition-appoints-jim-williamson-acting-chief-executive-officer", "tags": ["management"]}
{"id": 42886332, "time": "2025-01-08 16:13:22", "headline": "Adicet Bio Highlights Key 2025 Milestones Following 2024 Progress", "summary": "", "symbols": ["ACET"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42886332/adicet-bio-highlights-key-2025-milestones-following-2024-progress", "tags": []}
{"id": 42886340, "time": "2025-01-08 16:13:56", "headline": "Redburn Atlantic Initiates Coverage On RELX with Buy Rating", "summary": "", "symbols": ["RELX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42886340/redburn-atlantic-initiates-coverage-on-relx-with-buy-rating", "tags": ["analyst_init"]}
{"id": 42886353, "time": "2025-01-08 16:14:57", "headline": "Vigil Neuroscience Plans To Report Data From Phase 1 VG-3927 Trial For AD In Q1 2025; Final Analysis Of IGNITE Phase 2 Iluzanebart Trial For ALSP In Q2 2025; Pursues Accelerated Approval; Strategy Involves Exploring New Neurodegenerative Disease Targets", "summary": "", "symbols": ["VIGL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/01/42886353/vigil-neuroscience-plans-to-report-data-from-phase-1-vg-3927-trial-for-ad-in-q1-2025-final-analys", "tags": ["fda"]}
{"id": 42886379, "time": "2025-01-08 16:15:09", "headline": "Earnings Breakdown: Saratoga Investment Q3", "summary": " ", "symbols": ["SAR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/01/42886379/earnings-breakdown-saratoga-investment-q3", "tags": ["earnings"]}
{"id": 42886380, "time": "2025-01-08 16:15:14", "headline": "Earnings Breakdown: Franklin Covey Q1", "summary": " ", "symbols": ["FC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/01/42886380/earnings-breakdown-franklin-covey-q1", "tags": ["earnings"]}
{"id": 42886381, "time": "2025-01-08 16:15:14", "headline": "Here's How Much You Would Have Made Owning Tyler Technologies Stock In The Last 20 Years", "summary": " ", "symbols": ["TYL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/01/42886381/heres-how-much-you-would-have-made-owning-tyler-technologies-stock-in-the-last-20-years", "tags": []}
{"id": 42886449, "time": "2025-01-08 16:16:06", "headline": "Jefferies Financial Gr Q4 2024 GAAP EPS $0.93 Beats $0.91 Estimate, Sales $1.957B Beat $1.775B Estimate", "summary": "", "symbols": ["JEF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/01/42886449/jefferies-financial-gr-q4-2024-gaap-eps-0-93-beats-0-91-estimate-sales-1-957b-beat-1-775b-estimate", "tags": ["earnings"]}
{"id": 42886459, "time": "2025-01-08 16:16:14", "headline": "Costco Wholesale Reports Net Sales Of $27.52B For Retail Month Of December, Up 9.9% From $25.03B Last Year", "summary": "", "symbols": ["COST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42886459/costco-wholesale-reports-net-sales-of-27-52b-for-retail-month-of-december-up-9-9-from-25-03b-last-ye", "tags": []}
{"id": 42886495, "time": "2025-01-08 16:17:19", "headline": "Citigroup Upgrades Carvana to Buy, Raises Price Target to $277", "summary": "", "symbols": ["CVNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42886495/citigroup-upgrades-carvana-to-buy-raises-price-target-to-277", "tags": ["analyst_up", "price_target_up"]}
{"id": 42886502, "time": "2025-01-08 16:17:46", "headline": "Avadel Pharmaceuticals Sees Prelim. Q4 Revenue ~$50.0M Vs $52.312M Est.", "summary": "", "symbols": ["AVDL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42886502/avadel-pharmaceuticals-sees-prelim-q4-revenue-50-0m-vs-52-312m-est", "tags": ["earnings"]}
{"id": 42886506, "time": "2025-01-08 16:18:07", "headline": "Costco Wholesale December Comparable Sales Up 7.4%; Comp Sales, Excluding Impacts From Changes In Gasoline Prices And Foreign Exchange, Up 9.9%", "summary": "", "symbols": ["COST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42886506/costco-wholesale-december-comparable-sales-up-7-4-comp-sales-excluding-impacts-from-changes-in-gasol", "tags": []}
{"id": 42886519, "time": "2025-01-08 16:18:46", "headline": "Greenbrier Companies Q1 2025 GAAP EPS $1.72 Beats $1.16 Estimate, Sales $876.00M Beat $849.50M Estimate", "summary": "", "symbols": ["GBX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/01/42886519/greenbrier-companies-q1-2025-gaap-eps-1-72-beats-1-16-estimate-sales-876-00m-beat-849-50m-estimate", "tags": ["earnings"]}
{"id": 42886520, "time": "2025-01-08 16:18:46", "headline": "Avadel Pharmaceuticals Sees FY25 Net Product Revenue $240M-$260M Vs $291.526M Est.", "summary": "", "symbols": ["AVDL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42886520/avadel-pharmaceuticals-sees-fy25-net-product-revenue-240m-260m-vs-291-526m-est", "tags": ["earnings"]}
{"id": 42886521, "time": "2025-01-08 16:18:47", "headline": "Citigroup Maintains Buy on Coupang, Lowers Price Target to $28", "summary": "", "symbols": ["CPNG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42886521/citigroup-maintains-buy-on-coupang-lowers-price-target-to-28", "tags": ["analyst_other", "price_target_down"]}
{"id": 42886535, "time": "2025-01-08 16:19:39", "headline": "CNBC: Disney Announces 157M Ad-Supported Monthly Active Users Across Streaming Services", "summary": "", "symbols": ["DIS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42886535/cnbc-disney-announces-157m-ad-supported-monthly-active-users-across-streaming-services", "tags": []}
{"id": 42886540, "time": "2025-01-08 16:20:06", "headline": "Earnings Summary: Pricesmart Q1", "summary": " ", "symbols": ["PSMT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/01/42886540/earnings-summary-pricesmart-q1", "tags": ["earnings"]}
{"id": 42886541, "time": "2025-01-08 16:20:11", "headline": "Earnings Breakdown: Penguin Solutions Q1", "summary": " ", "symbols": ["PENG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/01/42886541/earnings-breakdown-penguin-solutions-q1", "tags": ["earnings"]}
{"id": 42886542, "time": "2025-01-08 16:20:15", "headline": "Greenbrier Sees FY25 Revenue $3.35B-$3.65B Vs $3.544B Est.", "summary": "", "symbols": ["GBX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42886542/greenbrier-sees-fy25-revenue-3-35b-3-65b-vs-3-544b-est", "tags": ["earnings"]}
{"id": 42886641, "time": "2025-01-08 16:21:09", "headline": "Jefferies Quarterly Investment Banking Net Revenues $987M, Up 73% YoY", "summary": "", "symbols": ["JEF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/01/42886641/jefferies-quarterly-investment-banking-net-revenues-987m-up-73-yoy", "tags": []}
{"id": 42886644, "time": "2025-01-08 16:21:40", "headline": "ScanTech AI Systems Charts Growth Path Following Successful De-SPAC Transaction; Shares Spike Higher", "summary": "", "symbols": ["STAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/01/42886644/scantech-ai-systems-charts-growth-path-following-successful-de-spac-transaction-shares-spike-higher", "tags": []}
{"id": 42886726, "time": "2025-01-08 16:22:50", "headline": "Greenbrier Renews $100M Share Repurchase Authorization Through January 31, 2027", "summary": "", "symbols": ["GBX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42886726/greenbrier-renews-100m-share-repurchase-authorization-through-january-31-2027", "tags": ["buyback"]}
{"id": 42886739, "time": "2025-01-08 16:23:33", "headline": "Citigroup Initiates Coverage On West Pharmaceutical Servs with Buy Rating, Announces Price Target of $400", "summary": "", "symbols": ["WST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42886739/citigroup-initiates-coverage-on-west-pharmaceutical-servs-with-buy-rating-announces-price-target-of", "tags": ["analyst_init"]}
{"id": 42886740, "time": "2025-01-08 16:23:35", "headline": "Vanda Pharmaceuticals Pens Letter To FDA Commissioner Regarding Approval For Tradipitant For Treatment Of Patients With Gastroparesis", "summary": "", "symbols": ["VNDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/01/42886740/vanda-pharmaceuticals-pens-letter-to-fda-commissioner-regarding-approval-for-tradipitant-for-trea", "tags": ["fda"]}
{"id": 42886746, "time": "2025-01-08 16:24:02", "headline": "Global Medical REIT Announces Succession Plan; CEO Transition Expected In 2025; Jeffrey Busch To Remain On Board Of Directors As Non-Executive Chairman; Lori Wittman Appointed Lead Independent Director Effective January 1, 2025", "summary": "", "symbols": ["GMRE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42886746/global-medical-reit-announces-succession-plan-ceo-transition-expected-in-2025-jeffrey-busch-to-remai", "tags": ["management"]}
{"id": 42886488, "time": "2025-01-08 16:17:08", "headline": "Jefferies Increases Quarterly Dividend From $0.35 To $0.40 Per Share", "summary": "", "symbols": ["JEF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42886488/jefferies-increases-quarterly-dividend-by-14-3-to-0-40share", "tags": ["dividend"]}
{"id": 42886821, "time": "2025-01-08 16:26:36", "headline": "Sealsq Shares Are Falling Today: What's Going On?", "summary": "Sealsq Corp.&#39;s stock is trading lower Wednesday as the broader quantum computing sector declined sharply following remarks by Nvidia CEO Jensen Huang.", "symbols": ["IONQ", "LAES", "QBTS", "RGTI"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/trading-ideas/movers/25/01/42886821/sealsq-shares-are-falling-today-whats-going-on", "tags": ["why_moving", "management"]}
{"id": 42886823, "time": "2025-01-08 16:26:43", "headline": "Horizon Technology Finance Originates $59.1M in Q4 Loans, Ends 2024 with $206.5M Backlog", "summary": "", "symbols": ["HRZN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42886823/horizon-technology-finance-originates-59-1m-in-q4-loans-ends-2024-with-206-5m-backlog", "tags": []}
{"id": 42886870, "time": "2025-01-08 16:29:40", "headline": "Canaccord Genuity Downgrades Accolade to Hold", "summary": "", "symbols": ["ACCD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42886870/canaccord-genuity-downgrades-accolade-to-hold", "tags": ["analyst_down"]}
{"id": 42886898, "time": "2025-01-08 16:30:20", "headline": "$100 Invested In L3Harris Technologies 20 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["LHX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/01/42886898/100-invested-in-l3harris-technologies-20-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 42886962, "time": "2025-01-08 16:30:56", "headline": "Roku Shares Are On The Rise: What You Need To Know", "summary": "Roku shares are trading higher Wednesday after the company reported surpassing 90 million streaming households in the first week of January 2025.", "symbols": ["ROKU"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/general/entertainment/25/01/42886962/roku-shares-are-on-the-rise-what-you-need-to-know", "tags": ["why_moving"]}
{"id": 42887020, "time": "2025-01-08 16:32:04", "headline": "Wells Fargo Maintains Overweight on EQT, Raises Price Target to $53", "summary": "", "symbols": ["EQT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42887020/wells-fargo-maintains-overweight-on-eqt-raises-price-target-to-53", "tags": ["analyst_other", "price_target_up"]}
{"id": 42887030, "time": "2025-01-08 16:32:19", "headline": "Applied Dna Sciences Announced That It Has Rescheduled Its Investor Update Call To Thursday, February 13, 2025", "summary": "", "symbols": ["APDN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42887030/applied-dna-sciences-announced-that-it-has-rescheduled-its-investor-update-call-to-thursday-february", "tags": []}
{"id": 42887043, "time": "2025-01-08 16:33:01", "headline": "Wells Fargo Maintains Overweight on Verona Pharma, Raises Price Target to $74", "summary": "", "symbols": ["VRNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42887043/wells-fargo-maintains-overweight-on-verona-pharma-raises-price-target-to-74", "tags": ["analyst_other", "price_target_up"]}
{"id": 42887042, "time": "2025-01-08 16:33:07", "headline": "X CEO Linda Yaccarino Talks Free Speech, Elon Musk, And Advertising 'Holy Grail' At CES", "summary": "Linda Yaccarino praised the move by Meta and Mark Zuckerberg to copy X&#39;s Community Notes during her CES keynote.", "symbols": ["META"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/general/social-media/25/01/42887042/x-ceo-linda-yaccarino-talks-free-speech-elon-musk-and-advertising-holy-grail-at-ces", "tags": ["management"]}
{"id": 42887076, "time": "2025-01-08 16:34:11", "headline": "Globus Medical Reports Preliminary Q4 Sales $657M, Up 6.6% YoY; FY24 Sales $2.52B, Up 60.6% YoY; Sees 2025 Revenue $2.66B-$2.69B Vs $2.67B Est.; Non-GAAP EPS $3.40-$3.50 Vs $3.42 Est.", "summary": "", "symbols": ["GMED"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/01/42887076/globus-medical-reports-preliminary-q4-sales-657m-up-6-6-yoy-fy24-sales-2-52b-up-60-6-yoy-sees-2025-", "tags": ["earnings"]}
{"id": 42887092, "time": "2025-01-08 16:35:06", "headline": "Jefferies Financial Gr Earnings Analysis: Q4 Recap", "summary": " ", "symbols": ["JEF"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/01/42887092/jefferies-financial-gr-earnings-analysis-q4-recap", "tags": ["earnings"]}
{"id": 42887136, "time": "2025-01-08 16:36:44", "headline": "Wells Fargo Maintains Overweight on Flutter Entertainment, Lowers Price Target to $285", "summary": "", "symbols": ["FLUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42887136/wells-fargo-maintains-overweight-on-flutter-entertainment-lowers-price-target-to-285", "tags": ["analyst_other", "price_target_down"]}
{"id": 42887154, "time": "2025-01-08 16:37:16", "headline": "Sphere Entertainment Appoints Former Disney Executive Robert Langer As EVP, CFO, And Treasurer Effective January 13, 2025", "summary": "", "symbols": ["DIS", "SPHR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42887154/sphere-entertainment-appoints-former-disney-executive-robert-langer-as-evp-cfo-and-treasurer-effecti", "tags": ["management"]}
{"id": 42887183, "time": "2025-01-08 16:37:49", "headline": "Acurx Pharmaceuticals CEO David Luci Reported Purchase Of 98,522 Shares @ Avg Price Of $0.51/Share In Form 4 Filing", "summary": "", "symbols": ["ACXP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42887183/acurx-pharmaceuticals-ceo-david-luci-reported-purchase-of-98-522-shares-avg-price-of-0-51share-in-fo", "tags": ["insider", "management"]}
{"id": 42887207, "time": "2025-01-08 16:40:06", "headline": "Greenbrier Companies Q1 Earnings Assessment", "summary": " ", "symbols": ["GBX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/01/42887207/greenbrier-companies-q1-earnings-assessment", "tags": ["earnings"]}
{"id": 42887219, "time": "2025-01-08 16:40:26", "headline": "Penguin Solutions Stock Climbs On Strong Q1 Results: Details", "summary": "Penguin Solutions reported its first-quarter financial results after Wednesday&#39;s closing bell. Here&#39;s a look at the details.", "symbols": ["PENG"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/news/earnings/25/01/42887219/penguin-solutions-stock-climbs-on-strong-q1-results-details", "tags": ["earnings"]}
{"id": 42887292, "time": "2025-01-08 16:44:17", "headline": "D. Boral Capital Maintains Buy on New Horizon Aircraft, Maintains $2 Price Target", "summary": "", "symbols": ["HOVR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42887292/d-boral-capital-maintains-buy-on-new-horizon-aircraft-maintains-2-price-target", "tags": ["analyst_other"]}
{"id": 42887301, "time": "2025-01-08 16:45:13", "headline": "If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today", "summary": " ", "symbols": ["DELL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/01/42887301/if-you-invested-1000-in-this-stock-5-years-ago-you-would-have-this-much-today", "tags": []}
{"id": 42887358, "time": "2025-01-08 16:47:37", "headline": "Needham Downgrades Accolade to Hold", "summary": "", "symbols": ["ACCD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42887358/needham-downgrades-accolade-to-hold", "tags": ["analyst_down"]}
{"id": 42887423, "time": "2025-01-08 16:51:44", "headline": "Bloomberg: Biden to Further Limit Nvidia, AMD AI Chip Exports in Final Push", "summary": "", "symbols": ["AMD", "FXI", "NVDA", "SMH", "SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/01/42887423/bloomberg-biden-to-further-limit-nvidia-amd-ai-chip-exports-in-final-push", "tags": []}
{"id": 42887680, "time": "2025-01-08 17:00:10", "headline": "Here's How Much You Would Have Made Owning Alamos Gold Stock In The Last 5 Years", "summary": " ", "symbols": ["AGI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/01/42887680/heres-how-much-you-would-have-made-owning-alamos-gold-stock-in-the-last-5-years", "tags": []}
{"id": 42887683, "time": "2025-01-08 17:00:14", "headline": "Where Globe Life Stands With Analysts", "summary": " ", "symbols": ["GL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42887683/where-globe-life-stands-with-analysts", "tags": []}
{"id": 42887702, "time": "2025-01-08 17:00:25", "headline": "Beyond The Numbers: 8 Analysts Discuss Asure Software Stock", "summary": " ", "symbols": ["ASUR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42887702/beyond-the-numbers-8-analysts-discuss-asure-software-stock", "tags": []}
{"id": 42887704, "time": "2025-01-08 17:00:36", "headline": "Deep Dive Into Dick's Sporting Goods Stock: Analyst Perspectives (5 Ratings)", "summary": " ", "symbols": ["DKS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42887704/deep-dive-into-dicks-sporting-goods-stock-analyst-perspectives-5-ratings", "tags": []}
{"id": 42887711, "time": "2025-01-08 17:00:44", "headline": "Expert Outlook: Amer Sports Through The Eyes Of 21 Analysts", "summary": " ", "symbols": ["AS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42887711/expert-outlook-amer-sports-through-the-eyes-of-21-analysts", "tags": ["guidance"]}
{"id": 42887719, "time": "2025-01-08 17:00:51", "headline": "Breaking Down Leidos Holdings: 14 Analysts Share Their Views", "summary": " ", "symbols": ["LDOS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42887719/breaking-down-leidos-holdings-14-analysts-share-their-views", "tags": []}
{"id": 42887725, "time": "2025-01-08 17:00:57", "headline": "Jefferies Financial Group Reports Better-Than-Expected Q4 Results: EPS Beat, Net Revenues Up 73% Year-Over-Year", "summary": "Jefferies Financial Group reported its fourth-quarter financial results after Wednesday&#39;s closing bell. Here&#39;s a look at the key figures from the quarter.", "symbols": ["JEF"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/news/earnings/25/01/42887725/jefferies-financial-group-reports-better-than-expected-q4-results-eps-beat-net-revenues-up-73-year-over-year", "tags": ["earnings"]}
{"id": 42887727, "time": "2025-01-08 17:01:01", "headline": "Adobe Stock: A Deep Dive Into Analyst Perspectives (21 Ratings)", "summary": " ", "symbols": ["ADBE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/42887727/adobe-stock-a-deep-dive-into-analyst-perspectives-21-ratings", "tags": []}
{"id": 42887749, "time": "2025-01-08 17:01:36", "headline": "Alamos Gold Appoints Robert S. Prichard As Chair Of Board, Effective January 8, 2025", "summary": "", "symbols": ["AGI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42887749/alamos-gold-appoints-robert-s-prichard-as-chair-of-board-effective-january-8-2025", "tags": ["management"]}
{"id": 42887805, "time": "2025-01-08 17:03:45", "headline": "TCTM Kids IT Education Receives Written Notification From Nasdaq Regarding Minimum Bid Price", "summary": "", "symbols": ["TCTM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42887805/tctm-kids-it-education-receives-written-notification-from-nasdaq-regarding-minimum-bid-price", "tags": []}
{"id": 42887889, "time": "2025-01-08 17:08:25", "headline": "Concrete Pumping Holdings Q4 2024 GAAP EPS $0.16 Beats $0.15 Estimate, Sales $111.48M Beat $110.36M Estimate", "summary": "", "symbols": ["BBCP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/01/42887889/concrete-pumping-holdings-q4-2024-gaap-eps-0-16-beats-0-15-estimate-sales-111-48m-beat-110-36m-esti", "tags": ["earnings"]}
{"id": 42887911, "time": "2025-01-08 17:10:36", "headline": "Concrete Pumping Expects FY25 Revenue Of $425M - $445M, Est $416.58M", "summary": "", "symbols": ["BBCP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42887911/concrete-pumping-expects-fy25-revenue-of-425m-445m-est-416-58m", "tags": ["earnings"]}
{"id": 42887955, "time": "2025-01-08 17:12:12", "headline": "Kimco Realty Announces Acquisition Of The Markets At Town Center In Jacksonville, Florida For $108M", "summary": "", "symbols": ["KIM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/01/42887955/kimco-realty-announces-acquisition-of-the-markets-at-town-center-in-jacksonville-florida-for-108m", "tags": []}
{"id": 42887993, "time": "2025-01-08 17:15:12", "headline": "Here's How Much $100 Invested In RBC Bearings 10 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["RBC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/01/42887993/heres-how-much-100-invested-in-rbc-bearings-10-years-ago-would-be-worth-today", "tags": []}
{"id": 42888034, "time": "2025-01-08 17:17:03", "headline": "Air Products Board Urges Shareholders To Vote Shares 'For' Company's Nominees And Discard Any Blue Proxy Card Received From Mantle Ridge", "summary": "", "symbols": ["APD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42888034/air-products-board-urges-shareholders-to-vote-shares-for-companys-nominees-and-discard-any-blue-prox", "tags": []}
{"id": 42888046, "time": "2025-01-08 17:18:38", "headline": "Mint Incorporation Prices IPO Of 1.75M Class A Ordinary Shares At $4.00 Per Class A Ordinary Share", "summary": "", "symbols": [], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42888046/mint-incorporation-prices-ipo-of-1-75m-class-a-ordinary-shares-at-4-00-per-class-a-ordinary-share", "tags": []}
{"id": 42888095, "time": "2025-01-08 17:21:41", "headline": "Costco Stock Climbs After December Net Sales Up 9.9% Year-Over-Year", "summary": "Costco Wholesale shares are trading higher after the company released its December sales results.\u00a0Here&#39;s what to know.", "symbols": ["COST"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/news/retail-sales/25/01/42888095/costco-stock-climbs-after-december-net-sales-up-99-year-over-year", "tags": ["why_moving"]}
{"id": 42888242, "time": "2025-01-08 17:24:02", "headline": "Arhaus Raises FY24 Net Revenue Expectations From $1.23B - $$1.25B To $1.27B - $1.28B, Est $1.239B", "summary": "", "symbols": ["ARHS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42888242/arhaus-raises-fy24-net-revenue-expectations-from-1-23b-1-25b-to-1-27b-1-28b-est-1-239b", "tags": ["earnings"]}
{"id": 42888283, "time": "2025-01-08 17:26:08", "headline": "Arhaus Expects FY24 Comparable Growth To Decline Between (9%) - (8%) Vs. Prior Outlook For Decline Of (12%) - (11%)", "summary": "", "symbols": ["ARHS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42888283/arhaus-expects-fy24-comparable-growth-to-decline-between-9-8-vs-prior-outlook-for-decline-of-12-11", "tags": ["guidance"]}
{"id": 42888294, "time": "2025-01-08 17:27:17", "headline": "Arhaus Expects Q4 Net Revenue Of $343M - $353M, Est $344.008M", "summary": "", "symbols": ["ARHS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42888294/arhaus-expects-q4-net-revenue-of-343m-353m-est-344-008m", "tags": ["earnings"]}
{"id": 42888322, "time": "2025-01-08 17:30:22", "headline": "Here's How Much You Would Have Made Owning Walmart Stock In The Last 5 Years", "summary": " ", "symbols": ["WMT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/01/42888322/heres-how-much-you-would-have-made-owning-walmart-stock-in-the-last-5-years", "tags": []}
{"id": 42888323, "time": "2025-01-08 17:30:22", "headline": "Belpointe OZ Receives Letter From NYSE American Indicating Noncompliant With Continued Listing Standards; Adjourns Annual Meeting To January 28, 2025", "summary": "", "symbols": ["OZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42888323/belpointe-oz-receives-letter-from-nyse-american-indicating-noncompliant-with-continued-listing-stand", "tags": []}
{"id": 42888365, "time": "2025-01-08 17:32:00", "headline": "Harley-Davidson Promotes Jonathan Root To President, Commercial; Root To Continue To Serve As Company's CFO", "summary": "", "symbols": ["HOG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42888365/harley-davidson-promotes-jonathan-root-to-president-commercial-root-to-continue-to-serve-as-companys", "tags": ["management"]}
{"id": 42888373, "time": "2025-01-08 17:33:10", "headline": "Equinox Gold Reports Producing 213,960 Ounces Of Gold In Q4 And 621,870 Ounces In 2024", "summary": "", "symbols": ["EQX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/01/42888373/equinox-gold-reports-producing-213-960-ounces-of-gold-in-q4-and-621-870-ounces-in-2024", "tags": []}
{"id": 42888380, "time": "2025-01-08 17:35:51", "headline": "Los Angeles Fires Shut Down Production Of TV Shows 'Fallout,' 'Abbott Elementary,' 'Hacks'; Film Premieres Canceled, Critics Choice Awards Delayed", "summary": "TV shows, movie premieres and awards shows have been impacted by the fires in the Los Angeles area. A look at the list and what&#39;s next.", "symbols": ["AMZN", "CMCSA", "DIS", "PARA", "PARAA", "WBD"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/general/entertainment/25/01/42888380/los-angeles-fires-shut-down-production-of-tv-shows-fallout-abbott-elementary-hacks-film-premieres-canceled-critics-choice-awards-delayed", "tags": []}
{"id": 42888479, "time": "2025-01-08 17:45:17", "headline": "Here's How Much You Would Have Made Owning Cleanspark Stock In The Last 5 Years", "summary": " ", "symbols": ["CLSK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/01/42888479/heres-how-much-you-would-have-made-owning-cleanspark-stock-in-the-last-5-years", "tags": []}
{"id": 42888773, "time": "2025-01-08 18:00:32", "headline": "Here's How Much $1000 Invested In Ecolab 20 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["ECL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/01/42888773/heres-how-much-1000-invested-in-ecolab-20-years-ago-would-be-worth-today", "tags": []}
{"id": 42888800, "time": "2025-01-08 18:04:32", "headline": "Goldman Sachs Flags Market Correction Risk As Inflation, Trump Policies Stir Uncertainty", "summary": "Goldman Sachs warns of increased equity drawdown risks in 2025 due to rising inflation, trade tensions and political uncertainty under Trump&#39;s second term, recommending hedging strategies.", "symbols": ["DIA", "UUP"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/economics/macro-economic-events/25/01/42888800/goldman-sachs-flags-market-correction-risk-as-inflation-trump-policies-stir-uncertainty", "tags": []}
{"id": 42888858, "time": "2025-01-08 18:15:11", "headline": "If You Invested $1000 In This Stock 15 Years Ago, You Would Have This Much Today", "summary": " ", "symbols": ["MU"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/01/42888858/if-you-invested-1000-in-this-stock-15-years-ago-you-would-have-this-much-today", "tags": []}
{"id": 42889111, "time": "2025-01-08 18:30:11", "headline": "Here's How Much You Would Have Made Owning Advanced Micro Devices Stock In The Last 20 Years", "summary": " ", "symbols": ["AMD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/01/42889111/heres-how-much-you-would-have-made-owning-advanced-micro-devices-stock-in-the-last-20-years", "tags": []}
{"id": 42889194, "time": "2025-01-08 18:45:10", "headline": "Here's How Much You Would Have Made Owning Digital Realty Trust Stock In The Last 20 Years", "summary": " ", "symbols": ["DLR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/01/42889194/heres-how-much-you-would-have-made-owning-digital-realty-trust-stock-in-the-last-20-years", "tags": []}
{"id": 42889402, "time": "2025-01-08 19:05:40", "headline": "NHL Game Canceled After Los Angeles Fires, NFL Monitoring Situation Ahead Of Monday Playoff Game", "summary": "Fires in Los Angeles have postponed at least one major sporting event with more changes possible, including an NFL Playoff game.", "symbols": ["DIS"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/general/sports/25/01/42889402/nhl-game-canceled-after-los-angeles-fires-nfl-monitoring-situation-ahead-of-monday-playoff-game", "tags": []}
{"id": 42889488, "time": "2025-01-08 19:20:21", "headline": "Pentagon Dismisses Greenland Invasion Plans Following Trump's Comments: 'We're Concerned With The Real National Security Concerns'", "summary": "The Pentagon denies any plans to invade Greenland after Trump hinted at military action for the autonomous Danish territory.", "symbols": [], "source": "benzinga", "author": "Shivdeep Dhaliwal", "url": "https://www.benzinga.com/25/01/42889488/pentagon-dismisses-greenland-invasion-plans-following-trumps-comments-were-concerned-with-the-real-national-security-concerns", "tags": []}
{"id": 42889692, "time": "2025-01-08 19:50:04", "headline": "Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["XTIA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/01/42889692/trading-halt-halted-at-7-50-00-p-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 42890014, "time": "2025-01-08 20:41:13", "headline": "Jim Cramer Warns On 'Quantum Stories' As Stocks Plunge: 'We Need You Out Before The Froth Goes Away'", "summary": "Tech stocks faced steep declines Wednesday as prominent market commentator Jim Cramer warned investors about overvaluation in quantum computing and AI sectors, following earlier skepticism from NVIDIA Corp. CEO Jensen Huang about quantum technology&#39;s timeline.", "symbols": ["IONQ", "NVDA", "RGTI", "SOUN"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/markets/equities/25/01/42890014/jim-cramer-warns-on-quantum-stories-as-stocks-plunge-we-need-you-out-before-the-froth-goes-away", "tags": ["management"]}
{"id": 42890015, "time": "2025-01-08 20:41:19", "headline": "D-Wave Quantum, Costco, AMD, Roku, And Tesla: Why These 5 Stocks Are On Investors' Radars Today", "summary": "The US stock market experienced a mixed day on Wednesday, with the Dow Jones index rising around 0.25% to 42,635.20.", "symbols": ["AMD", "COST", "QBTS", "ROKU", "TSLA"], "source": "benzinga", "author": "Benzinga Neuro", "url": "https://www.benzinga.com/25/01/42890015/d-wave-quantum-costco-amd-roku-and-tesla-why-these-5-stocks-are-on-investors-radars-today", "tags": []}
{"id": 42890191, "time": "2025-01-08 21:08:56", "headline": "Trump-Themed NFTs Debut On Bitcoin Network \u2014 One Card Gets Listed At $1.9 Million", "summary": "President-elect Donald Trump launched his latest non-fungible token collection, titled \u201cTrump Bitcoin Digital Trading Cards,\u201d on the Bitcoin (CRYPTO: BTC) network on Wednesday.", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/25/01/42890191/trump-themed-nfts-launch-on-bitcoin-network-for-first-timeheres-what-you-should-know", "tags": []}
{"id": 42890464, "time": "2025-01-08 21:58:19", "headline": "SoftBank-Owned Arm Eyes Acquisition Of Oracle-Backed Chip Designer Ampere Computing Amid Nvidia's Dominance: Report", "summary": "Arm Holdings PLC is exploring the potential acquisition of semiconductor designer Ampere Computing LLC, signaling further consolidation in the artificial intelligence chip sector.", "symbols": ["ARM", "INTC", "NVDA", "ORCL", "QCOM", "SFTBY", "TSM"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/markets/equities/25/01/42890464/softbank-owned-arm-eyes-acquisition-of-oracle-backed-chip-designer-ampere-computing-amid-nvidias-dominance-report", "tags": []}
{"id": 42890512, "time": "2025-01-08 22:17:40", "headline": "Disney's Ad-Supported Streaming Reaches 157 Million Users Globally, 112 Million In US: Here's How It Compares With Netflix And Amazon Prime", "summary": "Disney&#39;s streaming platforms\u2014Disney+, Hulu, and ESPN+\u2014have reached 157 million global monthly ad-supported viewers, reflecting the company&#39;s significant progress in the ad-supported streaming market.", "symbols": ["AMZN", "DIS", "NFLX"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/25/01/42890512/disney-now-has-157-million-monthly-ad-supported-viewers-on-disney-hulu-and-espn-globally", "tags": []}
{"id": 42890642, "time": "2025-01-08 22:56:00", "headline": "Bitcoin, Ethereum, Dogecoin Drop After Fed Minutes Casts Shadow Over Interest Rate Cuts: Top Analyst Says BTC Must Claim $100K To Overcome Bearish Outlook", "summary": "Leading cryptocurrencies dropped further on Wednesday as Federal Reserve minutes painted a bearish outlook for risk-on assets.", "symbols": ["BTC", "BTCUSD", "DOGEUSD", "ETHUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/25/01/42890642/bitcoin-ethereum-dogecoin-drop-after-fed-minutes-cast-uncertainty-top-analyst-says-btc-must-claim-100k-to-invalidate-bearish-outlook", "tags": ["guidance"]}
{"id": 42890773, "time": "2025-01-08 23:51:08", "headline": "Ex-Google CEO Eric Schmidt Invests In 3D-Printed Rocket Maker As SpaceX-Led Space Race Heats Up", "summary": "Ex-Google CEO Eric Schmidt invests in Relativity Space, a 3D-printed rockets company facing fundraising difficulties.", "symbols": ["AAPL", "GOOG", "GOOGL"], "source": "benzinga", "author": "Pooja Rajkumari", "url": "https://www.benzinga.com/general/space/25/01/42890773/former-google-ceo-eric-schmidt-invests-in-3d-printed-rocket-maker-as-spacex-led-space-race-heats-up", "tags": ["management"]}
